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ABSTRACT
Toxoplasma gondii is an obligate intracellular parasite that can infect a broad range of hosts,
including mammals and birds. Felines, including wild and domestic cats, are the sole definitive
hosts that can discharge millions of parasites into the environment through their feces in the form
of oocysts. Due to the massive number of oocysts one cat can shed, and their highly infectious and
resistant nature, the environmental contamination by oocysts poses a serious public health concern.
Therefore, a better understanding of T. gondii transmission in the environment is essential. To this
end, we compiled and analyzed genotypic data from animals in North America across a proximity
gradient from human settlements to the wilderness (Chapter 2). We demonstrated that, T. gondii
genotype distribution was associated with the spatial habitat and host species, and that parasite
diversity decreased towards the human environment, suggesting the human impact on parasite
transmission. To better understand the environmental contamination by oocysts, we developed a
comprehensive protocol to evaluate the contamination by T. gondii on a typical farm in Tennessee
(Chapter 3). T. gondii oocyst contamination in both soil and animals was detected on the farm.
The results demonstrated that animals, especially meso-predators (such as raccoons and skunks),
were good indicators of T. gondii prevalence in the environment. Thirdly, to reduce the
environmental contamination, methods were tested to produce a potential cat vaccine in cell
culture (Chapter 5). Lower temperature (31

) was used to generate viable parasites of a vaccine

strain (T263) in cell culture. Thus far, laboratory tests have lent evidence of the partial success.
Lastly, we investigated 11 cases of fetal toxoplasmosis in captive macropods (kangaroos and
wallabies) that occurred between 2014-2018 in the Busch Gardens Zoo, Florida (Chapter 4).
Parasites were isolated and characterized using molecular methods. The results revealed over these
three years, three independent infection events occurred at the zoo, suggesting frequent
contamination by T. gondii of the zoo environment.
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CHAPTER 1
INTRODUCTION
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Toxoplasma gondii
Toxoplasma gondii is an obligate intracellular parasite that can infect a broad range of hosts. It has
been more than 100 years since its discovery in 1908 in rodent in France and in rabbit in Brazil
(Dubey, 2010). T. gondii belongs to Phylum Apicomplexa and genus Toxoplasma and is the only
species in the genus (Dubey, 2010). The medical significance of T. gondii was not recognized until
1939 when the parasite was found in the tissues of a congenitally-infected infant in New York,
USA (Wolf et al., 1939). Likewise, its veterinary significance was not appreciated until it was
found to be the culprit of abortion storms in sheep in Australia (Hartley and Marshall, 1957). Onethird of the global human population has been chronically infected (Dubey, 2010). Among
individuals older than six years in the U.S., 13.2% have been infected in a cross-nation survey in
2009 - 2010 (Jones et al., 2014). Infection in immunocompetent individuals generally induces no
or mild symptoms. However, recent studies have reported acute infection in immunocompetent
people, which demands intensive treatment. Toxoplasmosis can be life-threatening in immunocompromised individuals, such as HIV patients (Weiss et al., 2013). Likewise, in seronegative
women, exposure to T. gondii during pregnancy can cause congenital toxoplasmosis, devastating
the fetuses and neonates (Remington et al., 2006).

Life Cycle
The T. gondii life cycle was not revealed until 60 years after its discovery. In 1970, Frenkel, Dubey,
and Miller unraveled its complex life cycle mystery (Frenkel et al., 1970). Felids, including the
domestic cats (Felis domesticus), are the sole definitive hosts of T. gondii and thus play a pivotal
role in its transmission (Hunter et al., 2012) (Figure 1.1).
Like many protozoa, T. gondii switches between several distinct life stages in response to
its environment. Three stages are observed in T. gondii. Being the fast-growing stage, tachyzoite
propagates and disseminates rapidly in its host, which marks the acute infection. The bradyzoite
is the semi-dormant stage in which the parasite replicates slowly in tissue cysts. The sporozoites,
existing as oocysts, are the environmental form, which can be widely dispersed and are therefore
responsible for the efficient and extensive transmission of the parasite.
Cats can contract infection through eating any of the three stages of parasite: tachyzoites,
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bradyzoites, and oocysts. Upon infection, the sexual reproduction occurs in the intestinal epithelial
cells of the definitive hosts. Parasites excyst from tissue cysts or oocysts upon digestion by
proteolytic enzymes in cat stomach. In the intestinal epithelial cells, tachyzoites sequentially
develop into schizonts, merozoites, and gametes. Macrogametes are fertilized by microgametes to
form diploid zygots which are enclosed by oocyst walls, released into the intestinal lumen, and
ultimately excreted into the environment (Dubey, 2010). In most cases, a parasite can self-mate in
cat epithelial cells; however, in rare cases, when a cat eats prey that contains more than one strain
of T. gondii, a genetic cross can take place. Oocysts disseminate in the environment and
contaminate environmental matrices such as water, vegetables, fruits, and soils. Ingesting oocysts
accounts for the infection in intermediate hosts such as humans and livestock. Intermediate hosts
can also contract infection via transplacental/vertical transmission or by eating meat containing
tissue cysts. After a few days to months of acute infection, parasites retire into host tissues and
become semi-dormant, which marks the onset of the chronic disease. Bradyzoites in the form of
tissue cysts reside in host tissues, especially muscular and neural tissues, typically for the lifetime
of the hosts. The life cycle of T. gondii is completed when the definitive hosts (felids) eat the
parasites residing in the tissues of the intermediate hosts (Weiss and Kim, 2013).
Two geographically separated life cycles are known to exist in T. gondii transmission,
namely sylvatic and domestic life cycles. The two cycles have wild felids and domestic cats as
definitive hosts, respectively (Shwab et al., 2018) (Figure 1.2). Before the rise of agriculture
11,000 years ago, the sylvatic life cycles likely sustained T. gondii in the environment with wild
felids being the definitive hosts and other wild mammals and birds being the intermediate hosts
(Shwab et al., 2018). The prosperity of human society afforded by agriculture engendered the
flourish of house mice and domestic cats, both of which formed close commensal relationships
with humans. The stored grains from successful agriculture attracted mice, which in turn attracted
cats (Rosenthal, 2009). Consequently, the success of human civilization and animal husbandry
inadvertently established the domestic cycle of T. gondii.
As human society continues to expand and prosper, humans slowly encroach upon the
wildness. As a result, the boundary between the wild and domestic spheres became increasingly
obscure. The dwindling interspace between the wild and the anthropized environment increased
territory overlapping between wild and domestic animals (Taiz, 2013; Mcdonald et al., 2008). The
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modern-day T. gondii transmission had featured an unprecedented overlapping of the two cycles
(Pongsiri et al., 2009). Two major routes contribute to the transmission overlapping of the two life
cycles, namely through the environmentally widespread oocysts or through carnivorism in which
wild animals eat domestic animals and vice versa (Figure 1.2). Noteworthily, oocyst contamination
of water due to soil runoff has been suggested to be the culprit of sea mammal infection (Sundar
et al., 2008). The overlapping of two life cycles is clearly reflected in sea otter (VanWormer et al.,
2014) and coyote (Jiang et al., 2018), as the dominant genotypes in domestic and those in wild
animals were found to co-dominate in these animals.

Tachyzoites, Bradyzoites, and Oocysts
Tachyzoite and bradyzoite
A tachyzoite, a size of 2 × 6 µm, is crescent-shaped with a pointed anterior end and a rounded
posterior end (Dubey et al., 2010). A tachyzoite has a centrally located nucleus and many
organelles, including rhoptries, micronemes, amylopectins, dense granules, and apicoplasts
(Figure 1.3). Although tachyzoites have no visible locomotive structures such as cilia, flagella or
pseudopodia, it can slightly move its body, such as gliding, flexing or rotating. Tachyzoites can
invade any nucleated mammalian cell. Host cell invasion is a process involving protein secrection
and actin-based motility and is divided into seven steps in Figure 1.3. During the invasion,
microneme (MI) secrete proteins to engage in host cell attachment and motility, whereas the
rhoptry neck (RN) secreted a wide array of proteins (RONs) to form moving junction (MJ), and
rhopty bulb secretes other proteins (ROPs) to modify parasitophorous vacuoles (PVs) and
modulate host cell transcription (e.g., the phosphorylation of transcription factors by ROP16)
(Figure 1.3).
Once formed moving junction, the parasite invaginates the plasma membrane of host cell
and finally enters host cell. Once inside, parasite is enclosed by a parasitophorous vacuole
membrane (PVM) to sequester parasites from the host cytosol. In addition to not fusing with
lysosomes or becoming acidic, the PVs also recruits host mitochondria and ER which may help
parasite obtain nutrients. After a lag period, tachyzoites within PVs start to replicate asexually via
endodyogeny, in which two progenies form in a mother cell and gradually consume the mother
4

cell. A rosette (8 or 16 parasites) is formed in the case of synchronous cell division. The burgeoning
tachyzoites soon rupture the host cells and are ready for next round of invasion.
Under the pressure of host immune system, especially the IFN- γ -dependent cell-mediated
immune response, tachyzoites convert to bradyzoites six to seven days after infection (Dubey et
al., 1998). Bradyzoite, a size of 1.5 ×7 µm, are enclosed by tissue cyst walls and become semidormant. The cyst wall is formed through the protein modification of PVM, although the exact
composition of the cyst wall is unclear. Being non-immunogenic, the cysts reside in host tissues,
awaiting a chance for transmission. Without the active and systemic host immune defense, the in
vitro formation of bradyzoite/cysts was different from that of in vivo in many perspectives. In cell
culture, tachyzoite and bradyzoite can spontaneously interconvert (Bohne et al., 1993). However,
the conversion of tachyzoites to bradyzoites is not a synchronized event in vitro as one vacuole
can harbor parasites expressing tachyzoite-specific antigens and those expressing bradyzoitespecific antigens (Gross et al., 1996).
T. gondii cysts have a propensity for neural (central nervous system, the eyes) and muscular
tissues (skeletal muscles, cardiac muscles), although a broad spectrum of visceral organs can
harbor tissue cysts, including lung, liver, kidney, and bone marrow (Skariah et al., 2010). The size
of the tissue cysts varies from 5 µm to 100 µm with varying number of bradyzoites enclosed. A
tissue cyst can harbor as few as two bradyzoites in the case of a young tissue cyst and as many as
thousands of bradyzoites in the case of an old tissue cyst. However, tissue cysts do occasionally
rupture and release bradyzoites which can flourish and cause diseases in the case of immune
suppression. The reactivation of bradyzoites is especially noteworthy in AIDS patients and cancer
patients who undergo chemo and or radiation therapy (Weiss et al., 2013).
The stage interconversion
The interconversion between tachyzoites and bradyzoites is significant in chronic infection as well
as disease reactivation. Understanding the molecular basis of the interconversion can aid in the
identification of drug targets to clear bradyzoites in the chronic stage.
Tachyzoites differ from bradyzoites in many perspectives (Dubey et al., 1998). Although
both are crescent-shaped, tachyzoites are plump, while bradyzoites are slender. Ultrastructurally,
bradyzoites have electron dense rhoptries, higher content of micronemes and amylopectin
5

granules, posteriorly located nuclei as opposed to centrally located nuclei. Bradyzoites are more
resistant to pepsin or trypsin digestion. Furthermore, tachyzoite and bradyzoite express different
cell surface proteins.
A wide range of approaches have been employed for tachyzoite and bradyzoite
interconversion in vitro. It has been known that tachyzoite to bradyzoite conversion is a stressrelated phenomenon. The high temperature at 43 ℃, high (8.0-8.2) or low (6.6-6.8) pH, chemical
stress (i.e., Na arsenite) can result in the upregulation of bradyzoite-specific gene expression and
the shutting down of tachyzoite-specific gene expression (Soete et al., 1994). Nitric oxide (NO),
an inhibitor of mitochondrial function, was believed to be a potent differentiation inducer. IFN- γ
triggered bradyzoite-specific surface protein expression was partially attributed to the downstream
induction of NO (Bohne et al., 1994). Sodium nitroprusside, a NO donor, was capable of inducing
tachyzoite to bradyzoite differentiation in vitro (Bohne et al., 1994). The in vitro produced
bradyzoites proved to be pepsin resistant (Dubey et al., 1998; Popiel et al., 1996) and can orally
infect both mice (Fux et al., 2007) and cats (Hoff et al., 1977). The conversion from bradyzoite to
tachyzoite is triggered when the immunological factors (e.g., IFN- γ) or host immune defense,
especially T cell response, is lacking (Lyons et al., 2002). Prolonged in vitro propagation has
favored tachyzoite formation and decreased the efficiency of bradyzoite formation in some
avirulent strains of T. gondii (Weiss and Kim, 2011).
Tachyzoite and bradyzoite are antigenically distinct (Lyons et al., 2002), which can be
utilized for stage identification. Concerning surface proteins, tachyzoite expresses unique proteins
including SAG1/p30, SAG2A, and SAG2B, whereas bradyzoite expresses a different repertoire of
antigens including SAG4/p18, BSR4/p36, BAG1/hsp30, SAG2C, and SAG2D. BAG1 (bradyzoite
antigen 1) is homologous to a small heat shock protein in plants. BAG1 protein expression on the
bradyzoite surface is an early event of differentiation and thus is widely used as a differentiation
marker. Cells expressing BAG1 were seen after 24 hours of exposure to stress such as pH
8.1(Weiss and Kim, 2011). Deletion of BAG1 did not prevent cyst formation but only hindered
the efficiency of cyst formation (Bohne et al., 1998). Bradyzoites also express lactate
dehydrogenase 2 (LDH2), enolase 1(ENO 1), and matrix antigen 1(MAG1). In contrast,
tachyzoites express LDH1 and ENO2, and have no MAG1 expression. The formation of the cyst
wall and cyst matrix are unique to the bradyzoite stage. MAG1 was found in the cyst matrix and
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not on bradyzoite. A 116 kDa glycoprotein CST1 containing N-acetylgalactosamine on the cyst
wall was capable of binding to Dolichos biflorus lectin (DBL). In addition, the cyst wall can also
bind to succinylated wheat-germ agglutinin (S-WGA). Consequently, DBL or S-WGA can be used
to detect cyst wall formation in mature cysts.
The metabolism of bradyzoites and tachyzoites are also different. While both utilize
glycolytic pathways to obtain energy, tachyzoite also utilizes tricarboxylic acid (TCA) cycle and
respiratory chain, whereas bradyzoite lacks the TCA cycle and respiratory chain (Denton et al.,
1996). As a result, the enzymatic activity in each stage form is different. The activity of lactate
dehydrogenase (LDH) and pyruvate kinase is higher in bradyzoite (Denton et al., 1996).
Bradyzoite relies on breaking down amylopectin to lactate for energy and therefore resistant to
acidic pH. Due to their metabolic differences, antibiotics interfering metabolism can also induce
stage differentiation. Oligomycin, an inhibitor of mitochondrial ATP synthase, and antimycin A,
an inhibitor of the electron transport chain, were shown to induce bradyzoite formation (Tomavo
et al., 1995).
Considering the nature of tachyzoites and bradyzoites, reducing growth rate in some strains
can induce tachyzoite to bradyzoite conversion (Bohne et al., 1994). T. gondii strain differences
were seen in the variations of cyst size, number, and the efficiency of cyst formation. Strains with
a slower growth rate and less virulence are predisposed to produce cysts in vitro. Slow-growing
and less virulent strains such as ME49 tend to have a higher rate of bradyzoite formation than
virulent and fast-growing strains such as RH strain (Soete et al., 1994). Drugs (i.e., pyrimethamine)
and cytokines (i.e., IFN- γ) that can reduce the growth rate of the parasite can induce tachyzoite to
bradyzoite switch (Bohne et al., 1994).
The signaling pathway and molecular mechanism of interconversion are unknown.
However, as a stress-induced response, the common stress-related pathways in eukaryotes are
implicated. Cyclic nucleotide kinase is believed to partly mediate this interconversion (Eaton et
al., 2006). A study has determined that inhibition of cAMP-dependent kinase and cGMPdependent kinase reduced parasite replication and induced the differentiation (Eaton et al., 2006).
Parasite-specific eukaryotic initiation factor-2 (eIF2) kinase was also implicated in the
differentiation process (Sullivan et al., 2004). As protein chaperones and transcription regulators,
heat shock proteins (HSP) induced in stress response gain research interest in elucidating the
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conversion process. After induction at pH 8.1, T. gondii hsp70 was induced 3-4 folds more than
that of at pH 7.1, consistent with results seen in other Apicomplexans (Weiss et al., 1998; Shiels
et al., 1997). Likewise, inhibition of HSP synthesis using quercetin hindered in vitro bradyzoite
development (Weiss et al., 1998).
Oocyst
Upon being discharged into the environment, an oocyst requires one to five days to sporulate to
become mature. One oocyst contains two sporocysts each with four haploid sporozoites.
Sporulated oocyst, a size of 11 to 13 µm in diameter, is enclosed by a five-layer oocyst wall (Dubey
et al., 1998).
As the environmental form of the parasite, oocysts possess important features which
ensures parasite’s effective transmission. First, oocysts are large in number. The number of oocysts
one cat can shed ranges from 3 to 810 million during a median shedding period of eight days
(Dubey, 2010). In California, the annual average oocyst burden in soil ranges from 94 to 4671
oocysts per square meter (Dabritz et al., 2007). Oocysts have been proved to be highly hardy and
infectious. Oocysts can survive in the environment for a prolonged period. Outdoors (6℃-36℃),
oocysts in cat feces had survived for 46 days when the feces were uncovered, for 334 days when
they were covered (Dubey et al., 1998; Frenkel et al., 1975). Oocysts are also resistant to chemical
inactivation, including sodium hypochlorite and ozone (Dubey, 2010). However, oocysts can be
destroyed by desiccation, or high temperature (55℃ for 2 min or 60℃ for 1 min) (Dubey, 1998).
It has been revealed that oocyst-induced infection is more severe than bradyzoite-induced infection
(Dubey et al.,1988; Dubey et al., 1973; Dubey et al., 1997a and 1997b). Oocysts are more
infectious than bradyzoite in intermediate hosts. One oocyst can potentially induce infection in a
laboratory pig (Dubey et al., 1996) or mouse (Dubey, 2010). Recent studies demonstrated that
oocysts caused 78% of congenital infections in North America (Boyer et al., 2011), and 43% in
Southern Chile (Munoz-Zanzi et al., 2010).
Infectivity of tachyzoite, bradyzoite, and oocyst
Cats are more susceptible to bradyzoite infection as compared to tachyzoite or oocyst infection;
the reverse is true for mice. Although cats can shed oocysts after ingesting any stage of the parasite,
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the prepatent period (time from infection to shedding oocysts) varies (Dubey, 2010). The prepatent
period is 3 to 10 days with bradyzoite, but ≥19 days with tachyzoite, and ≥18 days in case of oocyst
(Dubey, 2010). Moreover, the dose of tachyzoite required for oocyst shedding in a cat is
approximately 100 times higher than that of bradyzoite (Weiss et al., 2011). Oral infection of as
few as one bradyzoite can induce oocyst shedding in 16.6% (3/18) of cats, whereas 1,000
bradyzoites can only orally infect 50% (12/24) of mice (Dubey, 2001). One oocyst can cause
disease in a mouse, whereas 100 oocysts could not induce oocyst shedding in a cat (Dubey, 2001
and 2006a). T. gondii is adapted to be transmitted in cats via bradyzoites, whereas via oocysts in
mice (Dubey, 2010).

Population Genetics
The genetic information of T. gondii strains from geographically distinct locations and a wide array
of host species have been unveiled owing to the advanced molecular techniques. Microsatellite
DNA analysis (Ajzenberg et al., 2002 and 2010), polymerase chain reaction-restriction fragment
length polymorphism analysis (PCR-RFLP) (Howe and Sibley, 1995; Su et al., 2006 and 2010),
and intron sequencing (Khan et al., 2007 and 2011) have been used to investigate the genetic
variation of T. gondii. Among these methods, PCR-RFLP is the most commonly employed and
has been used on thousands of T. gondii strains. Examining the PCR-RFLP data of 1457 samples
collected worldwide, Shwab et al. (2014) summarized the population genetic structure of T. gondii
on a global scale (Figure 1.4). Based on this article, the northern hemisphere is dominated by a
few clonal genotypes, whereas the population structure of the southern hemisphere is a mosaic of
numerous atypical genotypes without dominant genotypes (Figure 1.4). The details of this pattern
are outlined below.
The designation of T. gondii genotypes has been streamlined using ToxoDB PCR-RFLP
nomenclature in which genotype is numbered based on the order of discovery (Shwab et al., 2014).
Genotype #1, #2 and # 3 were found worldwide, which are also the dominant genotypes in Europe.
In North America, genotype #1, #2, # 3, # 4 and #5 are prevalent. In Africa, the dominant genotypes
are #2 and # 3. #9 and # 10 are prevalent in East Asia. No genotypes seemingly predominate in
Central and South America. In North America, type 12 is found to dominate in wildlife, whereas
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type II and type III are believed to dominate in domestic animals. It is unknown as to what factor(s)
contribute to this genotype partition.

T. gondii Infection in Humans and Animals
Infection in humans
T. gondii is evolutionarily successful, infecting virtually all warm-blooded animals. In addition to
its expansive host range, T. gondii is geographically ubiquitous, having been found on every
continent, including Antarctica (Dubey, 2010). Seroprevalence of the human population varies
from as low as 4% in Korea and as high as 92% in Brazil (Dubey, 2010). In the period 1999-2004,
US-born women 15-44 of age had lower seroprevalence (11%) than women of the same age group
who are foreign-born (28.1%) (Jones et al., 2007). Infection is higher in Latin America than in
North America and East Asia. Infection rates are lower in cold, dry or high latitude regions as
compared to warm or low latitude areas (Dubey, 2010). It has been shown that infection prevalence
is associated with cooking habit, hygiene, and frequency of soil contact (Stagno et al., 1980; Jones
et al., 2008). Incidence at large is declining in the last few decades in many countries (Aspöck et
al., 1992; Kortbeek et al., 2004). A serosurvey conducted in the U.S. revealed that the age-adjusted
T. gondii prevalence of US-born persons 12-49 years old decreased from 14.1% in 1988-1994 to
9% in 1999-2004 and 6.7% in 2009-2010 (Jones et al., 2014).
Infection in immunocompetent people is generally asymptomatic. In some cases, mild
symptoms, such as fever, malaise, and lymphadenopathy can develop. In rare cases, the infection
causes severe ocular toxoplasmosis (e.g., retinochoroiditis), multi-visceral toxoplasmosis or even
fatal outcomes. In the U.S., it has been estimated that 2% of the infections manifested as ocular
toxoplasmosis; this number is 17.7% in southern Brazil (Holland, 2003). The underlying reasons
for these severe cases in immunocompetent patients are elusive. Variabilities of host immunity,
parasite strain, and other factors have been suspected to be relevant. It appears that these severe
cases are often associated with highly virulent strains such as those found in South America
(Carme et al., 2002; Demar et al., 2007). Over 50 cases of human toxoplasmosis had been reported
in French Guiana since 1998; isolates from these patients were found to be atypical and highly
virulent in mice; forest-related activities including eating undercooked game meat were suspected
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to be the cause (Dardé et al., 1998; Carme et al., 2002; Demar et al., 2007). In Brazilian children,
in addition to the higher occurrence, the severity of congenital ocular toxoplasmosis is also higher
than that in Europe (Gilber et al., 2008). Two thirds of T. gondii isolated from citizens of the United
States belong to type I (highly virulent) or atypical genotypes (Grigg et al., 2001).
One of the recent research interests of T. gondii is linking T. gondii chronic infection with
the tendency of patients to take risks (Johnson et al., 2018), tendency for accidents (Flegr et al.,
2002), behavior impairments (Sugden et al., 2016), and mental disorder (Brown et al., 2005). In
immunocompromised patients, the reactivation of latent infection can be life-threatening.
Encephalitis resulting from intracerebral focal lesion and or pneumonia are the hallmarks of
toxoplasmosis in AIDS patients (Dubey et al., 1998).
Infection during pregnancy in previously uninfected women can lead to congenital
infection in fetus or neonates. The risk of congenital infection is lowest (10-15%) in the first
trimester; however, the potential damage is the most severe if infected (Dubey and Jones, 2008).
On the contrary, infection risk in the third trimester is the highest (60–90%), and the damage is
less severe if infected (Dubey and Jones, 2008). The manifestation of congenital infection varies
from spontaneous abortion, stillbirth to congenital disabilities in newborns (Remington et al.,
2006). Symptoms of congenital toxoplasmosis in neonates include hydrocephalus, microcephalus,
cerebral calcification and retinochoroiditis (Remington et al., 2006). Some children may be healthy
at birth but could develop visual or neurological sequels (e.g., learning disability) later in life
(McLeod et al., 2006).
Infection in animals associated with human households (cats, rodents, pigs, chickens, cattle,
sheep, and goats)
Cats
As the definitive hosts, domestic cats are of utmost importance in the study of epidemiology and
transmission of T. gondii. Studies showed that T. gondii infection is scarce or lacking in areas
without cats (Dubey, 1997c; Munday et al., 1972; Wallace et al., 1969). Cats, historically used by
humans to protect stored grains from rodents, have long ago formed a commensal relationship with
humans dating back approximately 9,000 years (Driscoll et al., 2007). Today, one-third of
households in the United States own cats. It has been estimated that there are 78 million domestic
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cats and 73 million feral cats in the U.S. (Dubey, 2010).
Cats are also common on farms. A 1999 study demonstrated that a mean of 8.5 cats was
present on each pig farm in Illinois, of which six were seropositive for T. gondii (Weigel et al.,
1999). An average of 30% of cats worldwide has T. gondii antibodies, which suggests that they
have already shed oocysts and can re-shed oocysts upon reinfection (Dubey, 2010). Cats,
regardless of age, are capable of shedding oocysts. Most cats were believed only to shed oocysts
for a week once in their lifetime, however; empirical data attested that cats could re-shed oocysts
upon reinfection six years after the initial infection (Dubey, 1995). At any given time, 1% of cats
were expected to shed oocysts (Dubey, 2010). Taking advantage of the clinical samples
accumulated in an animal laboratory in the United States, a study showed that 31% of 12, 628 cats
had T. gondii antibodies, which coincides with the estimated global seroprevalence (30%) in cats
(Vollaire et al., 2005). Infection rates in cats can be much higher in other parts of the world. In
southern Brazil where a water-associated outbreak of toxoplasmosis had occurred, 84.4% (49/58)
of cats were seropositive for T. gondii (Dubey et al., 2004).
Unlike many other animals, cats can suffer from clinical toxoplasmosis. Some individuals
develop symptoms including lethargy, anorexia, or sudden death. Histological manifestations
involve inflammation or necrosis in multiple organs including heart, brain, eyes, liver, and
pancreas. At present, T. gondii isolates from domestic cats are scarce. Eight isolates were obtained
from cats on pig farms in Illinois, among which five were type 12 (Dubey et al., 1995).
Rodents
A large-scale bioassay using tissues from 5,166 rodents across 17 species revealed that only a
small proportion (0.9%) of rodents were infected with T. gondii (Hejlícek and Literák, 1998).
Rodents can harbor T. gondii but may have no detectable antibodies in their blood. Viable parasites
have been isolated from seronegative rodents (Dubey et al., 1995; Dubey et al., 1997d). Therefore,
bioassay is the definitive method for T. gondii detection in rodents. Immunological tolerance and
short lifespan of rodents are believed to account for the low infection rate in rodents. T. gondii
susceptibility in rodents varies highly even in closely related species. It has been known that rats
(genus Rattus) are resistant to T. gondii infection, whereas house mice (Mus musculus) are highly
susceptible (Dubey, 2010).
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Pigs
The prevalence of T. gondii in pigs varies. Feeder pigs and market pigs are typically raised indoors
in well-managed facilities, and thus their seroprevalence is declining (Dubey et al., 1995).
However, the seroprevalence of pigs raised in poorly managed or non-confined facilities is as high
as 68% (Dubey et al., 2008). Noteworthy risk factors of pig infection include direct contact with
oocysts and eating dead mice (Weigel et al., 1995b). Viable T. gondii has been frequently isolated
from pork for human consumption; isolation rate ranges from 0.3% to 92.7%, depending on the
age of pigs and pig farming conditions (Dubey and Jones, 2008).
Chickens
Chicken raised in the backyard are often infected with T. gondii with infection rates ranging from
27% to 100% worldwide (Dubey and Jones, 2008; Dubey et al., 2005b; Dubey et al., 2006b). A
study conducted in Paraná, Brazil revealed that 12.2% (47/386) of free-range chickens were
seropositive for T. gondii; PCR-RFLP revealed ten different genotypes from 18 isolates,
emblematic of the high genetic diversity in South America (Vieira et al., 2018). However, the
infection rate is low in chickens raised in confined and industrialized feeding operations. T. gondii
was not isolated from chicken breast meat, although T. gondii antibodies were found in the meat
juice (Dubey et al., 2005a).
Cattle
Cattle are resistant to T. gondii infection. Although cattle can be infected with T. gondii oocysts,
they can gradually clear parasite or reduce the infection to an undetectable level (Dubey and Jones,
2008). The underlying mechanism of parasite resistance in cattle is elusive. In an experimental
setting, 10,000 of oocysts were fed to each of the four steers weighing 100-150 kg; the fourth steer
became seronegative after 15 months, and no parasite was isolated using the cat bioassay three
years post infection (Dubey, 1992). Attempts to detect T. gondii antibodies using beef juice has
been futile (Dubey et al., 2005a).
Sheep and Goats
Sheep and goats have been susceptible to T. gondii infection as evidenced by the frequent reports
of abortion incidences and neonatal mortality. Congenitally infected lambs that survived can
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remain asymptomatic, which could be a source for human infection (Dubey and Kirkbride, 1989).
Besides abortion and neonatal mortality, clinical signs of toxoplasmosis have been observed in
adult goats (Dubey and Beattie, 1988), but not in adult sheep.
Infection in wild (white-tailed deer, bobcats) or captive animals
T. gondii infection has been steadily reported in wildlife. White-tailed deer and bobcats are among
animals that are frequently sampled (Dubey et al., 2011). The infection in white-tailed deer heralds
oocyst contamination in the wilderness because deer are strict herbivores. A recent study surveyed
241serum samples from white-tailed deer in North America showed that 41.0% of these animals
had T. gondii antibodies; 13 isolates were obtained with ten being ToxoDB genotype #5 (Gerhold
et al., 2017). Infections in bobcats can be either through ingesting oocyst or through carnivorism.
In one study, T. gondii antibodies were present in 51.7% of 58 bobcats from North America,
Central America and South America (Kikuchi et al., 2004). In another study, parasites were
isolated from 21 of 35 bobcat samples; the dominant genotype #5 (18/21) was revealed among
these isolates (Verma et al., 2017).
The infection in marine mammals indicates land-to-water oocyst contamination. Sea otter,
sea lions, dolphins, and seals have been reported to have T. gondii associated encephalitis and T.
gondii antibodies (Dubey et al., 2003). The sea otter was listed as a threatened species in the United
States due to its dwindling population. T. gondii, capable of causing death in sea otter, had been
suspected to be the principal culprit of sea otter’s decline. However, T. gondii and Sarcocystis
neurona combined are responsible for the death of a small percentage (39/334=11.3%) of sea otter
(Thomas et al., 2007). Seroprevalence in sea otter has been considered high, ranging from 47% to
100% (Dubey and Jones, 2008). Sea otter seroprevalence is higher in California than in
Washington. Bottlenose dolphins from both coasts of the United States have high T. gondii
seropositivity (53%-100%), although not many isolates have been obtained (Dubey et al., 2003).
Marsupials and New World primates are highly susceptible to T. gondii infection. Acute
toxoplasmosis has been reported in many species including squirrel monkeys (Saimiri sciureus)
(Oh et al., 2018), ring-tailed lemurs (Lemur catta) (Juan-Sallés et al., 2011), marmoset (Saguinus
imperator) (Epiphanio et al., 2000), woolly monkey (Lagothrix lagotricha) (Hessler et al., 1971),
and golden-headed lion tamarins (Leontopithecus chrysomelas) (Epiphanio et al., 2000).
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T. gondii has significant veterinary importance especially in zoos and theme parks. Acute
and often fatal infection in captive kangaroos and wallabies was frequently reported worldwide
(Basso et al., 2007; Boorman et al., 1977; Miller et al., 1992; Guthrie et al., 2017). As a result,
zoos and theme parks had suffered from significant economic loss due to the death of expensive
animals. Clinical signs of toxoplasmosis in macropods include blindness, weight loss, respiratory
distress, diarrhea, neurological deficits, and sudden death. Necropsy and histological examination
reveal hepatitis, inflammation, and necrosis in cardiac, skeletal, and smooth muscles (Portas,
2010). Acutely infected macropods often succumb suddenly, and medicine treatment (e.g.,
sulfonamides and pyrimethamine, atovaquone) appears to be impotent to save lives (Portas, 2010).

The Arms Race with Its Hosts
T. gondii is an epitome of host-parasite coadaptation. The arms race between host defense and
parasite virulence ensues as each imposes intense selective pressures on the other. Mice and cats
are T. gondii’s natural and ancient hosts, whereas humans and many other intermediate hosts that
are not part of natural feline’s food chain are considered as accidental hosts. As a result, the mice
immune system is under prolonged selective pressures of the parasites, but not the human immune
system– the very reason human lacks the immune defense mechanisms found in mice. The tolllike receptor (TLRs) (TLR11, TLR12) and immunity-related GTPase (IRG) proteins are absent or
nonfunctional in humans.
Host immunity
Among the host defense mechanism against parasite, Th1 cell-mediated immune response, namely
the signaling pathway of IL12 – Th1– IFN- γ – intracellular killing, is the most significant (Figure
1.5). In mice, endosomal TLR 7 and TLR 9 can recognize parasite RNA or DNA, whereas
endosomal TLR11 and TLR12 recognize parasite profilin-like protein (PRF) (Gazzinelli et al.,
2014). Profilin is an essential protein of the parasite, governing parasite invasion and motility. The
detection of profilin by a dendritic cell is a “detection at a distance” scheme. In addition to
endosomal TLRs, cell surface TLR 2 and TLR 4 are also involved in the recognition of T. gondii.
TLR 2 and TLR 4 can both be activated by T. gondii glycosylphosphatidylinositol (GPI), or T.
gondii derived heat-shock protein 70 (HSP70); however, the immune effect initiated by these two
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receptors is likely marginal as compared to other toll-like receptors.
Upon sensing the parasite, dendritic cells and monocytes are activated to produce IL-12,
which triggers the production of IFN- γ mainly by NK cells, Th1 cells (Figure 1.5). The function
of neutrophils in combating parasite includes the secretion of IL-12 and IFN- γ, phagocytosis, and
the formation of extracellular DNA net (Bliss et al., 1999; Filisetti and Candolfi, 2004). Although
neutrophils can produce reactive oxygen species, the role of ROS in parasite killing remains
controversial (Murray and Teitelbaum, 1992). The production of IFN- γ in NK cells and T cells
are IL-12 dependent, whereas the secretion of IFN- γ in neutrophils are regulated by TNF- α and
IL-1ß. IFN- γ not only induces the production of proinflammatory mediators but also fosters the
maturation of Th1 cells, which in turn enhance IFN- γ production. The IRG proteins produced in
both myeloid cells and non-myeloid cells induced by IFN- γ are among the most effective
parasiticidal effectors. In comparison to the conservative TLR 11 and TLR 12, IRG proteins are
relative polymorphic, counteracting the mutative virulent factors of the parasite.
In humans, the TLR11 gene contains three stop codons, which renders the gene unable to
encode a functional protein. TLR12 is not present in the human genome. In the case of human
immune defense, it is suspected that TLR7, TLR8, and TLR9 play similar roles in parasite
recognition and subsequent activation of dendritic cells and monocytes (Gazzinelli et al., 2014).
In addition, IRG proteins are missing in humans. It is intriguing and yet perplexing that TLR11,
TLR12, and IRG proteins are absent in most mammals that T. gondii are capable of parasitizing.
IFN- γ is a major effector in the killing of intracellular parasites through at least three
mechanisms (Yarovinsky, 2014). First, IFN- γ induces the production of indoleamine 2, 3dioxygenase (IDO), which converts tryptophan to N-formylkynurenine, leading to tryptophan
deprivation and parasite starvation. Another downstream effect of IFN- γ is the activation of nitric
oxide synthase, which can release nitric oxide (NO). NO intermediates are nonpolar and uncharged
which allow them to enter PVs to interact with parasites directly. NO modifies metabolic enzymes,
rendering them nonfunctional. In addition, during the biosynthesis of NO, arginine is deprived due
to the fact that L-arginine is a precursor of NO. T. gondii is an arginine auxotroph - the reason why
arginine starvation can trigger tachyzoite to bradyzoite switch. Without arginine, the replication of
the parasite is staunched. The third mechanism is through the induction of IRG proteins and p65
guanylate-binding proteins (GBPs). Mice seem to highly rely on IRGs for host defense as there
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are 22 members of IRG proteins in mice and only one in human (expressed in testes) (Howard et
al., 2011). In human, the IRG homolog – IRGM is truncated and is not regulated by IFN- γ (Bekpen
et al., 2005). It is unknown whether IRGM is participating in host defense against the parasite. The
localization of IRGs onto PVs results in the disruption of PVs (Figure 1.6). Parasites are vulnerable
once exposed to the cytosol and soon are disintegrated by lysosome (Figure 1.6). GBPs (seven
GBPs in humans; 13 in mice) were believed to indirectly combat parasite by recruiting IRGs onto
PVs (Selleck et al., 2013).
In addition to Th1, CD8+ T cell is another component of the specific acquired immune
response. Upon the activation by IL-2 (secreted by Th1), CD8+ T cells exert cytotoxic activity on
infected cells or extracellular tachyzoites. The humoral immune response is also involved in the
battle with the parasite. IgM appears in serum one week after infection, which is followed by IgG.
IgG plays a critical role in maternal protection for the fetus as IgG can pass placenta. Antibodies
play a role in killing extracellular tachyzoites through antibody-dependent cytotoxicity or
opsonization.
Parasite virulence
T. gondii virulence has apparent strain variation in sensitive hosts (e.g., outbred mice) with type I
being highly virulent (LD100=1), type II being intermediately virulent (LD50 ≥ 102 -104), and type
III being avirulent (LD50 ≥105). The quantitative trait locus (QTL) mapping was used to identify
virulence factors using progenies from sexual crosses among Type I, II, and III (Saeij et al., 2006;
Taylor et al., 2006; Behnke et al., 2011). T. gondii strain virulence in mice seems to be
geographically distinct. A recent study pinpoints that 61% of 427 isolates from Central and South
America are highly virulent to house mice, whereas only 7% of 193 isolates from North America
are virulent (Shwab et al., 2018). There is no apparent association between host species and T.
gondii virulence.
The polymorphic rhoptry-secreted kinase (ROPs) are first identified using forward genetics
approach (Taylor et al., 2006, Saeij et al., 2006) as the significant virulent factors to counteract
IRGs and GBPs. ROP18 is functional in Type I and II and not functional in type III due to the
insertion in its promoter region (Boyle et al., 2008). ROP18 is capable of phosphorylating specific
threonine residues in IRGs and thus hampers the disruption of PVs by IRGs. Using the same
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forward genetics approach, ROP5 was identified and was found to be indispensable to parasite
resistance as highly virulent parasite completely lost virulence without ROP5 (Reese et al., 2011,
Behnke et al., 2011). Despite being a pseudo-kinase, ROP5 forms a complex with ROP18 to
facilitate the phosphorylation of IRGs (Figure 1.6) (Etheridge et al., 2014). ROP5 also complexes
with ROP17 to target threonine residues of the IRGs (Figure 1.6) (Etheridge et al., 2014). ROP5
is evolutionarily under intense selective pressure and thus being highly polymorphic. The
interacting regions of ROP5 and IRGs are also their polymorphic sites, exemplifying the arms race
between parasite and its host as each diversifies under selective pressure of the other. Similar to
ROP18, the functionality of ROP5 varies in different strains: type I and III have a virulent form of
ROP5, whereas ROP5 in type II is avirulent. ROP18 and ROP5 gene alleles combined can be used
to predict T. gondii strain virulence in mice (Shwab et al., 2016).

Dissertation Objectives
Toxoplasma gondii is an inclusive parasite, inhabiting virtually all warm-blooded animals on every
continent. Because of its undiscriminating host range and broad geographical distribution, we can
use it as a model organism to study pathogen transmission and ecology in the context of human
intervention on the environment. The recent few decades have witnessed an extensive genetic
characterization of the parasite and thus enriched our understanding of parasite transmission and
distribution on the planet. Studies of population genetics have unveiled an intricate and yet unique
T. gondii genotype global landscape as a result of the evolutionary adaptation of the parasite to a
wide array of distinctive environments. The northern hemisphere is dominated by a few clonal
lineages, whereas numerous genotypes exists in South and Central America. Factors that shape the
global genetic diversity of T. gondii has been addressed in a recent publication (Shwab et al.,
2018). According to the paper, the rise of agriculture 11,000 years ago and the concomitant
flourishing of cat and mouse engendered the domestic life cycle of T. gondii. It was suspected that
certain lineages of T. gondii were selected in the domestic life cycle and was expanded worldwide
through agricultural expansion and human migration. In addition, a superinfection model was
proposed to explain the virulence diversity in different continents. Alternatively, it has been
speculated that the unique climate and the wide variety of wildlife in South America likely sustain
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the high diversity of T. gondii. Nonetheless, the cause of the contemporary T. gondii genetic
structure is multifactorial.
One of the primary implications of understanding transmission is to actively hamper the
transmission to control parasite contamination in the environment. As cats are the ancestral and
definitive hosts of T. gondii, it comes as no surprise that T. gondii infection is prevalent in cats,
which indicates previous oocyst-shedding events and potential re-shedding upon reinfection. To
make matters worse, the oocysts shed by cats are highly infectious and recalcitrant to disinfection.
Given the number of domestic and feral cats in the United States and the number of oocysts each
cat could shed, the environmental contamination by oocysts poses a threat to public health. The
overarching goal of this dissertation is to understand T. gondii population genetics, its
transmission, and ecology to develop control tactics to reduce its environmental contamination,
thus alleviating the social-economic burden of this notorious parasite.
Chapter 2 objectives
To tackle the problem of environmental contamination, a better understanding of T. gondii
transmission in the environment is fundamental. In recent decades, PCR-RFLP genotyping and
microsatellite have considerably advanced the genetic characterization of T. gondii. With the
accretion of genetically characterized strains of T. gondii, the population genetics of T. gondii has
been steadily revealed, which aids in a better understanding of parasite transmission. Previous
studies have indicated that North American T. gondii population is clonal and dominated by four
archetypal lineages identified as types I, II, III, and type 12, Furthermore, type 12 is mainly found
in wildlife; type II and III are mainly found in domestic animals (Dubey et al., 2011b). Factors that
shape the genetic structure of T. gondii in North America are elusive. To tease them apart, we
compiled and analyzed existing genotypic data from animals across a proximity gradient from the
anthropized environment to the wilderness in North America. We aimed to investigate the effect
of host habitat and host species on T. gondii transmission. We asked the following questions:
•

What are the genotype compositions of T. gondii in animal populations with different
proximities to anthropized environment? How are these genotype compositions different?

•

How does human activity influence T. gondii diversity and genotype distribution?
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•

Does T. gondii genotype distribution have host specificity?

Chapter 3 objectives
To control T. gondii enviormental contamination, we proposed that sandboxes can be used to
reduce the environmental contamination by T. gondii. The hypothesis was inspired by the
defecation behavior of cats who prefer loose sand to defecate to bury their feces (Turner and
Bateson, 2000). The hypothesis was also supported by empirical data in which feral cats frequently
used sandboxes (whether experimental set up in parks or those in school playground) to defecate
(Lass et al., 2009; Uga et al., 1995 and 1996). To test that hypothesis, a typical dairy farm in East
Tennessee was chosen as research site. It was planned that the farm contamination would be
evaluated which would be compared to that of two years after sandbox implementation. As the
project progressed, the initial idea of using the sandboxes to reduce environmental contamination
was abandoned due to the low contamination of the farm by T. gondii. However, a systemic
evaluation method was developed to assess the environmental contamination by T. gondii using
animal infection in conjunction with soil oocyst detection. In this study, we sought to answer the
following questions:
•

Are oocysts detectable in soil on a typical dairy farm harboring cats? Can we use oocyst
contamination as an indicator of farm contamination?

•

How prevalent is T. gondii in domestic and wild animals appearing on the farm? Can we
use animal infection rate to assess farm contamination?

Chapter 4 objectives
Captive macropods have suffered from fatal toxoplasmosis worldwide (Basso et al., 2007;
Fernández-Aguilar et al., 2013; Guthrie et al., 2017). Recent reports of fatal toxoplasmosis in
captive macropods in the United States have accentuated the significance of T. gondii infection in
these animals and shed light on the urgency of developing control measures to reduce T. gondii
contamination in zoological settings. Toxoplasmosis in this setting is noteworthy as theme
parks/zoos suffer from myriad economic loss due to the death of expensive animals. Furthermore,
congregation of humans at oocyst-contaminated themes parks or zoos provide a ready opportunity
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for human infection. In this chapter, we attempted to isolate and characterize T. gondii from six
cases of fatal toxoplasmosis from macropods in a theme park in Tampa, Florida. We sought to
investigate the genetic features of the causative agent to understand the infection source of these
fatal cases. We attempted to address the following questions:
•

Are T. gondii antibodies and viable parasite present in macropod sera and tissues,
respectively?

•

What are the genetic characteristics of these T. gondii isolates? Could the genetic
characteristics aid in the understanding of infection source?

Chapter 5 objectives
Attempts have been made to use vaccines to reduce T. gondii infection. However, these efforts
have had limited success thus far. A live cystless strain (S48) of tachyzoite has been used in sheep
to reduce neonatal mortality in Europe and New Zealand (Buxton et al., 1993). A vaccine for
human use is not yet available as killed strains provide at best marginal protection and attenuated
or mutant strains pose the risk of infection especially to fetuses (Dubey, 2010). The most effective
vaccination strategy is in favor of the immunization of definitive hosts. A 3-year field trial revealed
that vaccination of cats on eight commercial farms using T263 provided promise to reduce the
infection in farm animals (finishing pigs and mice) (Mateus-Pinilla et al., 1999). However, the
application of this cat vaccine is stalled due to several factors. The key problems are the exacting
requirement for storage of tissue cysts produced in mice and the cumbersome procedures for
preparation, which render the high price of the vaccine and result in the lack of interest of cat
owners. In the conventional vaccine production, a mutant strain, T263, is injected into mice. Brain
tissue is harvested, homogenized, digested with pepsin, and preserved in liquid nitrogen. Because
parasites cannot survive long at room temperature, immediate administration to cats is required
upon thawing of the vaccine for no more than 15 mins (Frenkel et al., 1991).
To simplify the vaccine production and to reduce its price, we sought to develop a
methodology to produce live bradyzoites in vitro. To accomplish this, developing a way to convert
T263 tachyzoite to bradyzoite in vitro is essential. In our lab, we tested vacuum conditions or low
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temperature to induce the conversion from tachyzoite to bradyzoite. In this chapter, we aimed to
answer the following questions:
•

Are vacuum conditions capable of inducing tachyzoite to bradyzoite conversion?

•

Is low temperature (31℃) capable of inducing tachyzoite to bradyzoite conversion?
To help address the above questions, we used three criteria to distinguish between

bradyzoites and tachyzoites and to assess the quality of treated tachyzoites under vacuum
conditions or low temperature. We asked the following questions:
•

Do treated tachyzoites express BAG1 proteins and form cyst wall?

•

Are treated tachyzoites more resistant to pepsin digestion?

•

Are treated tachyzoites able to induce infection in mice via oral route?
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Chapter 1 Appendix

Figure 1. 1 The life cycle of T. gondii (Hunter et al., 2012).
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Figure 1. 2 The domestic and sylvatic life cycles of T. gondii (Shwab et al., 2018).
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Figure 1. 3 T. gondii host cell invasion process (Jones et al., 2017).
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Figure 1. 4 The population structure of Toxoplasma gondii (Shwab et al., 2014).
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Figure 1. 5 The Th1 mediated immune response (Yarovinsky et al., 2014).
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Figure 1. 6 The interaction between IRGs and ROPs (Etheridge et al., 2014).
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CHAPTER 2
A PARTITION OF TOXOPLASMA GONDII GENOTYPES ACROSS
SPATIAL GRADIENTS AND AMONG HOST SPECIES, AND
DECREASED PARASITE DIVERSITY TOWARDS AREAS OF HUMAN
SETTLEMENT IN NORTH AMERICA
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Abstract
Toxoplasma gondii counts among the most consequential food-borne parasites, and although the
parasite occurs in a wide range of wild and domesticated animals, farms may constitute a specific
and important locus of transmission. If so, parasites in animals that inhabit agricultural habitats
might be suspected of harboring genetically distinct parasite types. To better understand habitat
effects pertinent to this parasite’s transmission, we compiled and analyzed existing genotypic data
of 623 samples from animals across a proximity gradient from areas of human settlement to the
wilderness in North America. To facilitate such analysis, T. gondii isolates were divided into three
groups: (i) from farm-bound animals (with the most limited home ranges on farms); (ii) from freeroaming animals (with wider home ranges on or near farms); and (iii) from wildlife. In addition,
parasite genotype distribution in different animal species was analyzed. We observed no absolute
limitation of any of five major genotypes to any one habitat; however, the frequency of four
genotypes decreased across the gradient from the farm-bound group, to the free-roaming group,
then the wildlife, whereas a fifth genotype increased along that gradient. Genetic diversity was
greater in free-roaming than in farm-bound animals. The genotypic composition of parasites in
wildlife differed from those in farm-bound and free-roaming animals. Furthermore, parasite
genotypes differed among host species. We conclude that T. gondii genotype distributions are
influenced by the spatial habitat and host species composition, and parasite diversity decreases
towards areas of human settlement, elucidating facts which may influence transmission dynamics
and zoonotic potential in this ubiquitous but regionally variable parasite.
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Introduction
The ubiquity of certain pathogens can reveal important differences in their local transmission
dynamics. Habitat effects may be important in structuring the dynamics of transmission, and these
differences may be epidemiologically consequential. Global analyses, and certain regional studies,
have suggested that farming has disseminated a peculiar and especially consequential transmission
dynamic, overlapping with (but qualitatively distinct from) conditions that prevail among wildlife
hosts (Crosby, 2004; Rosenthal, 2009; Cincotta and Gorenflo, 2011). Toxoplasma gondii, the agent
of human toxoplasmosis, has an extraordinarily broad intermediate host range, and is found in
every habitat inhabited by its definitive feline hosts; but differences among habitats (and the
composition of potential hosts) may significantly alter which parasites predominate (Mercier et
al., 2011). Here, we sought to apply decades of molecular characterization in order to discern the
extent and quality of differences among regions and hosts of this widespread parasite.
Toxoplasma gondii is a successful apicomplexan parasite that infects a broad spectrum of
hosts including mammals and birds. It is estimated that, on average, one-third of the global human
population is infected (Dubey, 2010; Weiss and Kim, 2013). In 12–49-year-old US born
individuals, 6.7% have been exposed to T. gondii (Jones et al., 2014). Infection can be lifethreatening in immunocompromised individuals such as HIV patients and those undergoing
chemotherapy or radiation. Similarly, in pregnant women who have not been previously exposed
to the parasite, infection during gestation can lead to congenital toxoplasmosis, which occurs in
approximately 30–40% of babies born of infected mothers (Dubey, 2010). Manifestations of
congenital toxoplasmosis vary from spontaneous abortion and stillbirth to ocular and cerebral
damage to the infants. Infection in immunocompetent people generally causes mild symptoms
such as fatigue and malaise, followed by chronic infection in which the parasite resides in host
tissues and becomes semi-dormant. However, in rare cases, severe diseases may occur which
require hospitalization or intensive health care (Demar et al., 2007; Elbez-Rubinstein et al., 2009).
The cause of these severe cases is unclear, but they are most likely due to infection by highly
virulent strains identified in South America (Ajzenberg et al., 2004; Demar et al., 2007; ElbezRubinstein et al., 2009; Grigg and Sundar, 2009; de-la-Torre et al., 2013).
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Beside humans, a wide variety of animals are infected by T. gondii, ranging from terrestrial
and marine mammals to birds. As its sole definitive host, felids (domestic and wild cats) can shed
millions of oocysts in their faeces and thereby contaminate the environment. Intermediate hosts,
including humans and animals, become infected via accidentally ingesting oocysts disseminated
in environmental matrices such as soil, water, fruit and vegetables. Upon infection, parasites reside
in the form of tissue cysts in the muscular or neural tissues of the intermediate hosts. Toxoplasma
gondii can be transmitted horizontally or vertically. In the case of horizontal transmission,
bradyzoites in tissues or oocysts in the environment are ingested by intermediate hosts or definitive
hosts. Vertically, parasites in pregnant hosts can pass through the placenta and can thus be
transmitted to the foetus (Dubey, 2010).
Toxoplasma gondii is genetically diverse among animal populations globally (Shwab et al.,
2014). Genetic diversity of this parasite is low in Europe and high in South America, with the
diversity in North America being intermediate. There are a few lineages of T. gondii dominant in
North America (Dubey et al., 2011b; Khan et al., 2011; Shwab et al., 2014). ToxoDB genotypes
#4 and #5 (collectively known as type 12) are the dominant genotypes in wildlife in North America
(Dubey et al., 2011b), while genotypes #1 and #3 (collectively known as type II) are often
identified in domestic animals (Dubey et al., 2008b; Velmurugan et al., 2009). However, a
comparison of genetic profiles of T. gondii in animal populations with differing degrees of human
association has not, to our knowledge, been conducted. Here we have compiled and analyzed
genetic data of T. gondii isolated from domestic and wild animals in North America. We have
categorized T. gondii populations into three groups based on spatial distribution of animal hosts,
and by animal species. We show a stratified distribution of genotypes along the spatial gradient
from areas of human settlement to the wild. In addition, there is an association of T. gondii
genotypes with animal host species, and parasite diversity decreases towards an area of human
settlement. This is of importance in understanding the transmission of T. gondii in animals and
humans.
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Materials and Methods
Data collection
Genotyping data of 623 T. gondii samples from animals in the USA and Canada were collected
from published reports (Table 2.1). All samples were originally characterized using 10 multilocus
PCR-RFLP markers (Su et al., 2010; Shwab et al., 2014). The 623 T. gondii samples were
classified as having derived from farm-bound animals (n = 195), free-roaming animals (n = 135),
or wildlife (n = 293).
The farm-bound group included pigs (Sus domesticus), chickens (Gallus gallus
domesticus), geese (Anser anser domesticus), house mice (Mus musculus) and domestic cats (Felis
catus). These samples were collected from six US states including Illinois, Maryland, Iowa,
Pennsylvania, Massachusetts and New Jersey (Table 2.1). Among the 195 samples, 168 pig
isolates were collected from more than eight farms across six states: 85 were from Iowa (Dubey et
al., 1995a; Mondragon et al., 1998; Velmurugan et al., 2009), 29 from Pennsylvania (Velmurugan
et al., 2009), 53 from Massachusetts (Dubey et al., 2002, 2005; Velmurugan et al., 2009), and one
from New Jersey (Dubey et al., 2005; Velmurugan et al., 2009). The remaining 27 samples were
obtained from domestic animals including 11 chickens (Dubey et al., 2007b), nine domestic cats
(Dubey et al., 1995b; Dubey and Prowell, 2012), six house mice (Dubey et al., 1995b) and one
goose (Dubey et al., 2007b). These animals were either raised on pig farms or raised as pets (Dubey
et al., 1995b, 2007b). For data analysis, the farm-bound animal group captures all animals that
have limited home ranges on farms; they are not necessarily physically penned.
The free-roaming animal group included goats (Capra aegagrus hircus), sheep (Ovis
aries), alpacas (Vicugna pacos), feral cats (Felis catus), organic pigs (Sus domesticus) and freerange chickens (Table 2.1). Given feral cats have larger home ranges and are likely to be away
from farms, we assigned them to this group for data analysis. From the 135 samples, two were
collected from Canada and the rest were collected from nine states in USA including Maryland,
Virginia, West Virginia, Pennsylvania, Ohio, Michigan, Massachusetts and Texas. Fifty-five of
these samples originated from sheep in a slaughterhouse in Baltimore, Maryland. These sheep
were between 6 and 12 months old and were raised in small flocks in Maryland, Virginia and West
Virginia (Dubey et al., 2008c). Three sheep isolates were obtained from Virginia (Dubey et al.,
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2014a). One T. gondii strain was isolated from a congenitally infected lamb during a lambing
season in Texas, USA (Edwards and Dubey, 2013). Twenty-nine T. gondii strains were collected
from goat meat sold in retail stores in Maryland. These goats were raised in small flocks in
Maryland, Virginia or Pennsylvania (Dubey et al., 2011a). Additionally, 22 chicken isolates were
from free-range chickens from Ohio and Massachusetts (Ying et al., 2017). Nineteen isolates were
obtained from organic pigs which were free roaming on the farms. Among these isolates, 15 were
from Michigan from two organic pig farms where pigs were raised according to organic standards
(Dubey et al., 2012); four were from Maryland, USA from a poorly managed farm in which pigs
with poor nutritional diets scavenged on the premises (Dubey et al., 2008a). Four T. gondii isolates
were obtained from feral cats with two from Canada (Dubey et al., 2008b), and two from
Pennsylvania (Dubey et al., 2015). Additionally, two T. gondii isolates were collected from alpacas
grazing on a pasture in Virginia (Dubey et al., 2014a).
Of the 293 T. gondii isolates from wildlife, 288 were collected from 23 states in the USA
and five samples from Canada (Table 2.1). The host animals from which parasites were
successfully isolated and genotyped included 54 white-tailed deer (Odocoileus virginianus), 46
sea otters (Enhydra lutris), 30 grey wolves (Canis lupus), 27 bobcats (Lynx rufus), 21 coyotes
(Canis latrans), 13 black bears (Ursus americanus), 13 red foxes (Vulpes vulpes), 12 raccoons
(Procyon lotor), 11 Canadian geese (Branta canadensis), and 24 additional wildlife species from
which 66 strains were obtained (Table 2.1).
Fourteen host species contained the requisite 10 or more T. gondii samples for inclusion in
the species analysis. These include pigs, chickens, cats, Canada geese, sheep, goats, red foxes,
black bears, raccoons, white-tailed deer, coyotes, bobcats, sea otters and wolves (Table 2.2).
Eleven chicken isolates from a farm in Illinois were counted as one isolate due to an outbreak of
toxoplasmosis among these chickens, and all 11 isolates belonged to the same genotype (#1)
(Dubey et al., 2007b). This sample together with the other 22 isolates from free-range chickens in
Ohio and Massachusetts were used as a population (Ying et al., 2017). The pig population
comprised 168 isolates from the farm-bound animals and 19 organic pig isolates from the freeroaming group. The cat population comprised nine isolates from farm-bound group and four feral
cat isolates from the free-roaming group. The other animal populations are described in Table 2.2.
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Data analysis
The frequency of genotypes in each population was represented in pie charts constructed using
GraphPad Prism (GraphPad Software, San Diego, CA, USA). Multilocus PCR-RFLP typing data
was coded for all genetic loci. For a given locus, the presence or absence of DNA restriction
fragments was coded with 1 s and 0 s, respectively. Therefore, a given locus was coded with a
string of 1 s and 0 s. The genetic differences between and within populations was compared using
Arlequin ver 3.5.1.2 (Excoffier and Lischer, 2010; Rajendran et al., 2012). For analysis with
Arlequin, the data type was set as ‘‘haplotypic” data, and the data form was set as ‘‘Standard”
which compares the data for their content at each locus without taking into special consideration
the mode of mutation of the alleles. Within-population genetic diversity was determined at the
haplotype level for each population. A between-population pairwise comparison was performed
by genetic structure analysis, with the statistical significance level established by 1000
permutations, and P = 0.001 was used as the statistical significance level.

Results
The spatial distribution of T. gondii genotypes
The spatial distribution of T. gondii genotypes is summarized in Fig. 2.1. For the farm-bound
animal group, seven genotypes were identified among the 195 T. gondii samples. ToxoDB
genotypes #1 and #3 (collectively known as type II) and #2 (type III) were the major genotypes
accounting for 56.4% (110/195) and 25.6% (50/195) of the total, respectively. Genotypes #4 and
#5 (collectively known as type 12) accounted for 12.3% (24/195) and 0.5% (1/195), respectively.
In addition, genotype #8 accounted for 4.6% (9/195), and #42 for 0.5% (1/195).
For the free-roaming animal group, 25 genotypes were identified from 135 T. gondii
samples. Genotypes #1, #2, #3, #4 and #5 accounted for 32.6% (44/135), 20.7% (28/135), 11.1%
(15/135), 8.9% (12/135) and 3.0% (4/135) of the samples, respectively. The remainders of the
isolates were represented by 20 atypical genotypes accounting for 23.7% (32/135) of the total (Fig.
2.1).
Within the wildlife group of 293 T. gondii samples, a total of 38 genotypes were identified
(Fig. 2.1, Table 2.1). Genotypes #1, #2, #3, #4 and #5 accounted for 11.6% (34/293), 9.6%
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(28/293), 8.9% (26/293), 5.1% (15/293) and 43.7% (128/293) of the samples, respectively. The
remaining isolates were represented by 33 genotypes, each of which accounted for a small
proportion of the total. Collectively, these accounted for 21.1% (62/293) of samples in the group
(Fig. 2.1).
Within-population diversity and pairwise comparison of genetic makeup of the three spatial
groups was performed using Arlequin v. 3.5.1.2. Within-population diversities for farm-bound
animals, free-roaming animals and wildlife were relatively high in each case (0.75 ± 0.01, 0.83 ±
0.02, and 0.78 ± 0.02, respectively) (Table 2.1). A pairwise comparison of genetic makeup showed
that T. gondii in the wildlife population was significantly different from that in the farm-bound
and free-roaming animal populations (P < 0.001) (Table 2.1). There was no significant difference
between farm-bound and free-roaming animal populations. In addition, there were 1, 11 and 23
unique genotypes for farm-bound, free-roaming and wildlife populations, respectively.
Toxoplasma gondii genotype distribution in animal species
The genotypic composition of each animal population with 10 or more isolates is shown in Table
2.2. Within-population genetic diversity of samples in bobcats (0.21 ± 0.10), wolves (0.31 ± 0.11),
sea otters (0.65 ± 0.05) and white-tailed deer (0.70 ± 0.07) encompassed notably low diversity.
However, between-population comparisons found these animal populations to be significantly
different from at least five other animal populations (Fig. 2.2). In particular, parasites from sea
otters significantly differed from those infecting 11 other species. Domestic animals (pigs, cats,
chickens, sheep, goats) had similar genotypic compositions, whereas wild animals tended to have
diverse populations. Genotype #5 dominated in a few wildlife species such as white-tailed deer,
coyotes, bobcats, sea otters and wolves (Fig. 2.2).

Discussion
We have compared the composition of T. gondii genotypes in animals with varying proximities to
areas of human settlement. There are several important findings. First, we found genotypes #1– #5
in all three habitats. Genotypes #1 and #2 dominated farm-bound and free-roaming animal groups,
while genotype #5 dominated wildlife (Fig. 2.1, Table 2.1). The frequencies of #1, #2, #3 and #4
decreased along the gradient from the farm-bound group to the wild. In contrast, the frequency of
50

#5 increases along the same gradient. These results indicate a spatial partitioning of T. gondii
genotypes across the habitat. Second, the within-population diversity in the free-roaming animals
was similar to that in wildlife, but significantly higher than that of the farm-bound animals (Fig.
2.1, Table 2.1), suggesting a lower genetic diversity of T. gondii in areas of human settlement than
in the wild. Third, comparison of between-population genetic compositions showed that the
wildlife group is significantly different from the farm-bound and the free-roaming groups (Fig.
2.1, Table 2.1), and there were increasing numbers of unique genotypes along the gradient from
farm-bound, to free-roaming, then to wildlife, suggesting different T. gondii genotypes are
circulating in different spatial habitats. Finally, genotypes of T. gondii were associated with animal
species (Fig. 2.2, Table 2.2). Farm animals (pigs, chickens, cats, sheep and goats) tended to harbor
similar T. gondii genotypes, with genotypes #1, #2, and #3 being the major ones. However, parasite
genotypes were more diverse in wildlife, with a clear dominance of genotype #5 in a few wildlife
species including white-tailed deer, coyotes, sea otters and wolves.
The low genetic diversity of T. gondii in areas of human settlement may be the result of a
reduced biological diversity of animal hosts. Intensive animal rearing results in a reduction of local
animal diversity and a dramatic increase in animal numbers, which in turn leads to a reduced
diversity of animal pathogens and influences their transmission dynamic (Crosby, 2004;
Mcdonalda et al. (2008); Pongsiri et al., 2009; Rosenthal 2009; Cincotta and Gorenflo, 2011).
Under this uniform selective pressure, a small number of parasite strains with increased fitness
would be expected to circulate in the population and to become dominant (Khan et al., 2014). In
our analysis, 56.4% of the genotypes identified from animal species with close human association
belong to the genotypes #1 and #3 (collectively known as type II), which suggests a selective
advantage for these genotypes within the domestic animal population. Given that these genotypes
also predominate in Europe, they may have established themselves in North America through
maritime animal transportation, especially in well-adapted hosts such as domestic cats and rodents
(Lehmann et al., 2006). The flourishing of agriculture and intensive animal farming may then have
facilitated their spread in the domestic population. Notably, these two genotypes were also found
in free-roaming animal populations and wild animals, accounting for 45.1% and 24.6% of
genotypes, respectively. This suggests that genotypes #1 and #3 may be overflowing from
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domestic animals to wild animals. Alternatively, these genotypes may enjoy especially efficient
transmission on farms.
In contrast to the agricultural environment, natural ecosystems such as forests support a
much greater biodiversity, including a high diversity of both hosts and pathogens. Consistent with
this trend, we showed that T. gondii genetic diversity is higher in wildlife species. Thirty-eight
genotypes were observed wild animals (more than five times the number observed in a sample of
nearly 10 times as many domesticated hosts). However, these 38 genotypes identified from wild
animals were not equally represented (Fig. 2.2). Genotype #5 dominated in a few wild animal
species, whereas #1, #2 and #3 dominated in domestic animals. It is particularly interesting that
bobcats have a limited diversity of T. gondii genotypes; #5 is overly dominant in this definitive
host. This result is in agreement with a previous study in which wild felids were 14 times more
likely to be infected with #5 (Type X) than feral domestic cats, and animals in less developed
landscapes were more likely be infected with #5 than developed landscape (VanWormer et al.,
2014). Taken together, it suggests a potential fitness advantage of particular genotypes in domestic
and wild animals, respectively. This phenomenon also lends support to the idea of distinct,
geographically separated domestic and sylvatic transmission cycles. Notably, the sea otter
population is extraordinarily unique (Fig. 2.2) as its genotypes comprised of approximately equal
numbers of #5 (n = 24), and #1 and #3 (type II, n = 18). This suggests that the genotypic
composition of sea otters may have two overlapping transmission cycles (VanWormer et al.,
2014).
We grouped domestic animals with wider home ranges into an independent group (freeroaming). These animals included goats, sheep and feral cats. From this group, 135 isolates were
collected, among which 25 different genotypes were identified. Parasites isolated from these
animals showed a higher diversity compared with those from the farm-bound group (seven
genotypes). Genotypes #1, #2, #3 and #4 were found to be the major genotypes in this group of
animals, which is most likely the result of the overlapping phenomenon of the domestic and
sylvatic transmission cycles. Moreover, the other genotypes found in this group are mostly
different from those identified in wild animals, which suggests genotypic specificity in different
animal hosts, or spatial separation of T. gondii genotypes. Due to the limited available data in this
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group, the genetic profile of this population may be incomplete. More isolates of this group from
a wider geographic region will be needed to draw firm conclusions.
In addition to the geographical location from which parasites were isolated, our findings
suggest that host animal species may shape the genetic structure of T. gondii populations in North
America. Strong genetic differences characterized populations derived from various host species,
perhaps owing to some degree of species-specific host adaptation. However, regional sampling
biases may contribute to the appearance of such differences. Thus, the degree to which each of
these two factors contributes to the genetic structure of T. gondii in North America remains
unclear. To more precisely define these contributions, future studies should examine the genetic
structure of sympatric parasites isolated from different host species, and others should examine a
given host species across its geographic range.
Host-specificity of T. gondii genotypes may have ramifications for human infection. The
eighty-four sheep and goat samples intended for human consumption, obtained from retail meat
stores or slaughterhouses, yielded twenty-four genotypes of T. gondii. This high level of diversity,
coupled with the established potential for parasite transmission to humans from these hosts, raises
concerns about the potential for the transmission, from ovine samples, of atypical parasite lineages
that may include especially virulent types. Future studies focusing on surveillance of parasite
infections in goats and sheep would not only help identify T. gondii strains present in the
environment but would also shed light on parasite-to-human transmission routes.
Taken together, our findings demonstrate an inverse relationship between parasite diversity
and the proximity of host habitat to areas of human settlement, indicating the dramatic impact of
human modification of habitat on the distribution of T. gondii strains in the environment. The
prevalence of genotype #5 strains in wild hosts suggests that they may have originated in wild
animals and have successfully circulated in the wilderness. However, difficulties in isolating
parasites from asymptomatic, chronically infected animals cloud our understanding of the true
prevalence and genotypic composition in many host species. For example, pigs contribute
disproportionately to our current description of genetic diversity in domestic animals. In contrast,
isolates from domestic cats, the definitive host that is the core of the domestic cycle, are scarce in
our study. A previous study showed that, due to its large population size, domestic feral cats
contribute more oocysts to contaminate areas of human settlement than wild felids, and therefore
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likely played a more important role in transmission of T. gondii in domestic animals and humans
(VanWormer et al., 2013). Further study focusing on T. gondii strains from domestic cats and a
broader host spectrum from more geographically diverse regions is imperative. These data
underscore the impact of host proximity to human society on parasite population structure. A
greater understanding of this relationship may be achieved through increased sampling from a
greater diversity of host species and geographic areas and should provide invaluable insights into
the dynamics of the transmission of T. gondii and potentially other important zoonotic human
pathogens.
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Chapter 2 Appendix
Table 2. 1 Toxoplasma gondii isolates from animals in different environments and geographical locations in North America
Spatial
groups

Animal species

Locationsa

Genotypes

Unique
genotypes

Farmbound
(n=195)

Pigs (n=168), chickens
(n=11), cats (n=9), house
mice (n=6), goose (n=1)

Iowa (n=85),
Massachusetts (n=53),
Pennsylvania (n=29),
Illinois (n=26),
Maryland (n=1), New
Jersey (n=1)

#1 (n=70), #2 (n=50),
#3 (n= 40), #4 (n=24),
#5 (n=1), #8 (n=9),
#42 (n=1). Total: 7
genotypes

Freeroaming
(n=135)

Sheep (n=59), goats
(n=29), free-range
chickens (n=22), organic
pigs (n=19), feral cats
(n=4), alpacas (n=2)

Maryland, Virginia and
West Virginia (n=55),
Maryland, Virginia and
Pennsylvania (n=29),
Ohio (n=15), Michigan
(n=15), Massachusetts
(n=7), Virginia (n=5),
Maryland (n=4),
Manitoba (Canada)
(n=2), Pennsylvania
(n=2), Texas (n=1)

#1 (n=44), #2 (n=28),
#3 (n=15), #4 (n=12),
#5 (n=4), #7 (n=4), #9
(n=1), #32 (n=1), #39
(n=3), #54 (n=1), #72
(n=1), #73 (n=2), #74
(n=1), #110 (n=1),
#113(n=1), #118
(n=1), #130 (n=1),
#131 (n=1), #143
(n=1),
#154 (n=1), #156
(n=1), #167 (n=1),
#170 (n=5), #216
(n=2), #230 (n=2).
Total: 25 genotypes

#42

Withinpopulation
haplotype
diversityb
0.75 +/0.01;
95% C.I.
(0.72 0.78)

Betweenpopulation
genetic
compositionc
Not different
from freeroaming, but
different from
wildlife.

#72, 73, 74,
110, 113,
118, 130,
131, 156,
170, 230.

0.83 +/0.02;
95% C.I.
(0.79 0.87)

Not different
from farmbound but
different from
wildlife.

References

Dubey et al.
(1995a, b, 2002,
2005, 2007b),
Dubey and Prowell
(2012),
Mondragon et al.
(1998),
Velmurugan et al.
(2009)
Dubey et al.
(2008a,b,c, 2011a,
2012, 2014a,
2015), Edwards, et
al. (2013), Ying et
al. (2017)
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Table 2.1 Continued
Spatial
groups

Animal species

Locationsa

Genotypes

Unique
genotypes

Wildlife
(n=293)

White-tailed deer
(n=54), sea otters
(n=46), wolves (n=30),
bobcats (n=27), coyotes
(n=21), red foxes (n=13),
Canadian geese (n=11),
black bears (n=13),
raccoons (n=12),
dolphins (n=7), hawks
(n=7), Bennett's
wallabies (n=6), arctic
foxes (n=5), geese (n=4),
wallabies (n=4),
skunks (n=4), swans
(n=3),
feral pigs (n=3), whitefooted mice (n=2),
Hawaiian crows (n=2),
moose (n=2), badgers
(n=2), opossums (n=2),
mouflon sheep (n=2),
bald eagles (n=2), elks
(n=2), brown bear (n=1),
woodrat (n=1), cougar
(n=1), European starling
(n=1), barn owl (n=1),
American kestrel (n=1),
mink (n=1)

Pennsylvania (n=43),
Mississippi (n=42),
Minnesota (n=37),
California (n=30),
Washington (n=17),
Wisconsin (n=15),
South Carolina (n=15),
Maryland (n=12),
Alaska (n=10),
Georgia (n=9), New
Jersey (n=9), Hawaii
(n=8), Colorado (n=7),
Tennessee (n=7),
Virginia (n=6),
Alabama (n=5),
Manitoba (Canada)
(n=2), British
Columbia (Canada)
(n=1), Quebec
(Canada) (n=1),
unknown location
(Canada) (n=1), Ohio
(n=4), Massachusetts
(n=3), North Carolina
(n=3), Michigan (n=2),
Texas (n=2),
Washington D.C.
(n=1), Rhode Island
(n=1)

#1 (n=34), #2 (n=28),
#3 (n=26), #4 (n=15),
#5 (n=128), #7 (n=3),
#8 (n=1), #9 (n=1),
#10 (n=1), #11 (n=1),
#14 (n=1), #15 (n=2),
#24 (n=2), #32 (n=2),
#39 (n=2), #54 (n=2),
#66 (n=1), #90 (n=1),
#141 (n=1), #143
(n=1), #146 (n=1),
#147 (n=1), #154
(n=1), #157 (n=1),
#167 (n=3), #177
(n=2), #180 (n=1),
#186 (n=1), #216
(n=11), #219 (n=1),
#220 (n=1), #221
(n=3), #249 (n=1),
#261 (n=3), #262
(n=1), #263 (n=6),
#266 (n=1), #267
(n=1).
Total: 38 genotypes

#10, 11, 14,
15, 24, 66,
90, 141,
146, 147,
157, 177,
180, 186,
219, 220,
221, 249,
261, 262,
263, 266,
267

Withinpopulation
haplotype
diversityb
0.78 +/0.02;
95% C.I.
(0.73 0.82)

Betweenpopulation
genetic
compositionc
Different
from farmbound and
free-roaming
animals.

References

Howe and Sibley
(1995), Dubey et
al. (2007a, 2008b,
2009, 2010, 2011b,
2013a, b, c, 2014b,
c, 2015, 2017),
Sundar et al.
(2008), Yu et al.
(2013), Verma et
al. (2015, 2016 a,b,
2017), Guthrie et
al. (2017), Gerhold
et al. ( 2017)

C.I., Confidence interval.
a
Locations are states of the USA except where otherwise indicated in parentheses.
b
Within-population diversity: the diversity in increasing order is free roaming animals > wildlife > farm-bound animals. The diversity of the free
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c

roaming animals is significantly higher than the farm-bound animals, P < 0.05.
Between-population pairwise genetic diversity analysis of three T. gondii populations. Statistical significance is set at P < 0.001.
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Table 2. 2 Toxoplasma gondii populations of 14 animal species from North America.
Animal hosts

Genotypes

Pigs (Sus
domesticus)
n=187

Locationsa

Within-population
diversity
0.75 +/- 0.02,
95% C.I. (0.72,
0.78)

References

0.66 +/- 0.06,
95% C.I. (0.54,
0.78)

Dubey et al. (2007b), Ying
et al., (2017)

#1 (n=67), #2 (n=53), #3
(n=36), #4 (n=17), #5 (n=1),
#7 (n=3), #8 (n=8), #42 (n=1),
#113 (n=1).
Total: 9 Genotypes
Chickens (Gallus #1 (n=8), #2 (n=11), #3 (n=1),
gallus
#170 (n=3).
domesticus)
Total: 4 Genotypes
n=23
Cats (Felis
#1 (n=1), #3 (n=1), #4 (n=6),
catus)
#5 (n=1), #8 (n=1), #130
n=13
(n=1), #216 (n=2).
Total: 7 Genotypes

Iowa (n=85),
Massachusetts(n=53),
Pennsylvania (n=29),
Michigan (n=15), Maryland
(n=4), New Jersey (n=1),
Ohio (n=15), Massachusetts
(n=7), Illinois (n=1)

Dubey et al. (1995a, 2002,
2005, 2008a, 2012);
Mondragon et al. (1998),
Velmurugan et al. (2009)

Illinois (n=8), Pennsylvania
(n=2), Manitoba (Canada)
(n=2), Maryland (n=1)

0.79 +/- 0.11,
95% C.I. (0.58,
1.01)

Dubey et al. (2008b, 2015),
Dubey and Prowell (2012)

Canada geese
(Branta
canadensis)
n=11
Sheep (Ovis
aries)
n=59

#1 (n=1), #2 (n=5), #4 (n=2),
#143 (n=1), #266 (n=1), #267
(n=1). Total: 6 Genotypes

Maryland (n=9),
Mississippi (n=1),
Pennsylvania (n=1)

0.80 +/- 0.11,
95% C.I. (0.58,
1.02)

Dubey et al. (2014c),
Verma et al. (2016a)

#1 (n=17), #2 (n=9), #3 (n=9),
#4 (n=9), #5 (n=1), #7 (n=1),
#9 (n=1), #32 (n=1), #39
(n=2), #72 (n=1), #73 (n=2),
#74 (n=1), #54 (n=1), #110
(n=1), #131 (n=1), #230
(n=2). Total: 16 Genotypes

Maryland, Virginia and
West Virginia (n=55),
Virginia (n=3), Texas (n=1)

0.86 +/- 0.03,
95% C.I. (0.80,
0.91)

Dubey et al. (2008c,2014a),
Edwards and Dubey (2013)
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Table 2.2 Continued
Animal hosts

Genotypes

Locationsa

Goats (Capra
aegagrus hircus)
n=29

#1 (n=9), #2 (n=4), #3 (n=4),
#4 (n=3), #5 (n=2), #39 (n=1),
#118 (n=1), #143 (n=1), #154
(n=1), #156 (n=1), #167
(n=1), #170 (n=1). Total: 12
Genotypes
#1 (n=1), #2 (n=2), #3 (n=3),
#4 (n=1), #54 (n=1), #141
(n=1), #216 (n=4). Total: 7
Genotypes
#1 (n=3), #2 (n=2), #4 (n=2),
#5 (n=2), #90 (n=1), #147
(n=1), #216 (n=2). Total: 7
Genotypes
#1(n=2), #2 (n=1), #4 (n=1),
#5 (n=4), #7 (n=2), #32 (n=2).
Total: 6 Genotypes

Maryland, Virginia and
Pennsylvania (n=29)

Red foxes
(Vulpes vulpes)
n=13
Black bears
(Ursus
americanus)
n=13
Raccoons
(Procyon lotor)
n=12
WT deer
(Odocoileus
virginianus)
n=54

Coyotes (Canis
latrans) n=21

#1 (n=2), #2 (n=4), #3 (n=4),
#4 (n=4), #5 (n=29), #146
(n=1), #154 (n=1), #167
(n=1), #216 (n=4), #220
(n=1), #221(n=3).
Total: 11 Genotypes
#1 (n=7), #3 (n=2), #4 (n=4),
#5 (n=7), #14 (n=1).
Total: 5 Genotypes

Within-population
diversity
0.87 +/- 0.04,
95% C.I. (0.79,
0.96)

References

Pennsylvania (n=11),
Alaska (n=2)

0.87 +/- 0.07,
95% C.I. (0.74,
1.00)

Dubey et al. (2011b, 2014c)

Pennsylvania (n=8),
Maryland (n=3), Alaska
(n=1), Quebec (Canada)
(n=1)
Wisconsin (n=5), Georgia
(n=3), Minnesota (n=2),
Manitoba (Canada) (n=1),
Texas (n=1)
Mississippi (n=19), South
Carolina (n=9), New Jersey
(n=9), Pennsylvania (n=7),
Ohio (n=4), Tennessee
(n=4), Alabama (n=1),
Minnesota (n=1)
Pennsylvania (n=10),
Wisconsin (n=7), Tennessee
(n=2), Georgia (n=1),
Minnesota (n=1)

0.91 +/- 0.05,
95% C.I. (0.82,
1.01)

Dubey et al. (2008b, 2010,
2011b, 2013b, 2015)

0.86 +/- 0.07,
95% C.I. (0.72,
1.00)

Dubey et al. (2007a,
2008b., 2011b), Verma et
al. (2016b)

0.70 +/- 0.07,
95% C.I. (0.57,
0.83)

Dubey et al. (2011b, 2013c,
2014b,c ), Yu et al. (2013),
Gerhold et al. (2017)

0.77 +/- 0.05,
95% C.I. (0.67,
0.87)

Dubey et al. (2007a,
2014c), Verma et al.
(2016b), Gerhold et al.
(2017)

Dubey et al. (2011a)
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Table 2.2 Continued
Animal hosts

Genotypes

Bobcats (Lynx
rufus)
n=27
Sea otters
(Enhydra lutris),
n=46

#2 (n=1), #5 (n=24), #24
(n=2).
Total: 3 Genotypes
#1 (n=6), #3 (n=12), #4 (n=1),
#5 (n=24), #39 (n=2), #54
(n=1). Total: 6 Genotypes

Locationsa

Within-population
diversity
Mississippi (n=20), Georgia 0.21 +/- 0.10,
(n=4), Alabama (n=2),
95% C.I. (0.01,
Pennsylvania (n=1)
0.41)
California (n=29),
0.65 +/- 0.05,
Washington (n=17)
95% C.I. (0.55,
0.76)

Wolves (Canis
#1 (n=2), #3 (n=1), #5 (n=25), Minnesota (n=28), Alaska
0.31 +/- 0.11,
lupus)
#9 (n=1), #219 (n=1).
(n=1), Wisconsin (n=1)
95% C.I. (0.10,
n=30
Total: 5 Genotypes
0.52)
C.I., confidence interval.
a
Locations are all states of the USA except where otherwise stated in parentheses.

References
Yu et al. (2013), Dubey et
al. (2015), Verma et al.
(2017)
Howe and Sibley (1995),
Sundar et al. (2008), Dubey
et al. (2011b)
Dubey et al. (2011b, 2013a)
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Figure 2. 1 Toxoplasma gondii genotype distribution along the spatial gradient from farm to the wild. The cartoon illustrates the
spatial gradient and animal populations with varied proximities to human habitat. Representatives of animal species in each population
are depicted. The numbers around pie chart edges indicate ToxoDB PCR-RFLP genotypes. The archetypal lineages (Type II, III, 12)
are overlaid on pie charts in bold lettering. The sizes of pie charts correlate with the total number (and percentage) of isolates; colors of
the slices represent different genotypes.
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Figure 2. 2 Pairwise comparison of 14 Toxoplasma gondii populations for different host species. The number of each species is
indicated in parentheses and the colors in the pie chart represent different genotypes. The between population comparison was conducted
using Arlequin ver 3.5.1.2. The cut-off value for statistical significance was P=0.001. The “+” sign indicates significant difference
between two populations. WT deer, white-tailed deer.
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CHAPTER 3
A SYSTEMIC EVALUATION OF TOXOPLASMA GONDII INFECTION ON
A FARM THROUGH THE EXAMINATION OF SOIL OOCYST
CONTAMINATION AND ANIMAL INFECTION
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Abstract
The environmental contamination by Toxoplasma gondii contributes to infection in humans and
animals. However, T. gondii environmental contamination is largely uninvestigated due to the lack
of a comprehensive evaluation system. In this study, a systemic evaluation method of T. gondii
environmental contamination was developed by examining soil oocyst contamination in
combination with wild and domestic animal infection on a farm. The study was conducted on a
typical dairy farm in East Tennessee from May 2016 to April 2017. Twenty-two soil samples were
collected from two cat habitats on the farm. Oocysts in the soil were sucrose-floated and subjected
to DNA extraction and PCR-RFLP. Three (13.6%) samples were PCR-RFLP positive; however,
T. gondii DNA was not consistently detected from these three samples on repeat testing. Rodents
and mesopredators were trapped on the farm with blood and or tissue samples obtained.
Serological tests via Modified Agglutination Test revealed that at a cutoff of 1:25, 18.5% (5/27)
of house mice, 40% (2/5) of white-footed mice, 70.6% (12/17) of raccoons and 50% (1/2) of farm
cats, were seropositive for T. gondii antibodies; no antibodies were found in one brown rat, six
cotton rats, one mole, sixteen opossums, and two skunks. Twenty-nine tissues samples from
rodents were also collected and subjected to PCR detection. T. gondii was not found in any of the
tissues of twenty-nine rodents via PCR-RFLP; however, one house mouse was positive for
Hammondia hammondi and another house mouse for Sarcocystis spp. Sera from thirty heifers from
the same farm were seronegative using MAT. In summary, soil sample oocyst contamination may
be not sensitive to determine T. gondii contamination, considering the low oocyst concentration in
soil due to the significant dilution of oocysts by soil. Further, our results indicated that mesopredators such as raccoons and cats are better indicators of T. gondii infection.
Keywords: T. gondii environmental contamination, oocyst, serological test.
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Introduction
Toxoplasma gondii is a coccidian parasite that has a broad spectrum of hosts, including humans,
mammals, and birds (Dubey, 2010). T. gondii chronically infects one-third of the global human
population and 6.7% of U.S. born individuals 12 to 49 years old (Jones et al., 2014). Seronegative
pregnant women are susceptible to T. gondii infection, creating a significant public health threat
due to the potential devastation to the fetus (Dubey, 2010). A fetal infection has a broad spectrum
of ramifications, including stillbirth, spontaneous abortion, and various congenital disabilities in
newborns (Dubey, 2010). There are an estimated 400-4000 cases of congenital toxoplasmosis each
year in the U.S. (Jones et al., 2001). Life-threating outcomes are seen in individuals with
compromised immune systems including HIV or cancer patients (Dubey, 2010). In immunecompetent people, infection generally consists of mild symptoms, such as fatigue or malaise;
however, infection can result in intensive hospitalization despite the competent immune system of
these patients. More serious cases likely result from infection with highly virulent strains of T.
gondii (Dardé et al., 1998).
T. gondii uses felids as definitive hosts. The central role of cats in T. gondii transmission
was validated as there was no or less T. gondii infection in areas without cats (Wallace, 1969).
Upon infection, felines, such as free-roaming domestic cats, shed millions of oocysts into the
environment (Dubey, 2010). These oocysts can be dispersed into environmental matrices including
water, vegetables, soil, and fruits. Intermediate hosts, such as humans and livestock, contract
infection via inadvertently ingesting oocysts disseminated in the environment.
As a companion animal of humans, the cat population increased with the growth of the
economy and human society. There are approximately 78 million domestic cats and 73 million
feral cats in the U.S. (Dubey, 2010). An average of 30% of cats worldwide is seropositive for T.
gondii, indicating a current or previous shedding of oocysts and a potential re-shedding upon
reinfection (Dubey, 2010). The number of oocysts one cat can shed ranges from 3 to 810 million
over the shedding period of approximately one week. In California, the annual average oocyst
burden in soil ranges from 94 to 4671 oocysts per square meter (Dabritz et al., 2007). Aside from
their abundance, oocysts are hardy and resistant. Outdoors (6℃-36℃), oocysts can survive for 46
days when feces are uncovered, 334 days in covered feces, and 18 months in feces buried under
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3-9 cm in soil (Dubey, 1998; Frenkel et al., 1975). The concentration of the disinfectants used to
sterilize drinking water such as sodium hypochlorite and ozone are unable to kill oocysts. High
infectivity is another attribute of oocysts, which, further, perpetuates the transmission of the
parasite. One oocyst alone can experimentally infect a pig (Dubey et al., 1996) or a mouse (Dubey,
2006).
The stability, high infectivity, and abundance of oocyst contribute to the successful
transmission of T. gondii, posing a threat to the public health. Inadvertently ingesting oocysts is
the primary source of human infection of T. gondii (Jones and Dubey, 2010). Severe clinical
toxoplasmosis outbreaks have been associated with ingesting oocysts in drinking water or food
(Bowie et al., 1997; De Moura et al., 2006). Oocysts have been identified as being responsible for
78% of congenital infections in North America (Boyer et al., 2011). Oocysts in the soil can be
washed off from terrestrial environments into large water bodies, leading to the infection of marine
animals. T. gondii infection in aquatic mammals in California and the Amazon river signified
oocyst contamination of water (VanWormer et al., 2014).
The surveillance of T. gondii contamination in the environment is critical to assess the
infection risks in both humans and animals. T. gondii infection in farm animals raised for human
consumption poses a risk for human infection on account of human consumption of undercooked
meat. The soaring demand for meat products from organically raised animals increased the odds
of human infection (Weigel et al., 1999). Recent studies have shown that the non-confinement
raised pigs have a higher rate of T. gondii infection (Dubey et al., 2012; Guo et al., 2016). The
evaluation of T. gondii environmental contamination is fundamental for the development of
methods to reduce the contamination. Controlling T. gondii environmental contamination is of
great importance to reduce human infection, thus alleviating the social and economic burden of
toxoplasmosis. To this end, it is imperative to establish a practical procedure to monitor T. gondii
contamination in the environment.
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Materials and Methods
Sample collection
The twenty-two soil samples were collected from a dairy farm (Figure 3.1A)- the Little River
Animal and Environmental Unit. The farm was located in Walland, Tennessee on 529 acres of
land. The farm is affiliated with the University of Tennessee and was mainly used for research and
education purposes. With a primary emphasis on milk and Holstein cow production, this farm is a
representation of the modern dairy farm. There were roughly eight feral cats on the farm according
to the farmers, which were kept for rodent control. The cats were fed by the farmers and had the
freedom to hunt. Twenty-two soil samples were collected from the farm in May 2016 (Figure
3.1B). Two locations were chosen for soil sample collection where cats were fed, resting, or seen
free-roaming (Figure 3.2A). The first location (N 35° 46.005’; W 083° 50.455’) was the calf raising
area where cats were fed and resting (Figure 3.2A, location # 1); The second location (N 35°
46.142’; W 083° 50.546’) was the maintenance shop and silage storage area, where cats were
found free-roaming (Figure 3.2A, location # 2). In each location, soil sampling sites were
intentionally chosen to greatly disperse over a large area and to represent different vegetative
cover. At each site, surface soil with a depth of no more than 2 cm in an area of 10 cm by 10 cm
was collected in bags. Approximately 20 g of soil from each site was collected and stored at 4℃
before processing.
Sugar floating method for oocyst extraction
Sugar floating method was used to float oocysts in soil (Figure 3.2B) (Lelu et al., 2011). First, soil
samples were dried and passed through a sieve with a mesh size of 2 × 2 mm at room temperature.
For each sieved soil sample, 5 grams or 10 grams were taken for testing. In a 50 ml tube, 5 g of
soil was mixed with 5 ml of 2% sulfuric acid. The mixture was then incubated at 4℃ overnight
and diluted with 15 ml ddH2O the following day. In a new 50 ml tube, 20 ml cold sucrose solution
(cane sugar; density: 1.20) was overlaid with the soil sample, which was subsequently centrifuged
at 1500 × g for 20 min. The aqueous phase (approximately 10 ml) and interphase (approximately
10 ml) were collected separately or collectively (Figure 3.2B) to test the location where oocysts
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concentrate in the solution after centrifugation. The content was washed and finally suspended in
100 µl ddH2O.
PCR-RFLP for oocyst detection
The concentrated oocysts were subjected to three cycles of freeze (-80℃) and thaw (+20℃) with
no fewer than 4 hours at each temperature. DNA was extracted from the oocyst lysates using
NucleoSpin soil DNA extraction kit (Macherey-Nagel, Duren, Germany; Cat: #740780.50). PCRRFLP targeting 18S ribosomal RNA (18S rRNA) gene was used for T. gondii detection using
extracted DNA (Silva et al., 2009). This PCR-RFLP method was able to differentiate T. gondii
from other closely related apicomplexans (Hammondia hammondi, Neospora caninum,
Sarcocystis spp) without sequencing. The 25 µM external primers Tg18s48F/Tg18s 359R and 50
µM the internal primers Tg18s 58F/Tg18s 348R were used for nested PCR amplification (Silva et
al., 2009). The PCR product was 290 base pairs in the case of Sarcocystis neurona, N. caninum,
T. gondii, and H. hammondi; a 310 base pair product was generated in the case of other Sarcocystis
spp. Restriction enzymes Ddel, Hpy188III, and MspI were used to digest PCR products to
differentiate among T. gondii, H. hammondi, N. caninum and Sarcocystis spp. Positive controls
included in our study were DNA from T. gondii (PTG strain) cell lysates, extracted DNA from H.
hammondi oocysts, and DNA from N. caninum cell lysates.
The same PCR-RFLP method was used to detect T. gondii in tissues of twenty-nine trapped
rodents. Five grams of tissues from brain and heart of trapped rodents were combined and
homogenized. DNA was extracted from 100 µl of homogenized tissue (100 grams) using DNeasy
Blood & Tissue Kit (Qiagen, Cat. No. 69504) and eluted in 100 µl AE buffer.
The efficiency of oocyst detection from soil
To test the sensitivity of the sugar floating method, H. hammondi oocysts (105 or 106) stored in
our lab were spiked into 5 grams of T. gondii-negative soil. H. hammondi was used as a substitute
for T. gondii due to its inability to infect humans and its close relation to T. gondii genetically
(Silva et al., 2009). The spiked soil samples were subjected to the same procedure as mentioned
above for oocyst detection.
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Animal trapping and the detection of T. gondii infection
Animals on the farm were trapped to investigate the prevalence of T. gondii infections. Two
periods of trapping were conducted from September 2016 to April 2017 (Figure 3.3). During the
first trapping period from September 2016 to November 2016, only rodents were trapped. The
second trapping period from December 2016 to April 2017, both rodents and meso-predators were
trapped; however, rodent trapping was terminated after March 5th, 2017 due to low seroprevalence
in rodents. Animal trapping and handling were conducted in compliance with the procedures
approved by the Institutional Animal Care and Use Committee (IACUC). Sherman traps (50-90)
and Tomahawk traps (10) were used to trap small rodents and meso-predators, respectively. Traps
were set at dusk and checked before dawn. Oatmeal was used as rodent bait, whereas sardine was
used as bait for meso-predator trapping. For rodent anesthesia, cotton balls soaked with isoflurane
were placed in traps. Rodents were then euthanized by heart injection of pentobarbital (Fatal-Plus
Solution, 390mg/mL) at a dose of 3.9 mg per gram of rodent body weight. Animal carcasses were
kept on ice and immediately transferred to the laboratory. Approximately 100 µl of blood sample
was collected from each rodent. Heart and brain tissues were also collected from each rodent.
Meso-predators were sedated using Ketamine (100mg/ml) and Xylazine (20mg/ml) at doses of 16
mg/kg and 3.2 mg/kg per kilogram of animal body weight, respectively. The weight of the animal,
pulse per min, breathing per min, and rectal temperature were recorded for each captured mesopredator. No more than 8% of animal total blood volume was taken during anesthesia.
Trapping was conducted in two major areas with distinct proximities to farm buildings
(Figure 3.1A, red and orange circles). Each trapping area had an approximate radius of 500 meters.
At the location near human settlements (Figure 3.1A, orange circle), trapping was conducted in
two primary locations- hay bales number #1 and number #2 (Figure 3.1B). At the location away
from farm buildings (Figure 3.1A, red circle), two brush piles (Figure 3.1C) were places where
trapping were densely conducted. Additional trapping locations along the Little River and within
the brush pile zone were delineated in yellow lines in Figure 3.4. Trapping locations were adjusted
to reach the maximum trapping potential. Both serum and tissues (brain and heart) of trapped
rodents were collected, whereas only sera were collected from trapped mesopredators. Tissues of
meso-predators were not collected unless animals were previously tested as seropositive for T.
gondii. Thirty heifer serum samples were obtained from farm veterinarians. Serum samples from
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trapped animals or heifers were tested via Modified Agglutination Assay (MAT) (Dubey and
Desmonts, 1987). The cutoff value was set at 1:25 which is the commonly used cutoff value
(Dubey et al., 1995a and 1995b); however, results using 1:50 as cutoff were also summarized for
comparison.

Results
Soil oocyst detection
To test the efficacy of the methodology, namely oocyst extraction in conjunction with PCR-RFLP
detection, we spiked 105 or 106 H. hammondi into 5 or 10 grams of T. gondii-negative soil samples.
We were able to detect H. hammondi from 5 or 10 grams of soil with 105 or more oocysts, which
indicated that the methodology was effective (Figure 3.5). To determine where the oocysts
concentrate in the centrifuged sugar solution, the aqueous layer (denoted with a letter “T”) and the
interphase (denoted with a letter “I”) were collected separately at the early stage of the study; and
the combined aqueous layer and the interphase were taken during the later period of this study. H.
hammondi was detected in solution from the interphase (Figure 3.5, P3I and P4I) or in mixed
solution combining the interphase and the aqueous layer (Figure 3.5, P2TI), but not in top aqueous
layer (Figure 3.5, P1T, P3T and P4T), indicating that H. hammondi oocysts concentrate in the
interphase.
DNA extracted from the concentrated oocysts from 5 grams of soil were subjected to PCRRFLP. On a 96-well plate, 25 percent of negative controls (sample to negative control ratio equals
to 3:1) were incorporated in the PCR-RFLP, for which DNA was replaced by water in PCR
reaction mix (Figure 3.5, Table 3.2). Positive controls using DNA from T. gondii (PTG strain), N.
caninum, and H. hammondi were also included (Figure 3.5, Table 3.2). The same experiment was
repeated the following day (Figure 3.5B). In the first test, T. gondii appeared in the positive
controls (PTG strain) and in soil samples number # 2 and number # 11 (Figure 3.5A, Table 3.2).
In the repeat experiment, number # 21 was positive for T. gondii, and earlier positive samples (#
2 and # 11) were not consistently positive (Figure 3.5B, Table 3.2). For validation, another 5 grams
of soil from each of the 22 samples were subjected to the same procedure as mentioned above. No
positive samples were detected using PCR-RFLP (Table 3.3). We further investigated whether
78

double the amount of soil would yield positive results. To that end, 10 grams of soil sample were
processed and subjected to PCR-RFLP (Table 3.3). No positive samples were detected. The
inconsistency of positive results across the independent tests suggests that the oocyst concentration
in the 22 soil samples was low relative to the sensitivity of the detection system.
Rodent trapping and T. gondii detection
Total forty rodents, both wild and domestic, were trapped with blood and tissue samples (heart and
brain) taken (Figure 3.4; Table 3.1). Serum samples were obtained from these 40 rodents, including
twenty-seven house mice, one brown rat, five white-footed mice, six cotton rats, and one mole
(Table 3.1). Two major trapping locations (hay bales number #1 and number #2) for domestic
house mice were indicated in Figure 3.1B and Figure 3.5. House mice were captured close to
human settlements (Figure 3.1A, yellow cycle), whereas the wild rodents were captured in areas
away from human settlements (Figure 3.1A, red cycle).
Serological tests via MAT revealed that with a cutoff at 1: 25, 18.5% (5/27) of the house
mice, 40% (2/5) of white-footed mice, 0% (0/1) of brown rats, 0% (0/6) of cotton rats and 0% (0/1)
of moles were positive for T. gondii antibodies. However, the positivity of rodents significantly
decreased with a cutoff set at 1:50. With a cutoff at 1:50, 3.7% (1/27) of house mice and 0% (0/5)
of white-footed mice were T. gondii seropositive. Brain and heart tissues from 29 rodents,
including seventeen house mice, five white-footed mice, five cotton rats, one brown rat, and one
mole, were subjected to PCR-RFLP. DNA was extracted from combined heart and brain tissues
and was subjected to PCR-RFLP for T. gondii detection. Four samples were positive for T. gondii
during the first test. However, these four samples were not consistently positive in the subsequent
experimental tests. Two samples, however, were consistently positive with one being H.
hammondi and the other being Sarcocystis spp (Table 3.4). No sample was found consistently
positive for T. gondii, indicating the absence of T. gondii DNA or the extremely low concentration
of T. gondii DNA in these tissues (Table 3.4).
Mesopredator trapping and T. gondii detection
Eighteen opossums were responsible for the sixty-eight captures (Figure 3.6). Due to the repeated
capture of the same animal, the home range of opossum was revealed. Note worthily, opossum
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number # 81, # 43 and # 47 were caught 15, 13 and 9 times, respectively at various locations,
among which, number # 47 had the largest home range (Figure 3.6). Seventeen raccoons were
responsible for the 25 captures (Figure 3.6). One otter was captured, but the attempt for blood
sampling was futile. Two skunks and two farm cats were responsible for 4 and 3 captures,
respectively (Figure 3.6). Serum samples were obtained from seventeen raccoons, sixteen
opossums, two farm cats, and two skunks (Table 3.1). When the cutoff value was set at 1:25, 70.6%
(12/17) of raccoons and 50% (1/2) of farm cats, 0% (0/16) of opossums and 0% (0/2) of skunks
were serologically positive for T. gondii (Table 3.1). When cutoff value was set at 1:50, 52.9%
(9/17) of raccoons and 50% (1/2) of farm cats positive for T. gondii (Table 3.1). All thirty heifer
serum samples were negative for T. gondii antibodies. Attempts to isolate parasites from animal
tissues was not conducted due to no recapture of T. gondii seropositive animals. Raccoons number
# 74 and number # 88 were recaptured and were seropositive at titer 1:100 and 1:25, respectively.
No parasite isolation was attempted due to their low titer (>=1:50) based on the first serological
test before the final titration.

Discussion
The stability, high infectivity, and abundance of oocysts ensure the perpetuation of the T. gondii
life cycle, which raises compelling public health concerns. Inadvertently ingesting oocysts
disseminated in the environmental matrices, such as soil, water, vegetables, and fruits, is an
important source of human infection of T. gondii. In Brazil, ingesting oocysts in drinking water or
food was the primary source of infection (Bahia-Oliveira et al., 2003). A myriad of studies have
substantiated that oocyst-mediated transmission route was more significant than tissue cystmediated transmission. First, oocyst induced infections are more severe than those induced by
orally ingesting bradyzoites in tissue cysts (Dubey, 1997a; Dubey et al., 1997b). Severe clinical
toxoplasmosis outbreaks were reported to be linked with ingesting oocysts in water or food (Boyer
et al., 2011; Bowie et al., 1997; Dubey, 2004; Moura et al., 2006). Second, oocysts are implicated
in water-related infection, which may lead to the disease of a considerable number of humans and
aquatic animals (Bowie et al., 1997; Kreuder et al., 2003). Third, oocysts are also associated with
congenital infection. Recent studies demonstrated that oocysts caused 78% of congenital infection
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in North America (Boyer et al., 2011); 43% in Southern Chile (Munoz-Zanzi et al., 2010), and
80% in swine in Southern Chile (Munoz-Zanzi et al., 2012).
Among the routes of T. gondii transmission, soil oocyst ingestion is the most implicated in
animal and human infection. It has been suggested that contacting contaminated soil rather than
handling pigs is responsible for T. gondii infection in farm workers (Weigel et al., 1999). Children
are more likely to be infected on account of frequent soil contact (Dattoli et al., 2011; Stagno et
al., 1980). The soil is the primary environmental matrix harboring oocysts, and through the soil,
oocysts can be dispersed onto food or into water matrices (Santos et al., 2011; Kreuder et al.,
2003). The presence of oocysts in soil heralds the environmental contamination and poses the risk
of human and animal infection. However, the environmental contamination by oocyst is largely
undefined. Published data had suggested that the concentration of oocysts in the environment was
not evenly distributed and that the detection rate of oocysts in soil was low in random areas.
However, the soil oocyst contamination rate was shown to be higher in cats’ habitats (Gotteland
et al., 2014) and their defecation sites (Afonso et al., 2008; Simon et al., 2017). Similarly, a spatial
distribution of T. gondii oocysts in the soil has been investigated on a farm, in which the soil oocyst
contamination rate plummets with distance from cat habitats (Gotteland et al., 2014). However, in
our study, we were unable to consistently detect oocyst in the 22 soil samples collected from two
cat habitats. The lack of positive sample signifies the absence of oocysts, or the extremely low
concentration of oocyst in the soil, which falls below the detection limit of our tests. Our results
coincide with the publication by Davis et al., in which no positive sample was detected from the
120 soil samples collected from the University of Hawaii at Mãnoa (Davis et al., 2017). However,
our study contradicts a report of high oocyst contamination rate (30.3%) in soil; nine thousand soil
samples were collected from Harbin, a northeastern city, in China; random locations to represent
land use and vegetative cover were chosen for soil collection (Gao et al., 2016).
Sugar floating technique was widely used to isolate oocysts from soil samples to eliminate
PCR inhibitors such as humic acid (Lelu et al., 2011). However, the sugar floating process also
might lose a certain number of oocysts. A recent study had modified the conventional floating
method by underlying a sugar solution with the soil suspension, generating a 10-fold higher yield
(Lelu et al., 2011). The detection sensitivity of oocysts in soil depends on oocyst sporulation status,
oocyst age as well as soil features. Sporulated oocysts, young oocysts, and soil with less sand
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reveal higher recovery rates (Lelu et al., 2011). With one-year-old or younger oocysts, a minimum
detectable concentration of 100-1000 oocysts per gram of soil has been reported (Afonso et al.,
2008).
Three cycles of free-thaw were shown to be effective to lyse oocyst for subsequent DNA
extraction (Manore et al., 2019). NucleoSpin soil DNA extraction kit (Macherey-Nagel, Cat. No.
740780) outcompeted four other DNA extraction kits in the detection of 50 spiked T. gondii
oocysts per gram of fecal sample (Herrmann et al., 2011). However, the DNA extraction process
also lost DNA as evidenced by a 100-time detection limit difference with or without DNA
extraction using lysed oocyst (Gerhold et al., 2015). In our study, attempts were made to detect T.
gondii directly from lysed oocyst without DNA extraction according to Gerhold et al. However,
concerns regarding PCR inhibition (inhibitors in the soil) as well as T. gondii contamination
strangled the continuation of directly using oocyst lysates for PCR; therefore, DNA extraction was
conducted before PCR detection. In our method of PCR-RFLP following sugar floating and DNA
extraction , we were able to detect H. hammondi DNA from 5 grams of soil experimentally seeded
with 105 and 106 H. hammondi oocysts.
In addition to using soil contamination to evaluate the contamination rate of the farm,
animal infection was investigated. Animals, either domestic animals or wild animals, contract
infections via ingesting oocysts disseminated in feeds, water, and soil (Weigel et al., 1995;
Lehmann et al., 2003). Oocysts have been found in pig feeds, soils, and water (Weigel et al., 1995).
Therefore, the seroprevalence of farm animals can help to assess T. gondii contamination on the
farm. It has been shown that the infection of farm-associated animals was closely associated with
the density of cats and their activities. The infection rate of finishing pigs positively correlates with
the number of cats on farms (Weigel et al., 1995). There was a positive correlation between the
seroprevalence of wild animals and the proximities of their habitats to pig stiles where cats
frequently roamed (Lehmann et al., 2003).
A partition of animal species was observed as wild and domestic rodents were captured in
landscapes with distinct proximities to human settlements. Twenty-seven house mice and one
brown rat were captured in the areas close to farm buildings, that were hay bale #1 and #2 (Figure
3.1B and 3.4); whereas the wild rodents, including five white-footed mice, seven cotton rats, and
one mole, were captured in the woods away from human dwellings (Figure 3.1C and 3.4).
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However, one house mouse was caught in the woods away from human households (Figure 3.1C
and 3.4).
Several serological tests for T. gondii antibody examination have been developed in the
laboratory. Sabin-Feldman dye test (DT) used to be the benchmark of the serological test but was
replaced due to the safety issues of working with live parasites (Dubey et al., 1988). The indirect
fluorescent antibody test is highly specific but is complicated due to the involvement of fluorescent
microscope and fluorescent-labeled antibodies (Dubey et al., 1988). ELISA shows high sensitivity
and specificity (Gamble et al., 2005) but requires further refinement of procedures (Dubey et al.,
1995a). MAT is less sophisticated and shows high sensitivity and specificity, thus being widely
used in serological tests (Shaapan et al., 2008; Afonso et al., 2006; Gamble et al., 1999). One
caveat of the serological test is that seronegative animals (i.e., rodents and avian) can still harbor
parasites. Another drawback of the serological test (i.e., MAT) is that it is difficult to determine
the cutoff value for different species without specific testing. The infection rate of T. gondii in
small rodents has been reported to be low. A large-scale survey revealed that the infection rate in
house mice was 0.7% (6/884) (Hejlícek and Literák, 1998). Our MAT results (cutoff: 1:25) showed
that the seropositivity of house mice and white-footed mice are 18.5% (5/27) and 40% (2/5),
respectively. The results using cutoff at 1:50 were also listed in Table 3.1. With a cutoff at 1:50,
the seropositivity in house mice was 3.7% (1/27), and no other rodents trapped was found positive
for T. gondii. Bioassay in mice or cats is the definitive route for T. gondii detection. The bioassay
was not conducted in our study because serum samples were either positive at low titer or negative.
Taken together, the serological testing of rodent serum sample is not a good indicator of T. gondii
infection.
It has been known that T. gondii infection rate in cattle is low and that cattle are resistant
to T. gondii infection (Dubey et al., 2005). No positive sample was identified in the thirty heifer
sera, which coincided with previous studies. Among the trapped mesopredators, the raccoon had
the highest infection rate (70.6%). In addition, one farm cat (50%) was infected, suggesting the
previous shedding of oocysts onto the farm. The higher infection rate of T. gondii in raccoons is
likely because being generalists, they have a broad spectrum of food sources. Further, raccoons
are susceptible to T. gondii infection. A recent study has shown that 59.2% (32/54) of raccoons
and 71.4% of skunks (5/7) captured in the state of Wisconsin were seropositive for T. gondii
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(Dubey et al., 2007a). Viable T. gondii was isolated from 5 of the 30 seropositive raccoon samples,
and 1 of the five skunk samples (Dubey et al., 2007a). In Canada, T. gondii was isolated from
tissues of 2 raccoons, two feral cats, and one skunk (Dubey et al., 2008b). In our study, the two
skunks were seronegative for T. gondii. It is perplexing that the sixteen opossums in our study
were all T. gondii negative. The seroprevalence in opossums varies among studies, and very few
isolates were obtained from opossums (Jiang et al., 2018). Dubey et al. (1995b) have reported a
22.7% (29/128) seroprevalence (MAT, cutoff at 1:25) in opossums trapped on 47 swine farms in
Illinois. However, the bioassay was not deployed to isolate the parasite (Dubey et al., 1995b).
Gerhold et al. had repoted a 50% (6/12) seroprevalence in opossums from southeastern U.S.
(Gerhold et al., 2017). The possible explanations for the current observation are, 1) opossums are
resistant to T. gondii infection, and or, 2) they are immunotolerant to T. gondii in addition to having
short life-spans as is the case in house mice.

Conclusions
Further study of T. gondii infection rate in these animals is imperative to understand not only the
susceptibility of these animals to T. gondii infection but also the contamination rate of the
environments where these animals inhabit. Taken together, our study showed that mesopredators,
especially the raccoon and cat, would be a suitable animal model to monitor T. gondii
environmental infection. Further research should focus on investigating animal infection as a
critical parameter to assess the environmental contamination especially in areas with low soil
contamination.
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Chapter 3 Appendix

50m
1km

50 m

Figure 3. 1 Soil sampling and animal trapping locations on the Little River farm. A) Two
trapping locations, near farm buildings and near the forest, were marked in yellow and red circles
with different proximities to human settlement. B) Two soil sampling locations were marked in
red circles; two trapping locations were marked in white circles. C) The two major trapping
locations were marked with red arrows.
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Note: for diagrammatical purposes; not to scale

Figure 3. 2 Two locations for soil sample collection. A) location #1 is the calf raising area where
cats were found feeding, resting and free-roaming. Location #2 is the maintenance shop and silage
storage area where cats were seen free-roaming. B) A schematic presentation of the sugar floating
for oocyst enrichment. Stages of before and after centrifugation were shown.
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Figure 3. 3 Trapping dates and statistics. (a). The first trapping period (09/2016 – 11/2016).
Trapping only targeted small rodents. Sherman traps (50-90) were set on the farm property in the
evening and examined the following morning. Sample from one trapped house mouse was not
obtained due to handling error (b). The second trapping period (12/2016 – 4/2017). Trapping
targeted small rodents and mesopredators during this period, although rodent trapping was
terminated after 3/5/2017. Sherman traps (50-90) and Tomahawk traps (10) were set on the farm
property in the evening and examined in the following morning. Animals in cages were counted
regardless of recapture or the success of blood sampling. Trips with no animal captured were
marked with inverted blue triangles.

93

200 m

Figure 3. 4 Locations for animal trapping as well as soil sampling on the farm. House mice
were trapped in hay bale #1 and #2 (white circles); wild rodents and meso-predators were trapped
along/across the river, along the woods, and around two brush piles. Soil was collected from two
cat habitats (red circles).
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Figure 3. 5 Soil oocyst detection via PCR-RFLP. Either the top aqueous layer (T) or the
interphase(I) or both (TI) were collected. PCR-RFLP was performed after DNA extraction. N
denotes negative control. M denotes marker. Positive controls are DNA from T. gondii (PTG), N.
caninum (Nc-1), and H. hammondi (Hh). 105 (in the case of P1T, P3I, P3T) or 106 (in the case
of P2TI, P4I, P4T) H. hammondi oocysts were spiked in 5 grams of soil samples to test the
efficiency of the detection method.
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200 m

Figure 3. 6 The trapping locations of meso-predators on the farm based on GPS coordinates.
Each teardrop is one GPS coordinate. At each GPS coordinate, total number of animals captured
or recaptured were counted; animal species and ID (ear tag No.) were also indicated. Opossum
#43 was marked in red to show its relatively wide home range.
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Table 3. 1 Seroprevalence of Toxoplama gondii in captured animals on the farm.

Species

No. of
sera
tested

Titer

<25

25

50

100

200

400

800

1600

10,000

³ 20,000

% positive
sera (cutoff
at 1:25)

% positive
sera (cutoff at
1:50)

House
mouse

27

22

4

1

0

0

0

0

0

0

0

18.5% (5/27)

3.7% (1/27)

Brown rat

1

1

0

0

0

0

0

0

0

0

0

0

0

5

3

2

0

0

0

0

0

0

0

0

40% (2/5)

0

6
1

6
1

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

Raccoon

17

5

3

0

2

0

2

1

2

1

1

Opossum

16

16

0

0

0

0

0

0

0

0

0

0
0
70.6%
(12/17)
0

Farm cat

2

1

0

0

0

0

0

0

1

0

0

50% (1/2)

50% (1/2)

Skunk

2

2

0

0

0

0

0

0

0

0

0

0

0

Whitefooted
mouse
Cotton rat
Mole

52.9% (9/17)
0
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Table 3. 2 PCR-RFLP results of 22 soil samples (first five grams of soil) collected from the little
river farm.

Sample ID
#1c
#2d
#3
#4
#5

Top
Nb
N
N
N

The first 5g of soil with DNA extractiona
Test #1 (7/11/16)
Repeat #1 (7/12/16)
Interphase
Top
Interphase
Not done
N
No done
T. gondii
N
N
N
N
N
N
N
N
N
N

#6

N

N

N

N

#7
#8
#9
#10
#11
#12
#13
#14

N
N
N
N
N
N
N
N
Band pattern
unknown
N
N
N
N
N
N
N

N
N
N
N
T. gondii
Band pattern unknown
N
N

N
N
N
N
N
N
N
N
Band pattern
unknown
N
N
N
N
N
T. gondii
N

N
N
N
N
N
N
N
N

#15
#16
#17
#18
#19
#20
#21
#22
T. gondii
H. hammondi
N. caninum
Negative
controls
Soil sample
spiked with H.
hammondi

Band pattern unknown
N
N
N
N
N
N
N

T. gondii
H. hammondi
N. caninum
Total 18 negative controls were included,
and all were negative
P1
N
P2
H. hammondi
P3T
N
P3I
H. hammondi
P4T
N
P4I
H. hammondi

N
N
N
N
N
N
N
N

T. gondii
H. hammondi
N. caninum
Total 18 negative controls were included, and all
were negative
P1
N
P2
H. hammondi
P3T
N
P3I
H. hammondi
P4T
N
P4I
H. hammondi

a

DNA was extracted from the soil extracts and then used for PCR-RFLP. P1 and P3 were positive controls
in which 105 H. hammondi oocysts were spiked in 5 grams of soil; P2, P4 were positive controls in which
106 H. hammondi oocysts were spiked in 5 grams of soil.
b
N: negative result.
c
Only top layer was collected for this sample
d
Top and interphase were combined for this sample

98

Table 3. 3 PCR-RFLP results of 22 soil samples (another five or ten grams of soil) collected
from the little river farm.
Sample ID

b

5g of soil-7/14/2016

10g of soil-9/10/2016

Test #1
Not done
Not done
c
N
Not done

Repeat #1
Not done
Not done
N
Not done

Test #1
N
N
H. hammondi
N

Repeat #1
T. gondii
N
H. hammondi
N

N
Unknown band
pattern
N
N
N
N
N
Unknown band
pattern

N

N

H. hammondi

N

H. hammondi

N

N
N
N
N
N

N
H. hammondi
N
N
Unknown band pattern
Unknown band pattern

#13

N

N

#14

N

N

#15

N

N

#16

N

#17

N

N
Unknown band
pattern

N
H. hammondi
N
N
N
Unknown band
pattern
Unknown band
pattern
Unknown band
pattern
Unknown band
pattern
N
N

T. gondii

#18

N

N

#19
#20

N
N

N
N

#21

N

N

#22

N

N

#1
#2
#3
#4
#5
#6
#7
#8
#9
#10
#11
#12

d

a

N

T. gondii
H. hammondi
N. caninum

T. gondii
H. hammondi
N. caninum

Negative controls

Total 15 negative controls were
included, and all were negative

Soil sample spiked
with H. hammondi

P16-1
P16-2
P19-1

H. hammondi
H. hammondi
H. hammondi

P19-2

H. hammondi

P20-1
P20-2

H. hammondi
H. hammondi

Unknown band
pattern
N
N
Unknown band
pattern
Unknown band
pattern

Unknown band pattern
Unknown band pattern
Unknown band pattern
N

Unknown band pattern
N
N
T. gondii
T. gondii

T. gondii
H. hammondi
N. caninum
Total 18 negative controls were included; one
was positive with T. gondii, and one was
positive with H. hammondi
#23-1

N

#23-2
#24-1

N

#24-2

H. hammondi
H. hammondi
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a,b

DNA was extracted from another 5 grams or 10 grams of soil from each sample.
To test if double the soil quantity would yield better results, ten grams of soil sample was subjected to
sugar flotation, DNA extraction, and PCR-RFLP.
c
N denotes negative result
d
Sample 23 and 24 were positive controls in which 106 H. hammondi oocysts were spiked in 10 grams of
soil.
b

100

Table 3. 4 PCR-RFLP results of 29 rodent tissue samples collected from the little river farm.
c
a

Sample ID

The first DNA extraction (11/18/2016)

Test #1
(11/28/2016)

c

The second DNA extraction
(12/2/2016)
Test #1
Repeat #1
(12/6/2016)
(12/6/2016)

Repeat #1
(12/6/2016)
Unknown
band pattern

Repeat #2
(12/6/2016)
Unknown
band pattern

H. hammondi H. hammondi

b

925HM2

T. gondii

1023HM1

H. hammondi

H. hammondi

1029HM1

T. gondii

T. gondii

T. gondii

N

N

1029CR1

T. gondii

N

T. gondii

N

N

1113HM1

T. gondii
Sarcocystis
spp
Unknown
band pattern
Seven
negative
controls were
included, and
all were
negative

N
Sarcocystis
spp

N
Sarcocystis
spp

N
Sarcocystis
spp

N
Sarcocystis
spp

N

N

N

N

1113HM2
1113CR1

Negative
controls

T. gondii
H.
hammondi
N. caninum

N

T. gondii
H. hammondi

Eight negative controls were included, and one was positive
for T. gondii

T. gondii

T. gondii

H. hammondi

H. hammondi

N. caninum

N. caninum

Twenty-nine rodent tissues were included for T. gondii detection using PCR-RFLP. DNA was extracted
from tissue homogenate. Samples that were initially tested negative were not included in this table; these
twenty-two samples included 94HM1, 910rat, 925HM3, 925HM4, 917HM1, 924WM1, 917HM2,
924WM2, 924HM1, 924HM2, 924WM3, 924HM3, 925HM1, 1023HM2, 1023HM3, 925WM1, 1022HM1,
1022WM1, 1029CR2, 1029mole, 1113CR2, 1114CR1.The seven samples that were tested positive were
subjected to further testing as listed in this table.
a

b
d

N: negative result
DNA was extracted from two equal amount of tissue homogenates on different dates
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CHAPTER 4
GENOTYPE IDENTIFICATION OF TOXOPLASMA GONDII IN
MACROPODS FROM A ZOOLOGICAL PARK IN FLORIDA, USA
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Abstract
Toxoplasma gondii is a common cause of mortality in macropods, but there are limited reports of
the genetic characterization of T. gondii infecting captive macropods in North America. A novel
genotype, ToxoDB PCR-RFLP genotype #263, was reported from six wallabies at a zoological
facility in Virginia, USA, prompting an investigation into the genotypes infecting macropods at a
zoological park in Florida, USA. Cardiac samples from an agile wallaby (n = 1), red kangaroos (n
= 8), red-necked wallaby (n = 1), and a tammar wallaby (n = 1) that died between 2014 and 2018
were collected. All 11 cases were confirmed to be infected with T. gondii via serology,
histopathology, or parasite isolation. A mouse bioassay was used for parasite isolation, and isolated
parasites were subjected to multilocus PCR-RFLP genotyping of T. gondii. Two cases of
toxoplasmosis were identified as the reported novel genotype, ToxoDB PCR-RFLP genotype
#263, but no common source of exposure could be identified between the two zoos. In addition,
five cases were identified as ToxoDB PCR-RFLP genotype #2 (type III strain), and four cases
were identified as ToxoDB PCR-RFLP genotype #216, a genotype that has been previously
reported in wildlife in North America. In addition, a freckled duck that died of toxoplasmosis at
the same park was genotyped as genotype #2. These results suggest that at least three distinct
sources and transmission events occurred at this park between 2014 and 2018. Genotype
identification can aid in understanding the sources of infective oocysts in a geographic area and
determining whether multiple mortalities are due to single or multiple exposure events. Further
research is needed to determine whether different genotypes vary in pathogenicity in macropods
and to identify effective preventive measures for captive macropods
Keywords: acute toxoplasmosis, genotype, macropod, Toxoplasma gondii
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Introduction
Toxoplasma gondii is a zoonotic intracellular parasite with a worldwide distribution and broad
host spectrum, including mammals and birds (Dubey, 2010). Felidae are the sole definitive host,
with the ability to discharge millions of oocysts into the environment (Dubey et al., 2011). Host
infection occurs through ingestion of oocysts dispersed in the environment, consumption of meat
containing parasite tissue cysts, or vertical transmission during pregnancy (Dubey et al., 2011).
Infection in immunocompetent animals is generally asymptomatic but can cause illness, including
respiratory or neurologic clinical signs, decreased reproductive success, and/or mortality (Dubey,
2010). Latent asymptomatic infection with subsequent recrudescence can occur as well (Dubey,
2010; Portas, 2010). Macropods, including kangaroos and wallabies, are particularly susceptible
to infection and death in North American zoos due to toxoplasmosis (Guthrie et al., 2017; Portas,
2010).
There are over 180 reported genotypes of T. gondii, and different genetic lineages exhibit
distinct geographic distribution (Shwab et al., 2014). In North America, the most commonly
reported lineages include ToxoDB PCR-RFLP genotypes #1 and #3 (collectively known as type
II), genotype #2 (known as type III) in domestic animals, and genotypes #4 and #5 (collectively
known as type 12) in wildlife (Dubey et al., 2011; Shwab et al., 2014). Certain genotypes are
associated with more severe clinical disease in humans, but the relationship between T. gondii
genotype and clinical disease in animals, including macropods, is unknown (Calero-Bernal et al.,
2015; Dubey et al., 2013; Su et al., 2012). A novel genotype, ToxoDB genotype #263, was reported
in six wallabies that died at the Virginia Zoo (Norfolk, Virginia, USA) in 2014 (Guthrie et al.,
2017). Three other wallabies from this zoo were infected with the genotype #4 strain, which was
previously reported in North American wildlife (Guthrie et al., 2017). By identifying the T. gondii
genotypes infecting captive macropods at a particular facility, one may better infer the number of
sources of infective oocysts during toxoplasmosis outbreaks and the pathogenicity of different
strains. Here, we attempted to isolate and/or genotype T. gondii from eleven fatal toxoplasmosis
cases from a zoological facility in Florida, USA.
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Materials and Methods
Animals, collection of samples, histopathology, and medical record review
Between 2014 and 2018, serum and fresh cardiac muscles were collected from a subset of
macropods that died due to suspected or known toxoplasmosis at a single zoological facility in
Florida, USA for T. gondii isolation and characterization. Species from which parasites were
isolation included red kangaroo (Macropus rufus, n = 4), agile wallaby (Macropus agilis, n = 1),
and tammar wallaby (Macropus eugenii, n = 1). Cases were selected for parasite isolation
opportunistically based upon the availability of personnel to complete the sampling and laboratory
mice for the bioassay isolation. The combined frozen heart and lung were used from five additional
cases for PCR-RFLP genotyping, including red kangaroo (n = 4) and red-necked wallaby
(Macropus rufogriseus, n = 1). Additionally, cardiac muscles from a freckled duck (Stictonetta
naevosa, n = 1) that died of toxoplasmosis at the same park was genotyped following the same
methods. The same veterinary pathologist performed a gross necropsy for each case. Tissues were
preserved in 10% neutral buffered formalin and stained with hematoxylin and eosin (H & E) for
histopathologic examination. Fresh cardiac and serum samples were refrigerated at 1.7-3.3°C, and
frozen samples were stored at -20 °C. Samples were shipped overnight to the Department of
Microbiology at the University of Tennessee (Knoxville, Tennessee, USA) for T. gondii detection,
isolation, and genetic characterization.
Medical and necropsy records of macropods that died between 2014 and 2018 at a
zoological facility in Florida, USA were retrospectively reviewed for cases of toxoplasmosis, and
information was collected regarding the clinical signs and treatment of the 11 cases reported herein
(Table 1).
Serologic testing
Serum was collected ante- or postmortem from 7 of the 11 cases. Competitive enzyme-linked
fluorescence assay (ELFA, n = 3) or modified agglutination test (MAT, n = 4) was used to detect
T. gondii antibodies using previously described methods. For ELFA, a positive test value threshold
of <1.6 was used (University of Tennessee Veterinary Medical Center Parasitology, 2019). For
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MAT, a positive dilution cutoff value of 1:25 was used by the method described previously (Dubey
and Desmonts, 1987).
Ethical statement
All procedures of mouse experiment were approved by the Institutional Animal Care and Use
Committee (University of Tennessee, IACUC protocol number 1419).
Bioassay to isolate T. gondii in mice
Bioassays were conducted in accordance with a previously described method (Dubey, 2010).
Briefly, five grams of heart tissues or heart and lung combined were cut into small pieces and
transferred into a 20 ml DT-20 dispenser tube (IKA ULTRA-TURRAX, Sigma-Aldrich, USA).
Fifteen milliliters of saline (0.85% NaCl) were added to the tube. The tissues were homogenized
using the IKA ULTRA TURRAX Tube Drive homogenizer (IKA ULTRA-TURRAX, SigmaAldrich, USA). One hundred microliters of homogenized tissue (approximately 100 mg) were
taken for DNA extraction using DNeasy Blood and Tissue kit (Qiagen; Cat No. 69504). The
homogenized tissues were digested with acid pepsin (Sigma, # P7000-25G) at 37°C for 40-60 min.
The digested tissues were gauze-filtered and washed by PBS and resuspended in PBS containing
10mg/ml gentamicin. One milliliter of prepared tissue in PBS, containing10 µg of gentamicin, was
injected intraperitoneal to each of three outbred CD-1 mice to isolate the parasites. Dexamethasone
phosphate (15 µg/ml) was added in the drinking water to suppress mouse immune response for
better parasite isolation. Mice showing symptoms of T. gondii infection (rough fur, lethargy)
between day 6 and day 12 were euthanized. Five milliliters of PBS with gentamicin were injected
into the peritoneal cavity, and the exudates were collected. One milliliter of peritoneal lavage was
spun down and resuspended in 100 µl PBS and subjected to DNA extraction using the Qiagen kit
above. DNA was eluted in 100 µl of buffer AE.
Genotyping of T. gondii samples
DNA samples directly extracted from heart tissue or combined heart and lung tissues or from
peritoneal lavage of infected mice were subjected to PCR-RFLP typing using 10 genetic markers
(SAG1, SAG2, SAG3, BTUB, GRA6, c22-8, c29-2, L358, PK1 and Apico) (Su et al., 2010).
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Results
Between 2014 and 2018, there were 27 macropod mortalities identified in which toxoplasmosis
was suspected based on histopathology (Fig. 4.1). Species affected included agile wallaby (n = 7),
red kangaroo (n = 15), red-necked wallaby (n = 3), tammar wallaby (n = 1), and western gray
kangaroo (Macropus fuliginosus, n = 1). Of these, 15 were acute or peracute cases of
toxoplasmosis, and 12 had another type of concurrent disease or chronic visual impairment
possibly due to ocular toxoplasmosis and were euthanized. Mortality dates for the animals
described in this reported are as follows: May 2014 (red kangaroo, n = 1; agile wallaby, n = 1),
July 2015 (red-necked wallaby, n = 1), September 2015 (red kangaroo, n = 1), April 2017 (red
kangaroo, n = 1), September 2017 (red kangaroo, n = 1), October 2017 (tammar wallaby, n = 1;
red kangaroo, n = 1), December 2017 (red kangaroo, n = 1), February 2018 (red kangaroo, n = 1)
and May 2018 (red kangaroo, n = 1) (Fig. 4.1). Clinical signs, treatment, serology results, and
necropsy findings from these 11 cases are summarized in Table 1. Peracute or acute death occurred
in 9 of the cases, while two of the cases had clinical signs for 3-4 days in duration. Case #6 was
euthanized due to a deteriorating clinical condition. Clinical signs varied in each case but included
lethargy, inappetence, tachypnea, recumbency, and seizures. Various treatments were attempted
in five cases, including subcutaneous fluid therapy, antibiotics, antiprotozoals, and a diuretic. Six
of the seven cases tested were seropositive at the time of death. MAT titers ranged from 1:50 to ³
8192. The agile wallaby in case 2 had a peracute mortality and was seronegative at the time of
death.
Toxoplasmosis was determined to be the cause of death in 10 of the cases. Concurrent
conditions were identified in some cases, including gastrointestinal ulceration with intralesional T.
gondii and Entamoeba (case 1), chronic ascending cholecystitis (case 2), gastric nematodiasis
(cases 3, 4, 10), gastric foreign material (case 4), minimal otitis externa (cases 7 and 10), jugular
hematoma (case 8), entamoebiasis of proximal saccular stomach (case 10), and bacterial dermatitis
of the pouch (case 10). In case 6, methemoglobinemia was determined to be the cause of death, as
it was severe enough to account for the clinical deterioration necessitating euthanasia. Although
toxoplasmosis was also present, methemoglobinemia was considered the more severe finding.
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Heart tissues from cases 1, 2, 6, 8, and 9 were used for bioassay to isolate T. gondii. Three
isolates were obtained from three red kangaroos (cases, 1, 6, 8) and designated as TgKgrFL1,
TgKgrFL2, and TgKgrFL3 (Table 2). Mice inoculated with heart tissue of case 2 (agile wallaby)
did not show obvious symptoms by day 14 post-infection. In this case, T. gondii was not isolated,
and genotyping was performed using heart tissue DNA. Mice inoculated with tissue of case 9 (red
kangaroo) were severely sick on day 2 post-infection, possibly due to toxic products from
degradation of the tissue (20 days post collection) and were euthanized. Heart tissue DNA was
subsequently used for genotyping of case 9. Case 8 was genotyped using both parasite isolate and
heart tissue DNA. The remaining cases were not bioassayed at the time of death, and genotyping
was performed using either fresh or frozen heart tissue DNA (Table 2).
Genotyping results revealed ToxoDB genotype #263 (cases 1 and 2), genotype #2 (cases
3, 4, 5, 6, 11), and genotype #216 (cases 7, 8, 9, 10) (Table 2). Additionally, a freckled duck from
an aviary adjacent to the macropod exhibit died of toxoplasmosis in July 2017 and was confirmed
to be genotype #2 using tissue DNA from combined heart and lung.

Discussion
Toxoplasmosis is commonly reported in captive macropods (Basso et al., 2007; Dubey and
Crutchley, 2008; Guthrie et al., 2017), and the outbreak occurred from May-June 2014 in this
report is unremarkable. Acute toxoplasmosis progresses rapidly, and sudden death can occur
(Miller et al., 1992, Patton et al., 1986). Treatment was initiated for toxoplasmosis when possible
based on clinical signs and included antiprotozoals, antibiotics, subcutaneous fluids, and diuretic
for treatment of pulmonary edema. Treatment varied depending on the presentation of the animal
and preference of the attending veterinarian. In one report, a trimethoprim and sulfadiazine
combination was used to treat acute toxoplasmosis in wallabies with marginal or no effect (Miller
et al., 1992). Dubey and Crutchley (2008) have reported successful treatment of toxoplasmosis in
four Bennett’s wallabies using atovaquone. Atovaquone has been shown to have a synergistic
effect when administered together with pyrimethamine, clindamycin, or sulfadiazine (Dubey and
Crutchley, 2008). Guthrie et al. (2017) reported the death in macropods due to toxoplasmosis,
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despite treatment with atovaquone. The effect of treatment varies from case to case (Jensen et al.,
1985; Guthrie et al., 2017) but is generally deemed unrewarding (Portas, 2010).
Serologic testing was not clinically useful for antemortem diagnosis in most cases at this
facility due to the rapid progression of clinical signs and death and possibility for a negative result
as seen in case 2 likely due to insufficient time for antibody production or a positive titer due to
chronic or latent infection (Basso et al., 2007; Mayberry et al., 2014). If the clinical course were
long enough to allow repeated testing, the demonstration of a rising titer would support the
diagnosis of toxoplasmosis (Miller et al., 2003).
We confirm the T. gondii genotypes #263, #2, and #216 from the 11 cases of toxoplasmosis
from a zoological park in Florida. This is the first report of genotype #216 in captive macropods.
Although little is known about the genetic characterization of T. gondii infection of wild
macropods, there have been several reports of the parasite’s genotyping from captive macropods.
Genotype #263 (which does not belong to any clonal type) and #4 (clonal type 12) were responsible
for the death of six and three red-necked wallabies in Virginia Zoo, respectively (Guthrie et al.,
2017). Genotype #263 has only been found in the Virginia wallabies and in cases 1 and 2 reported
here to date. It is possible that some or all of the other mortalities that occurred during the MayJune 2014 outbreak, along with cases 1 and 2, were due to this same genotype. It is interesting to
note that this strain was associated with a larger number of mortalities than typical at this zoo in
Florida as well as at the Virginia Zoo as reported by Guthrie et al. (2017). It is unknown if this is
coincidental or due to increased pathogenicity of genotype #263 in macropods. In humans, atypical
genotypes have been reported to cause severe toxoplasmosis in patients without immune
compromise (Dubey et al., 2011). Because genotype #263 is only reported from macropods from
these two facilities, the potential for a common source exposure was investigated. None of the
affected animals were ever housed at the same facility, and the food sources (both concentrate
ration and hay) were confirmed to be different at each facility (M. Spriggs, pers. comm.). Clonal
type III (ToxoDB PCR-RFLP genotype #2) was the one of the four clonal genotypes highly
prevalent in animals in North America and was isolated from one tammar wallaby and two
Bennett’s wallabies (Macropus rufogriseus) in Pennsylvania (Dubey and Crutchley, 2008; Dubey
et al., 2011; Jiang et al., 2018). Two T. gondii strains were isolated from one eastern grey kangaroo
(Macropus giganteus) and one red kangaroo at a zoo in Argentina, identified as clonal type II and
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III, respectively (Moré, et al., 2010). Genotype #6 was isolated from a captive Tammar wallaby
from National Zoo (District of Columbia, USA) and is also found in Africa and Brazil, while an
atypical strain with an undetermined genotype caused the death of a Bennett’s wallaby in Spain
(Dubey et al., 2011; Fernández-Aguilar et al., 2013). In North America, genotype #216 has been
identified in white-tailed deer (Odocoileus virginianus, n = 4), red fox (Vulpes vulpes, n = 4), black
bear (Ursus americanus, n = 2), and feral cats (Felis catus, n = 2) (Jiang et al., 2018).
From May-June 2014 outbreak of 11 mortalities, two cases were genotype #263, while two
cases between July and September 2017 were genotype #2, and three cases between October 2017
and February 2018 were genotype #216, suggesting that at least three different sources of
infections or three transmission events occurred. Precipitation was higher than average in May
2014 at this facility. It has been suggested that heavy rains may periodically wash infective oocysts
into the macropod and adjacent exhibits, but other sources have not been ruled out. Prevention of
toxoplasmosis in captive macropods is challenging given that there is no vaccine, prophylactic
therapy, or practical and effective means of environmental decontamination. Prevention of
exposure to infective oocysts remains key and includes eliminating feral or wild felids from zoo
grounds as well as any place where they have the potential to contaminate food or water sources.
It may also be prudent to design macropod exhibits in a way that prevents storm water, a potential
source of infective oocysts, from running into the exhibit.
Toxoplasma genotyping in captive macropods can provide insights into exposure and
transmission of the parasite within a group and over various timelines. It remains to be determined
whether certain strains are more pathogenic than others, and the prevalence of genotype #263 in
felids or other wildlife species is unknown. Ongoing research into the prevalence, pathogenicity,
and transmission of various genotypes within a geographic area is needed. This information can
help inform prevention strategies to reduce the effects of this important disease in captive
macropods.
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Chapter 4 Appendix

Figure 4. 1 The 20 mortalities of macropods between 2014 and 2018 in Busch Gardens,
Florida. The genotypes of the 11 cases reported in this study were indicated in the figure. The
mortality dates for the animals described in this reported are as follows: May 2014 (red kangaroo,
n = 1; agile wallaby, n = 1), July 2015 (red-necked wallaby, n = 1), September 2015 (red kangaroo,
n = 1), April 2017 (red kangaroo, n = 1), September 2017 (red kangaroo, n = 1), October 2017
(tammar wallaby, n = 1; red kangaroo, n = 1), December 2017 (red kangaroo, n = 1), February
2018 (red kangaroo, n = 1) and May 2018 (red kangaroo, n = 1).
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Table 4. 1 Toxoplasma gondii genotype, signalment, clinical signs, serology results, treatment, and necropsy findings from 11 macropod
mortalities diagnosed with toxoplasmosis at a zoological facility in Florida, USA.
Case
#

Genoty
pe #
(Isolat
e ID)

Species

Sex

Location
of birth

Date of
death

Age at
time of
death
(years)

Clinical
signs and
physical
examinatio
n findings
Inappetenc
e, lethargy,
dehydration
, tachypnea
Easily
approachab
le, sudden
collapse

Duration of
signs prior
to death
(days)

1

#263
(TgKg
rFL1)

Femal
e

Tampa,
FL
(BGT)

5/22/2014

0.8

2

#263

Red
kangaroo
(Macropus
rufus)
Agile
wallaby
(Macropus
agilis)

Femal
e

Kangaro
o
consevat
ion
center

5/22/2014

8.3

3

#2

Red-necked
wallaby
(Macropus
rufogriseus)

Femal
e

Tampa,
FL
(BGT)

7/24/2015

4

#2

Red
kangaroo

Male

Chatfiel
d

5

#2

Red
kangaroo

Male

Tampa,
FL
(BGT)

Serology
result at time
of death1

Treatment

Significant
comorbidities

1

Positive
(ELFA)

Fluid therapy2

None

Peracute
death

Negative
(ELFA)

None

Bacterial
cholecystitis =
(E. coli,
Acinetobacter
baumannii, and
Enterococcus)

1.6

Found dead

Peracute
death

Not done

None

None

9/11/2015

6.0

Diarrhea

Positive
(MAT titer ³
8192)

Fluid therapy2,
sulfadimethoxi
ne/pyrimetham
ine3
None

None

4/6/2017

0.5

Found dead

1

Peracute
death

Not done

None
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Table 4.1 Continued

1

Case
#

Genoty
pe #
(Isolat
e ID)

Species

Sex

Location
of birth

Date of
death

Age at
time of
death
(years)

Clinical
signs and
physical
examination
findings
Weight loss,
lethargy,
tachypnea,
grey mucous
membranes

Duration of
signs prior
to death
(days)

Serology
result at time
of death1

Treatment

Significant
comorbidities

6

#2
(TgKg
rFL2)

Red
kangaroo

Male

Unknow
n,
acquired
from
chatfield

9/10/2017

8.3

4

Positive
(MAT titer
1:1600)

Idiopathic
methemoglobin
emia

Easily
approachabl
e, lethargy,
tachypnea

3

Positive
(MAT titer
1:50)

Fluid therapy2,
ceftiofur
crystalline free
acid4,
ponazuril5,
euthansia
None

7

#216

Tammar
wallaby
(Macropus
eugenii)

Femal
e

10/3/2017

8

#216
(TgKg
rFL3)

Red
kangaroo

Femal
e

Wild?
Acquire
d from
Lincoln
chidren’
s zoo
Tampa,
FL
(BGT)

4.5

10/19/201
7

1

Recumbency
, tachypnea,
seizures

<1 day

Positive
(MAT titer ³
1:3200)

Fluid therapy2,
atovaquone6,
furosemide7

None

9

#216

Red
kangaroo

Femal
e

Tampa,
FL
(BGT)

12/20/201
7

1.2

Recumbency
, seizures

Peracute
death

Not done

None

None

10

#216

Red
kangaroo

Femal
e

Tampa,
FL
(BGT)

2/18/2018

1.3

Lethargy,
shaking,
tachypnea

1

Not done

Atovaquone6,
ponazuril5,
furosemide7,
antibiotic

None

11

#2

Red
kangaroo

Femal
e

Zoo
Atlanta

5/30/2018

8.3

Found dead

Peracute
death

Positive
(ELFA 0.4)

None

None

None

ELFA = competitive enzyme linked fluorescence assay; no titer is reported. MAT = modified agglutination test, >1:25 considered positive
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2

Lactated Ringer’s Injection USP (Hospira, Lake Forest, Illinois, USA), 40 ml/kg, SQ (case 1); 32 ml/kg, SQ (case 4); 27 ml/kg, SQ (case 6); 22 ml/kg, SQ (case
8)
3
Sulfadimethoxine/pyrimethamine suspension (250 mg/ml and 12.5 mg/ml), 32 mg/kg, PO
4
ExcedeÒ ceftiofur crystalline free acid (200 mg/mL, Zoetis, Parsippany, New Jersey, USA), 5.4 mg/kg, SQ (case 8); 6.5 mg/kg, SQ (case 10)
5
MarquisÒ (15% w/w ponazuril, Merial, Duluth, Georgia, USA), 1.6 mg/kg, PO (case 3); 21.4 mg/kg, PO (case 10)
6
Mepron® Atovaquone suspension (750 mg/5 ml, GlaxoSmithKline, Philadelphia, Pennsylvania, USA), 21.9 mg/kg, PO (case 8); 97.4 mg/kg, PO (case 10)
7
SalixÒ furosemide (50 mg/ml, Merck, Madison, New Jersey, USA); 2.2 mg/kg, IV (case 8); 1.9 mg/kg, IM (case 10)
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Table 4. 2 Results of PCR-RFLP typing of Toxoplasma gondii from cases of toxoplasmosis in macropods and a freckled duck at a
zoological park in Florida, USA.
Case #
(sample
ID)
1

Sample for
genotyping

SAG
1

SAG
2

altSAG2

SAG
3

BTU
B

GRA6

C228

C292

L35
8

PK
1

I

I

I

I

I

I

III

I

III

I

2

Isolate1 and
tissue2
Tissue2

I

I

I

I

I

I

III

I

III

I

Apico T. gondii ToxoDB
isolate ID Genotyp
e
III
TgKgrFL #263
1
III
#263

3

Tissue2

II/III

III

III

III

III

nd4

III

III

III

III

III

#2

4

Tissue2

II/III

III

III

III

III

III

III

III

III

III

III

#2

5

2

II/III

III

III

nd

III

III

III

nd

III

III

III

#2

1

Tissue

6

Isolate

II/ III

III

III

III

III

III

III

III

III

III

III

7

Tissue3

I

I

I

III

III

I

III

III

III

I

III

8

1

I

I

I

III

III

I

III

III

III

I

III

9

Isolate and
tissue3
Tissue3

I

I

I

III

III

I

III

nd

III

I

III

#216

10

Tissue3

I

I

I

III

III

I

III

nd

III

I

III

#216

11

3

II/III

III

III

III

III

III

III

III

III

III

III

#2

Tissue

TgKgrFL
2

#2
#216

TgKgrFL
3

#216

1

T. gondii parasite isolate from a mouse bioassay was used for genotyping.
DNA extracted from heart tissue was used for genotyping.
3
DNA extracted from heart and lung tissues was used for genotyping.
4
“nd” denotes no data
2
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CHAPTER 5
THE STUDY OF TACHYZOITE TO BRADYZOITE CONVERSION OF
TOXOPLASMA GONDII: ATTEMPTS TO PRODUCE A CAT VACCINE
T263 IN VITRO
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Abstract
Felids are the only hosts that can excrete Toxoplasma gondii oocysts into the environment. Oocysts
are environmentally resistant and highly infectious. Inadvertent ingestion of oocysts disseminated
in soil, water, and food accounts for an important route of animal and human infection. Thus far,
the most effective way to reduce human and animal infection is to reduce the environmental
contamination by oocyst. Controlling oocyst shedding by cats through the development of a
vaccine becomes the goal of this study. One dose of an oral live bradyzoite vaccine T263 can
prevent oocyst shedding in 84% (Frenkel et al., 1991) and 45% (Mateus-Pinilla et al., 1999) of
cats in laboratory and in field, respectively. Due to its high cost resulting from its cumbersome
preparation, the vaccine has not been commercialized. To produce the vaccine, T263 is injected
into mice; a month later, mice brain and heart tissues are harvested, homogenized, and digested
with pepsin. The vaccine was then fed to cats for immunization. To simplify the vaccine
production, we investigated two strategies to convert T263 from tachyzoites to bradyzoites in vitro
to bypass the heretofore required mouse bioassay. We tried vacuum conditions and low
temperature at 31℃ to switch tachyzoites to bradyzoites in cell culture. Conversion efficacy was
tested via acid-pepsin digestion, indirect fluorescent assay (IFA), and mouse bioassay. Vacuum
conditions were able to convert TgCkVe6 strain from tachyzoites to bradyzoites as evidenced by
the expression of bradyzoite antigen 1 (BAG1) and cyst wall protein (CST1) but was unable to
convert T263. However, low temperature at 31℃ was able to convert T263 as evidenced by the
expression of BAG1 and CST1. Low temperature treated T263 were infectious to mice via oral
route and was more prone to produce brain tissue cysts as compared to untreated T263. To
conclude, in preliminary experiments, we showed that low temperature (31℃) treatment can
produce T263 bradyzoites in vitro. Further study should test the whether the in vitro produced
T263 brayzoites can induce immunity to oocyst shedding in cats.
Keywords: T263 vaccine, tachyzoite, bradyzoite, Toxoplasma gondii.
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Introduction
Toxoplasma gondii is a coccidian parasite that infects a broad spectrum of hosts, including humans,
animals, and birds (Dubey, 2010). Infection is ubiquitous as one-third of the global human
population has been exposed to T. gondii. Toxoplasmosis, the disease caused by T. gondii, has
been shown to cause social and economic loss (Scharff, 2012; Hoffmann et al., 2012). Notably,
infection can cause spontaneous abortion, stillbirth or severe congenital disabilities in newborns
(Dubey, 2010). Infection can cause fatal outcomes in immunocompromised individuals, such as
AIDS patients and those who undergo radiation therapy for cancer treatment. Immunocompetent
individuals experience a short period of flu-like symptoms after the initial infection, which is
followed by an asymptomatic chronic infection. Severe consequences in immunocompetent
patients manifested as ocular toxoplasmosis, systematic toxoplasmosis, or death, have been
reported especially in the recent few decades (Holland, 2003; Carme et al., 2009; Demar et al.,
2007).
Three parasitical stages exist in the life cycle of T. gondii: tachyzoite, bradyzoite, and
sporozoite (Dubey, 2010; Weiss et al., 2013). Tachyzoites are the fast-replicating form that can
induce an IFN-γ-dependent host immune response. Bradyzoites are the slow-growing, semidormant stage and are enclosed by cyst walls which sequester parasites to evade host immune
attack. Sporozoites, the environmental form of the parasite, reside in sporulated ooysts. Upon
infection, in the pressure of host immune response, tachyzoites are converted to bradyzoites; the
latter form cysts that reside in host tissues (Skariah et al., 2010). Reactivation of bradyzoites takes
place in immune-compromised people such as T. gondii-infected AIDS patients (Grant et al.,
1990). During the conversion from tachyzoites to bradyzoites, the gene expression profile altered,
resulting in a decrease in immunogenic surface proteins, metabolic enzymes, and an increase in
proteins necessary for the entry into G0 (Blader and Saeij, 2009).
Concerning surface protein expression, bradyzoite expresses bradyzoite antigen 1 (BAG1).
BAG1 protein is a characteristic protein solely expressed on the bradyzoite surface and is therefore
often used as a marker for bradyzoite identification (Blader and Saeij, 2009). Cells expressing
BAG1 were seen after 24 hours of exposure to stress such as pH 8.1 (Weiss and Kim, 2011).
Deletion of BAG1 did not prevent cyst formation but only hindered the efficiency of cyst formation
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(Bohne et al., 1998). In addition, the formation of cyst wall, often recognized by detecting cyst
wall protein (CST1), is another hallmark of bradyzoite formation (Blader and Saeij, 2009). The
exact structure and composition of the cyst wall is not clear but was proved to contain
polysaccharides and chitin (Boothroyd et al., 1997). The N-acetylgalactosamine contained in a 116
kDa glycoprotein CST1 accounts for the binding of DBL (Dolichos biflorus lectin) to cyst wall
(Skariah et al., 2010; Lyons et al., 2002; Fux et al., 2007).
T. gondii infection is prevalent in humans and animals. The high infection rate in domestic
animals raised for human consumption poses serious public health concerns. The seroprevalence
of pigs raised in poorly managed or non-confined facilities is as high as 68% (Dubey et al., 2008).
Viable T. gondii has been frequently isolated from pork destined for human consumption; isolation
rates range from 0.3% to 92.7%, depending on the age of pigs and pig farming conditions (Dubey
and Jones, 2008). Worldwide, chickens raised in the backyard are steadily infected with T. gondii
with infection rate ranging from 27%- 100% (Dubey and Jones, 2008; Dubey et al., 2005b; Dubey
et al., 2006). A study conducted in Paraná, Brazil revealed that 12.2% (47/386) of serum samples
from free-range chickens were T. gondii positive (Vieira et al., 2018). Sheep and goats are
susceptible to T. gondii infection evidenced by frequent reports of abortion and neonatal mortality.
Congenitally infected lambs that survived can remain asymptomatic, which could be a source of
human infection (Dubey and Kirkbride, 1989). Clearly, the high prevalence of T. gondii and its
concomitant health risk call for methods to intervene its transmission.
T. gondii is transmitted through three major routes, including ingesting oocysts
disseminated in the environment, eating undercooked meat that contains tissue cysts, and
congenital transmission. As the sole definitive hosts able to shed oocysts into the environment,
cats play a central role in the epidemiology and transmission of T. gondii. Studies have shown that
T. gondii infection is scarce or absent in areas without cats (Dubey, 1997; Munday et al., 1972;
Wallace et al., 1969). The facts that cats are widespread and that they are predisposed to T. gondii
infectioin pose a risk to human health. Approxmiately, one-third of households in the United States
own cats. There are an estimated 78 million domestic cats and 73 million feral cats in the U.S.
(Dubey, 2010). An average of 30% of cats worldwide have been infected with T. gondii (Dubey,
2010). Cats are also the common animals on farms. A 1999 study demonstrated that a mean of 8.5
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cats was present on each pig farm in Illinois, of which six were seropositive for T. gondii (Weigel
et al., 1999).
Thus far, using vaccines to prevent infection has been mostly ineffective. The only
commercialized vaccine is for sheep, which is a strain (S48) that does not form tissue cysts in
sheep, used during lambing season to prevent abortion in Europe and New Zealand (Buxton et al.,
1993). A vaccine to directly immunize humans has not yet been available. Many obstacles posed
in human vaccine production as killed strain provides at best marginal protection and attenuated
or mutant strains pose the risk of infection especially to fetuses (Dubey, 2010).
The most effective and rewarding vaccination strategy leans toward the immunization of
definitive hosts. A 3-year field trial revealed that vaccination of cats on eight commercial farms
using T263 showed promise to reduce the infection in farm animals (finishing pigs and mice)
(Mateus-Pinilla et al., 1999). T263 was a mutant produced by exposing tachyzoite to the alkylating
agent, N-methyl-N’-nitro-N-nitroso guanidine (Frenkel et al., 1991; Popie et al., 1994) and was
selected for its resistance to adenine arabinoside. T263 is genetically mutated and could not form
oocyst in the intestinal epithelial cells of the cat (Dubey, 2010). Therefore, oral administration of
T263 cannot induce oocyst shedding in cats but can induce immunity to oocyst shedding upon
challenge with a wild strain. The oral administration to cats of the bradyzoite/tissue cyst form of
T263, not the tachyzoite form, is required to produce immunity to oocyst shedding (Freyre et al.,
1993; Freyre et al., 1993).
The application of this cat vaccine had been unsuccessful due to several factors, principally
the cumbersome procedure for preparation and the resulting high cost per dose (Frenkel et al.,
1991; Freyre et al., 1993; Mateus-Pinilla et al., 1999). Mice are required for vaccine production,
whereby brain tissue cysts are allowed to develop for a month. A month later, mice are euthanized,
and the brain tissues are harvested and homogenized, digested with pepsin, and preserved in liquid
nitrogen (Choromanski et al., 1995). At the time of immunization, vaccine is thawed and orally
admistered to cats.
To simplify vaccine production and to reduce its price, we sought to develop a
methodology to produce live bradyzoites in vitro. To achieve that, we aimed to develop a technique
to convert T263 tachyzoites to bradyzoites in vitro. Previously, low or high pH and heat shock
(43℃ for 12-48 h) were used to induce the conversion (Lyons et al., 2002). However, in our
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attempts, these methods produced significant damage to host cells, which rendered the production
of bradyzoites inadequate. In this study, we investigated two conversion strategies, namely,
applying vacuum conditions and low temperate at 31℃. We first tested the effect of vacuum
conditions on a T. gondii strain isolated from a chicken in Venezuela (Rajendrana et al., 2012).
The conversion potential of vacuum conditions was inadvertently discovered in TgCKVe6 in an
event of developing a method to ship cell culture between labs. We were able to slow down the
growth of T. gondii strains TgCkVe6 and T263 using vacuum conditions and low temperate at
31℃, respectively. Three approaches were used to evaluate the in vitro produced bradyzoites:
Indirect fluorescent assay (IFA), pepsin digestion assay, and mouse oral infectivity assay.

Materials and Methods
Cell culturing and treatment conditions
Toxoplasma gondii was routinely cultured in Human Foreskin Fibroblasts (HFFs) in Dulbecco's
Modified Eagle Medium (DMEM) containing 10% Fetal Bovine Serum (FBS). HFFs were grown
in either T25 flasks for pepsin digestion assay and mouse bioassay or on glass coverslips inserted
into 6-well plates for IFA.
For vacuum conversion treatments, HFFs were infected with TgCkVe6 or T263 in either
T25 flasks or 6-well plates at 37°C, 5% CO2 overnight for 12h. The next day, media was changed
to remove cell debris; the T25 flask or 6-well plate with infected HFFs was transferred into a
vacuum bag. Air in the bag was depleted using handheld rechargeable vacuum sealing system
(FoodSaver FreshSaver, Walmart # 007428735). The cell culture in flask or plate in a vacuumed
bag was then incubated at room temperature (20-25°C) for three or four days. Afterward, cell
culture was transferred back to 37°C, 5% CO2 incubator and kept for another seven to ten days.
For low temperate conversion treatment, HFFs were infected with T263 at 31℃ in a T25
flask or a 6-well plate. Cell culture was then kept at 31℃ for seven to eight days.
For IFA, 10 to 15 drops of media containing parasites (3–5× 105 parasites) were inoculated
into each well of a 6-well plate with confluent HFFs on coverslips. For pepsin digestion assay and
mouse bioassay, approximately 6–8 × 105 parasites were inoculated into a T25 flask with confluent
HFFs.
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Detection of protein expression via IFA
The presence of BAG1 and CST1 in in vitro produced bradyzoites were detected using IFA. After
the conversion treatment, cell culture infected with TgCkVe6 or T263 in a 6-well plate was fixed
in 4% formaldehyde at RT (room temperature) for 30 mins, permeated with 0.5% Triton at RT for
20 mins, and blocked with blocking buffer (PBS with 0.1% Triton and 10% BSA) at RT for 1 h.
Each step was followed by three times of washing with ice-cold PBS. For primary antibody
staining, monoclonal rabbit anti-BAG1 antibodies (1:100) (Weiss et al., 1992) was added and
incubated at 4℃ overnight. The next day, upon washing, secondary antibodies Alexa Fluor 594
goat anti-rabbit IgG (Invitrogen, A11012) at 1:100 were added and incubated at RT for 1 hour.
Finally, after washing, FITC-conjugated Dolichos biflorus agglutinin (Fisherbrand, FL-1031) at
1:300 was added for CST1 staining at RT for 1 hour. After incubation, cells on coverslips were
washed with PBS; coverslips were taken out, air dried, and mounted onto glass slides. Fluorescent
microscopy (Leica DMRX, Leica Microsystems) was used to detect protein expression. As
controls, the non-treated parasites (presumably tachyzoites) were subjected to the same IFA
procedure.
Pepsin digestion assay
We utilized an acid-pepsin digestion assay to evaluate the treated parasites by comparing the
survival rates of treated and non-treated parasites upon pepsin digestion. This method replies on
the fact that bradyzoites, cell culture-derived or animal tissue-derived, are more resistant to acidpepsin (Lyons et al., 2002; Weiss et al., 2011; Popie et al., 1994). Viable parasites of treated and
non-treated TgCkVe6 or T263 in a T25 flask were enumerated via plaque assay before pepsin
digestion. To release parasites from host cells and parasitophorous vacuoles (PVs), we scraped
host cells from the bottom of the flask and pressed them through a 22-gauge needle in a 10 ml
syringe four times. Upon washing, parasites from one T25 flask (either treated or non-treated) were
equally split into two portions: one was subjected to pepsin digestion (0.26 mg/ml pepsin in
0.170M NaCl, pH1.4), and the other served as negative control in which the base solution (0.170M
NaCl) was added. Digestion was conducted for 15 or 30 mins at 37℃. The pepsin digestion was
followed by addition of 1.2% sodium bicarbonate (pH 8.3) to bring the solution to neutral pH. The
neutralized pepsin solution or base solution was then removed via centrifugation. Finally, parasites
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in each of the four groups (treated parasites with pepsin solution, treated parasites with base
solution, non-treated parasites with pepsin solution, non-treated parasites with base solution) were
enumerated again via plaque assay. The survival rates of treated and non-treated parasites with or
without pepsin digestion were compared.
For plaque assay, cell suspension was serially diluted across a range of 10-1 to 10-4;
inoculum of 100 µl at each concentration (10-1 to 10-4) was transferred into each well of a 6-well
plate; plate was incubated at 37 ℃ for seven days. After incubation, cell medium was removed,
and cells were fixed in 70% ethanol. The plaque number was enumerated under bring light
microscope.
Mouse bioassay
We intended to test whether the in vitro produced T263 bradyzoites can be liquid nitrogen (LN)
preserved. The 31℃ treated T263 were preserved at seven days post-infection to simulate the
vaccine preservation. After seven days at 31℃, cell culture was scratched from the flask and mixed
with 50% FBS in DMEM and was subsequently mixed with 20% dimethyl sulfoxide (DMSO) in
DMEM. The mixture was then transferred to LN upon overnight on dry ice. After four months, on
the day of mice infection, in vitro produced bradyzoites were thawed, washed, and resuspended in
PBS. The number of cysts was enumerated using hemocytometer to prepare 2.5 ×104 cysts/ml in
5ml PBS.
We also tested the infectivity of freshly prepared T263 bradyzoites. Seven days post
infection at 31°C, cells were scraped off from three T25 flasks, washed and resuspended in PBS.
The number of cysts was counted using hemocytometer to prepare 2.5 ×104 cysts/ml in 5ml PBS.
Tachyzoites of T263 were included as control. The fast-growing T263 was cultured at
37 °C and reached a growth speed of 2-day passage. Two days after infection, parasites were
bursting from host cells. Cell culture was pressed through a 22-guage needle to further separate
tachyzoites from host cells. The number of tachyzoites was enumerated using hemocytometer to
prepare 2.5 ×104 tachys/ml in 5 ml PBS.
Fifteen mice were evenly divided into three groups of five. Each group of mice were
infected with parasites of a different preparation, namely, LN preserved bradyzoites, freshly
prepared bradyzoites, and fresh tachyzoites. Each mouse in a group was orally fed 1ml of prepared
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parasites which contained 2.5 ×104 LN preserved cysts, 2.5 ×104 fresh cysts, and 2.5 ×104 fresh
tachyzoites. Mice were monitored for three weeks. After three weeks, mice were euthanized; brain,
heart, and lung tissues were taken for PCR detection of T. gondii; the brain was also used for DBL
staining of tissue cysts. Blood was taken for Modified Agglutination Assay (MAT) (Dubey and
Desmonts, 1987); the cutoff value was set at 1:25 (Dubey et al., 1995a and 1995b).
For tissue DNA examination, brain, heart, and lungs were pooled and homogenized; DNA
was extracted using DNeasy Blood and Tissue kit (Qiagen; Cat No. 69504). PCR targeting the18S
ribosomal RNA (18S rRNA) gene was used for T. gondii detection (Silva et al., 2009). The primer
pair Tg18s 58F/Tg18s 348R at a concentration of 50 µM were used for PCR amplification (Silva
et al., 2009). The expected DNA fragments with a size of 290 base pairs (bp) was examined on a
2% agarose gel.
For brain tissue cyst examination, one quarter of the brain tissue was taken and
homogenized by sequentially syringing through gauge 16 and 20 needles. The tissue homogenate
was fixed and permeated in fixing/permeabilizing solution (6% formaldehyde, 0.2% TritonX-100
in PBS) for 20 mins at 4°C. Cells were washed with 10% goat serum in PBS. DBL at 1:300 final
concentration (10µl DBL in 3ml 10% goat serum) was used to stain brain tissue cysts for one hour
at RT in the dark. After two washings in 10% goat serum, the cysts were resuspended in 2 ml PBS.
Ten microliters of cysts in PBS was mounted onto a glass slide and examined for tissue cysts under
a fluorescent microscope (Leica DMRX, Leica Microsystems).

Results
Detection of protein expression of vacuum treated TgCkVe6 via IFA
Four days in a vacuum bag at room temperature (RT), the morphology of TgCkVe6 became
unrecognizable, and parasites in PVs deformed and merged into dotted smudges. Recover slowly
took place in 37 ℃, 5% CO2 incubator, and eventually after 7 -10 days, parasites formed large
persisting cysts.
The staining of BAG1 was indicated by the green fluorescence (Figure 5.1). The
monoclonal rabbit anti-BAG1 antibodies (1:100) was used as primary antibody, and FITCconjugated goat anti-rabbit IgG (1:100) was added as secondary antibody.
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In another independent experiment (Figure 5.2), CST1 was stained with FITC conjugated
DBL (1:300). A significant number of cysts were stained as indicated by the green fluorescence
(Figure 5.2).
To compare the protein expression of treated TgCkVe6 and non-treated TgCkVe6, we
simultaneously stained BAG1 and CST1 (Figure 5.3) of treated and non-treated parasites. The
nuclei were also stained with DAPI. For BAG1 staining, the secondary antibodies Alexa Fluor 594
goat anti-rabbit IgG at 1:100 was used. In Figure 5.3, the staining of BAG1 was observed in both
treated and non-treated groups; however, CST1 expression was only observed in treated TgCkVe6.
The cross-emission of FITC and DAPI was pronounced in Figure 5.3 as FITC emission extended
to DAPI channel and vice versa.
Acid-pepsin digestion of vacuumtreated TgCkVe6
All TgCkVe6, vacuum treated and non-treated, succumbed after 30mins acid-pepsin digestion at
37℃. Therefore, a shorter digestion period, namely 15 mins, was chosen for further testing. The
results of the acid-pepsin digestion assay were summarized in Table 5.1. A small proportion
(0.24%) of treated TgCkVe6 were pepsin resistant, whereas all non-treated parasites succumbed
after 15min acid-pepsin digestion at 37℃. Results of a repeat testing of the pepsin resistance were
summarized in Table 5.2. No pepsin resistant parasite was identified regardless of whether the
conversion treatment was applied (Table 5.2). In addition, the survival rate (150%) for those kept
in the 0.9% NaCl for 15 mins at 37℃ was rather implausible as it exceeded 100% (Table 5.2). The
problem lay in the enumeration process. The incomplete disruption of tissue cysts likely skewed
the initial enumeration via plaque assay; those tissue cysts later ruptured and released a larger
number of parasites during incubation in 0.9% NaCl.
Detection of protein expression of 31°C treated T263 via IFA
T263 produced notable large, persistent cysts at 31°C six days post-infection (Figure 5.4). Staining
was done on BAG1 and CST1. The staining protocol was described in 2.2. DAPI was not used due
to cross-emission with FITC. Although both treated and non-treated T263 express a certain degree
of BAG1, indicating spontaneous conversion in the case of non-treated T263 (Figure 5.5).
However, the cyst wall staining was only seen in treated T263 (Figure 5.5). The repeat testing of
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cyst wall expression of 31°C treated T263 was done seven days post-infection (Figure 5.6). Two
different doses of T263, namely 105 (Figure 5.6 A) and 104 (Figure 5.6 B), were used to infect
HFFs in each well of a 6-well plate. As shown in Figure 5.6, the infection rate of panel A was
much higher than that of panel B. The CST1 expression was observed but with less intensity of
fluorescence (Figure 5.6 A and B) as compared to that of in vitro produced TgCkVe6 (Figure 5.2).
Oral infectivity of 31°C treated T263
The three groups of total 15 mice were observed on a daily basis for three weeks. One mouse to
which 2.5 ×104 tachyzoites were orally fed suffered from pain (hunched back, dehydration) two
days after infection and succumbed five days post infection. The cause of death is unclear but
could be the accidential damage of stomach tissue during the oral inoculation. As a result, no tissue
or blood sample was taken from this mouse. One mouse to which 2.5 ×104 LN preserved
bradyzoites were fed showed symptoms 17 days post-infection and was euthanized with tissues
and blood collected. The remaining 13 mice survived 21 days post-infection and were euthanized
with blood and tissue samples obtained.
T. gondii antibody detection in blood showed that two out of five mice infected with LN
preserved bradyzoites were T. gondii antibody positive with a titer of 1:400 (Table 5.3). Two out
of four mice infected with tachyzoites were seropositive for T. gondii with titers of no less than
1:1600 and 1:3200, respectively (Table 5.3). No seropositive sample was identified in the group
of mice infected with fresh in vitro produced bradyzoites.
PCR detection of tissue DNA confirmed serological results. T. gondii DNA was amplified
from the tissues of four seropositive mice (Figure 5.7).
DBL staining of tissue cysts were consitent with serological and PCR results with the
exception of LNB No.5. LNB No.5 was from a mouse that showed symptoms 17 days postinfection and was euthanized. Tissue cysts appear in mouse brain tissue at around two weeks postinfection (Cristina et al., 2008), and requires a couple of weeks to grow large enough to be clearly
observed under microscope. This may explain why no tissue cysts were seen in LNB No.5. More
tissue cysts were identified in 10µl of brain suspension (one-quarter of brain in 2 ml PBS) in LNB
No.1 than the other two samples (Tachy No. 1 and No.2) (Figure 5. 8). A total of seven cysts were
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found in LNB No.1 in 10µl of brain suspension, whereas only two were found in Tachy No. 2 and
one in Tachy No. 1.

Discussion
Vaccines to control T. gondii infection have been up to now unsuccessful. Immunizing
intermediate hosts have at best limited benefits, and the fact that there is rarely any commerilazed
vaccine available for intermediate hosts compounds the problem. A cystless strain S48, the only
commercialized vaccine thus far, has been used to vaccinate sheep to reduce neonatal mortality in
New Zealand and Europe (Buxton et al., 1993). With limited propagation in sheep, this vaccine
can protect animals against T. gondii induced abortion for up to 18 months with one dose (Buxton
et al., 1993; Innes et al., 1995). Vaccine candidates for pigs have been tested to have promising
outcomes in laboratory. RH strain, a non-persistent strain, has been shown to protect pigs and to
prevent tissue cyst formation in pig tissues (Dubey et al., 1991). CpG Oligodeoxynucleotide has
been used in conjunction with RH strain to enhance protective immunity in pigs (Kringel et al.,
2004). In addition, a DNA vaccine cocktail (GRA1-GRA7) had shown promises in eliciting strong
humoral and Th1-mediated immune response in pigs (Jongert et al., 2008).
A safe and effective vaccine for human use has not been developed. As T. gondii is an
obligate intracellular parasite, the cell-mediated immune response induced by active parasite
invasion is essential, which explains why vaccines using live parasites are necessary to stimulate
protective immunity. However, live parasites pose a risk to human vaccine recipients as well as to
those who handle vaccines. Obstacles and risks associated with human T. gondii vaccination
highlight the importance of developing vaccine to immunize cats, its definitive hosts, to interrupt
the human infection cycle.
The mutant T263 demonstrated great promise in reducing T. gondii contamination by
preventing cats from shedding oocyst (Mateus-Pinilla et al., 1999). Under laboratory conditions,
one dose of T263 can prevent 84% of cats from shedding oocysts (Frenkel et al., 1991); two doses
can prevent 100% of cats from shedding oocysts (Freyre et al., 1993). The corresponding numbers
are lower, however, under field conditions. The seroconversion rate of cats in field experiment is
45% with one vaccination and 67% with two vaccinations (Mateus-Pinilla et al., 1999).
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The short shelf-life, demanding storage requirement, and cumbersome procedures for
preparation hindered the application of vaccine T263. To simplify the vaccine production, an in
vitro method to convert tachyzoite to bradyzoite is essential. It has been known that tachyzoite to
bradyzoite conversion is a stress-related phenomenon. Conventionally, high temperature (43 ℃),
high (8.0-8.2) or low (6.6-6.8) pH, chemical stresses (i.e., sodium arsenite) can induce tachyzoite
to bradyzoite conversion (Soete et al., 1994). However, the use of these methods in our attempts
caused host cells damage severe enough to render them unable to support parasites growth.
We investigated two methods to convert T263 from tachyzoites to bradyzoites to bypass
the mouse bioassay. We showed that vacuum conditions can successfully convert TgCkVe6 to
bradyzoites. We fortuitously stumbled upon this method from attempts to develop a technique for
shipping of cell cultures. Obstacles posed in cell culture shipping is that the media often become
acid, which become detrimental to host cells and parasites. To maintain a neutral pH, we put the
cell cutures (HFFs infected with TgCkVe6) into a vacuum bag with air depleted. The cell cultures
in a vacuum bag was incubated at RT for four days to simulate the duration of shipping. To test
the duration of recovery of the cell culture once delivered, we transferred the cell culture to 37 ℃,
5% CO2 incubator. After seven to eight days, large persisting cysts were unexpectedly observed,
which prompted us to utilize the vacuum for conversion.
The in vitro produced TgCkVe6 bradyzoites expressed BAG1 and formed tissue cysts as
evidencd by CST1 detection via IFA. Pepsin digestion assay showed that a small percentage of
treated parasite TgCkVe6 were able to survive acid pepsin treatment for 15 min. However, the
pepsin digestion assay was not repeatable as no resistant parasites were identified on repeat testing.
It has been shown that the in vitro produced bradyzoites were acid-pepsin resistant (Dubey et al.,
1998; Popiel et al., 1996) and can orally infect both mice (Fux et al., 2007) and cats (Hoff et al.,
1977). The pepsin resistance rate of the in vitro alkaline-induced bradyzoite (9 days post-infection)
ranges from 0.03% to 9.4%, depending on the strain (Fux et al., 2007). The discrepancy seen
between our results and those in publications may be attributable to the preparation procedure and
the different methods used to estimate bradyzoite numbers before pepsin digestion. In our
experiment, in order to precisely measure the quantity of bradyzoites, we completely released
parasites from PVs and host cells and enumerated bradyzoites using plaque assay. In published
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studies, cysts were enumerated using hemocytometer under microscope, and the number of
bradyzoites in cysts were roughly estimated as 10 to 20 bradyzoite per cyst (Fux et al., 2007).
In contrast, when the vacuum was applied to T263, no large persisting cysts were formed.
Instead, due to the harsh vacuum conditions, T263 disintegrated after treatment, leaving numerous
empty vacuoles in host cells. The discrepancy seen between TgCkVe6 and T263 reflects T. gondii
strain variation. A wide array of factors account for the observed discrepancy of conversion ability
under vacuum conditions. It’s known that strains with a slower rate of replication and lower
virulence are more likely to develop cysts in vitro (Matsukayashi et al., 1963; Weiss and Kim,
2011). This holds true in the case of TgCkVe6 which is slow-growing and prone to form large
vacuoles even at 37 ℃ with 5% CO2.
Luckily, we also tested the temperature effect on the growth of T263, including high
temperature at 43℃ and 41℃, low temperature at 33℃ and 31℃. At 43℃, both host cells and
T263 were unable to survive. At 41℃, parasites invade and lyse host cells as efficiently as those
at 37℃. At 33℃, the growth of the parasite slowed down but not enough to form large persisting
cysts. However, at 31℃, parasites were able to develop large persisting cysts. We used IFA and
mouse bioassay to validate the conversion from tachyzoites to bradyzoites. Pepsin digestion was
not conducted on this strain due to its inconsistency when used on vacuum-treated TgCkVe6. The
expression of BAG1 and CST1 were evident in converted T263, indicating successful conversion.
However, when compared to the vacuum-treated TgCkVe6, less CST1 expression was found in
31℃ treated T263.
Through oral infection of mice, we demonstrated that the LN preserved bradyzoites of
T263 at a dose of 2 × 104 cysts were able to infect 40% (2/5) of mice and form a significant number
(7 × 200 × 4 = 5,600) of tissue cysts in a mouse brain. This proved that our in vitro produced T263
bradyzoites were infectious after four months of preservation in liquid nitrogen, indicating the
feasibility of preserving in vitro produced bradyzoites in liquid nitrogen. Although two (2/4=50%)
mice in the tachyzoite group were also infected, we found less tissue cysts (1,600 or 800) in their
brains. This preliminarily suggests that our in vitro produced T263 bradyzoites are more prone to
form tissue cysts in mice. Dubey has shown that the number of bradyzoites required to orally infect
a mouse is 1000, whereas the corresponding figure for tachyzoite is >106 (Dubey, 1998). In our
study, 2 × 104 T263 tachzyoites were able to establish infection in mice. The discrepancy seen
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between Dubey’s results and ours indicates strain variation. Fux et al. have shown that 1000 pepsin
resistant bradyzoite were able to infect 50% of mice (Fux et al., 2007). In our study, we presumably
used much more than 1,000 bradyzoites as one cyst contains more than one bradyzoite. It is
possible that the conversion rate in our study is low resulting in few mature bradyzoites in each
tissue cysts. Alternatively, we have used a much higher dose of bradyzoites in mice infection.
Further study should increase the conversion efficiency using 31℃. To increase the conversion
efficiency, no more than two passages of T263 at 37 ℃ after revived from liquid nitrogen should
be allowed before the conversion treatment. Observation has been made that frequent passage of
T263 37 ℃ resulted in difficulties in conversion. The growth of T263 could not be easily slowed
down by the sole treatment of 31℃ once parasites were in burgeoning state.
Counterintuitively, our freshly prepared T263 bradyzoites failed to infect mice. The
problem lay in the inadequate number of mature bradyzoites fed to each mouse. Although the same
number of parasites (6 × 105 to 8 × 105 parasites) were initially used to infect HFFs in a T25 flask,
these parasites were not in their most active state at the time of infection. CO2 supply was briefly
disrupted during the course of the treatment. Cell culture likely experienced a shock due to CO2
outage, which may account for the compromised growth of the parasites.
The signaling pathways and the molecular mechanisms of interconversion are unknown.
However, as a stress-induced response, the common stress-related pathways in eukaryotic
organisms are implicated. Cyclic nucleotide kinase is believed to partly mediate the differentiation
(Eaton et al., 2006). A study has determined that inhibition of cAMP-dependent kinase and cGMPdependent kinase reduced parasite replication and induced differentiation (Eaton et al., 2006).
Parasite-specific eukaryotic initiation factor-2 (eIF2) kinase was also implicated in the
differentiation process (Sullivan et al., 2004). As both protein chaperones and regulators of
transcription, the heat shock proteins (HSPs) induced during stress response have gained
significant research interests. After alkaline stress at pH 8.1, hsp70 was induced three to four folds
more than that of at pH 7.1, consistent with the induction seen in other Apicomplexans (Weiss et
al., 1998; Shiels et al., 1997). Inhibition of HSPs synthesis using quercetin hindered the in vitro
bradyzoite development (Weiss et al., 1998).
The molecular mechanisms underlying the induced conversion using vacuum and 31 ℃ are
unknown. Vacuum conditions implicate various cellular stresses, including deprivation of CO2,
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O2, and low temperature at RT, for both the host and the parasite. Temperature change has been
known to induce differentiation. Heat shock (43℃) host cells for two hours with or without heat
shock of infected cells for 12-48 h has been used for bradyzoite differentiation (Skariah et al.,
2010). Low temperature (RT or 31 ℃) likely reduces the growth rate of both host cells and
parasites, which contributes to the conversion (Weilhammer et al., 2012).
Secondly, hypoxia likely alters host and parasite metabolisms and contributed to the
conversion. The hypoxia-inducible transcription factor (HIF-1 α), a transcription factor that is
activated by hypoxia, is likely activated under vacuum conditions. HIF-1α is critical in preserving
the health of both host cells and parasites, especially under hypoxia. It has been shown that HIF1α and its downstream signaling pathways (glycolysis, growth-factor signaling, and angiogenesis)
were upregulated in T. gondii infected fibroblasts (Gail et al., 2001; Blader et al., 2001). In
addition, HIF-1α also plays an essential role in T. gondii growth and organelle maintenance at 3%
oxygen (Spear et al., 2006).
Lastly, low CO2 may also be a trigger of conversion under vacuum conditions. Previously,
low CO2 (0.03%) has been used to induce tachyzoites to bradyzoites conversion (Bohne and Roos,
1997). Depleting of CO2 or low CO2 was thought to cause pyrimidine starvation as CO2 is the
substrate for de novo pyrimidine biosynthesis.
The successful development and large-scale application of a cat vaccine based on T263 are
only possible when the obstacles involved in vaccine production are overcame, among which is
the cumbersome, time-consuming, and expensive procedure for bradyzoite production. Our study
identified a new technique to produce bradyzoites in vitro. Further refinement of the technique,
followed by tests in cats, is needed to validate the efficacy of the method. In particular, it’s
imperative to test whether the in vitro produced T263 bradyzoite can induce protective immunity
to oocyst shedding in cats upon challenge with a wild strain.
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Chapter 5 Appendix

120 µm

400 ×
Figure 5. 1 The examination of BAG1 expression of T. gondii TgCkVe6 using IFA. TgCkVe6
was vacuum treated as described in 2.1. Seven days post incubation at 37 ℃, 5% CO2, TgCkVe6
formed large persisting cysts under bright light microscope. The primary antibody, monoclonal
anti-BAG1 antibodies (1:100), was added and incubated at 4℃ overnight. The next day, FITCconjugated goat anti-rabbit IgG (1:100) were added as secondary antibodies. Fluorescent
microscope (Leica) was used for observation at 1000×. The green fluorescence indicated the
expression of BAG1 on parasite surface. The above image illustrates two large adjacent tissue
cysts with BAG1-expressing parasites enclosed.
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120 µm

400 ×
Figure 5. 2 The examination of CST1 expression of T. gondii TgCkVe6 using IFA. TgCkVe6
was vacuum treated as described in 2.1. Seven days post incubation at 37 ℃ 5% CO2, TgCkVe6
formed big persisting cysts. The FITC conjugated DBL (1:300) was used to stain CST1 for one
hour at RT. Fluorescent microscope (Leica) was used for observation at 400×. The above image
indicates the expression of CST1 on cyst wall surface in green. The overlapping area of two tissue
cysts was brighter in green, indicating the staining of tissue cysts walls.
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120 µm

120 µm

120 µm

120 µm

120 µm

120 µm

Figure 5. 3 Simultaneous examination of BAG1 and CST1 in treated or non-treated T. gondii
TgCkVe6 using IFA. The monoclonal rabbit anti-BAG1 antibodies (1:100) was used as primary
antibodies, and secondary antibodies were Alexa Fluor 594 goat anti-rabbit IgG at 1:100. Upon
washing, FITC-conjugated DBL at 1:300 was added for CST1 staining at RT for one hour. Nuclei
were also stained with DAPI for five minutes at RT. Fluorescent microscope (Leica) was used for
observation at 400×. The expression of BAG1 was indicated in green fluorescence, whereas the
expression of CST1 was shown in red fluorescence. The staining of nuclei was in blue. The crossemission of FITC and DAPI was pronounced, especially in the non-treated group.
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120 µm

400 ×
Figure 5. 4 The large vacuoles of T263 at six days post-infection at 31 °C. T263 was allowed
to infect HFFs at 31 °C and kept at 31 °C 5% CO2 incubator for seven to eight days. The big
persisting cysts were seen under bright light microscope at 400 ×.
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120 µm

120 µm

400 ×
Figure 5. 5 Simultaneous staining of BAG1 and CST1 of T263 (six days post-infection at 31
°C) using IFA. T263 was allowed to infect HFFs at 31 °C and kept at 31 °C, 5% CO2 incubator
for six days. The monoclonal rabbit anti-BAG1 antibodies (1:100) and Alexa Fluor 594 goat antirabbit IgG (1:100) were used as primary and secondary antibodies, respectively. FITC-conjugated
DBL at 1:300 was used for CST1 staining. Images were taken at 400× magnification.
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120 µm

120 µm

400 ×
Figure 5. 6 DBL staining of T263 seven days post-infection at 31°C using IFA. A) 3 ×105 T263
tachyzoites were used to infect HFFs in each well of a 6-well plate. FITC-conjugated DBL at 1:400
was added for CST1 staining; B) 3 × 104 T263 tachyzoites were inoculated into each well of a 6well plate. FITC-conjugated DBL at 1:400 was added for CST1 staining.
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A)

B)

Figure 5. 7 PCR detection of T. gondii DNA from tissues of experimentally infected mice. A)
Two out of five mice (LNB No.1–No.5) infected with liquid nitrogen preserved bradyzoites (LNB)
were positive for T. gondii in their tissues (heart, brain, and lungs); two out of four mice (Tachy
No. 1–No.4) that were infected with fresh tachys were positive for T. gondii in their tissues (heart,
brain, and lungs). No positive sample was detected in a group of five mice (FB No.1–No.5)
infected with fresh bradyzoites (FB); GT1 was a T. gondii strain used as positive control. N denotes
negative control in which DNA was not added. B) A paralle repilcate of panle A. PCR was done
on the same 96-well plate.
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120 µm

120 µm

120 µm

400 ×
Figure 5. 8 DBL staining of brain tissuse cysts. A quarter of brain tissue was homogenized and
stained with FITC-conjugated DBL. A total of three positive samples were identified, namely LNB
No.1, Tachy No.2, and Tachy No.1. Seven cysts were found on a glass slide with 10µl of brain
suspension in LNB No. 1, whereas two were found in Tachy No. 2, and one was found in Tachy
No.1. A) Two cysts were shown from sample LNB No.1 which was from a mouse that were orally
infected with liquid nitrogen preserved bradyzoites; B) One image from Tachy No. 1 which was
obtained from a mouse that was orally infected with in vitro produced fresh tazhyoites. C) One
representative image from sample Tachy No. 2.
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Table 5. 1 Acid-pepsin digestion of vacuum-treated and non-treated TgCkVe6 for 15 mins.
Treated parasites
Initial
5 x 10 5

After treatment
1.36 x 10 5

Survival rate
27 %

5 x 10 5

1.2 x 10 3

0.24 %

0.9% NaCl, 15 mins

Initial
2.05 x 10 5

After treatment
1.52 x 10 5

Survival rate
74 %

Pepsin, 15 mins

2.05 x 10 5

0

0%

0.9% NaCl, 15 mins
Pepsin, 15 mins
Non-treated parasites
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Table 5. 2 A repeat of acid-pepsin digestion of vacuum-treated and non-treated TgCkVe6 for 15
mins.
Treated parasites
Initial
2.25 x 10 4

After treatment
2.24 x 10 4

Survival rate
99.6 %

2.25 x 10 4

0

0%

0.9% NaCl, 15 min

Initial
8 x 10 4

After treatment
1.2 x 10 5

Survival rate
150 %

Pepsin, 15 min

8 x 10 4

0

0%

0.9% NaCl, 15 min
Pepsin, 15 min
Non-treated parasites
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Table 5. 3 Seroprevalence of 14 mice orally infected with 31°C treated T263.

Titer

No. of
sera
tested

<25

25

50 100 200 400 800 >=1600 >=3200

5

3

0

0

0

0

2

0

0

0

Tachys

4

2

0

0

0

0

0

0

1

1

Fresh
bradys

5

5

0

0

0

0

0

0

0

0

Sample ID

LNB

a

b

c

%
positive
sera
(cutoff at
1:25)
40%
(2/5)
50%
(2/4)
0

a

A group of five mice were orally infected with liquid nitrogen preserved bradyzoites (LNB);
A group of five mice were orally infected with in vitro produced fresh tachys; one mouse died
due to accidental puncture of lung whose carcass was simply discarded without collecting samples.
c
A group of five mice were orally infected with fresh bradyzoites produced in vitro.
b
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CHAPTER 6
CONCLUSION
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Conclusion
The research conducted in this dissertation represents four of the many aspects of current T. gondii
study. My first project continued the interest of our lab and investigated the genetic structure of T.
gondii in North America. We were able to summarize the genotyping data generated in the past
decade and examine the underlying factors in shaping the population structure of T. gondii in North
America. My second project aimed to evaluate the environmental contamination by T. gondii on a
farm with cats. The evaluation of environmental contamination is fundamental to the development
of control measures to reduce T. gondii infection in humans and animals. My third project focused
on the isolation and characterization of T. gondii from clinal fatal toxoplasmosis from macropods.
T. gondii infection in captive macropods continues to be a problem as zoos and theme parks suffer
from the enormous economic loss. In my last project, I strived to convert tachyzoites to bradyzoites
in vitro in hope to simplify the preparation of a cat vaccine T263 to reduce its costs.
Investigating factors shaping T. gondii genotype landscape in North America
Our lab has been interested in the population genetics of T. gondii. The genotypes of T. gondii
were defined by the multilocus PCR-RFLP genetic markers; the method was initiated by Howe
and Sibley (Howe and Sibley, 1995) and refined later (Su et al., 2006 and 2010). Our lab has
worked to expand the application of multilocus PCR-RFLP to make data comparable across labs
worldwide. With the extensive use of this methodology, a collection of 1400 samples from across
the world has been genotyped by 2014 (Shwab et al., 2014). The genetic structure of T. gondii was
revealed on a global level. My first project built upon the publication of Shwab et al. in 2014 and
focused on the genotype landscape in North America. I particularly researched the human
influence on T. gondii genotype distribution, and whether T. gondii genotype had host species
specificity. We concluded that T. gondii genotype diversity and the host proximity to human
settlement had an inverse relationship. Moreover, the dominant genotypes in groups of animals
with different association with human activities were different. Type II and type III were found
predominant in farm-bound animals, whereas type 12 dominated in wildlife. The dominant
genotypes in farm-bound animals (Type II and III) and that in wildlife (Type 12) were found almost
equally prevalent in the free-ranging domestic animal group. The observed phenomena signified
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human influence on T. gondii transmission. A between-population comparison was conducted to
study the effect of host specificity on T. gondii genotype distribution. Fourteen populations based
on animal species with more than ten isolates were selected. The significant differences were found
between certain animal populations, indicating that host specificity affected T. gondii genetic
structure. In the future, more samples from the definitive host especially cats and bobcats, are
necessary to understand the transmission dynamics of T. gondii in the environment.
The assessment of T. gondii environmental contamination on a dairy farm
This body of research aimed to develop a feasible method to evaluate environmental contamination
by T. gondii. A typical farm affiliated with the University of Tennessee at Knoxville was chosen
to perform the research. We affirmed that the soil oocyst contamination is marginal to the
sensitivity of the current detection system. The sugar floating method (Lelu et al., 2011) in
conjunction with PCR-RFLP following DNA extraction method (Silva et al., 2009) was used in
our study. As we are aware of the potential loss of oocyst during the process of DNA extraction,
we made attempts to skip the DNA extraction process. However, when DNA extraction was
omitted, issues arose from PCR contamination or PCR inhibition by soil substances (e.g., humic
acid). The low concentration of oocyst in soil is likely due to a few factors. First, the massive
nature of soil dictates that oocysts excreted by cats will be extremely diluted in the soil. In addition,
the unpredictable, harsh environmental conditions, such as desiccation and radiation from sunlight,
likely disintegrated oocyst over time. Above all, soil oocyst DNA detection offered no information
concerning the viability of oocyst, and thus bore little or no implicative values to the infection in
animals and humans. Therefore, results generated based on soil oocyst detection may be difficult
to interprete due to potential contamination. In summary, soil oocyst detection may not be a
suitable parameter for future contamination evaluation.
The focus of the research then switched to the evaluation of infection in farm animals, both
domestic and wildlife. Our study herein demonstrated that rodents had low infection rate.
However, a partition of rodent habitats was discovered as human household associated house mice
were geographically captured away from those of wild rodents. This supports the idea of two
geographically separated T. gondii transmission cycles, namely the domestic cycle and the sylvatic
cycle. The meso-predators were found to be good targets for evaluation. Raccoons and cats
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particularly have higher T. gondii infection and thus are better targets for contamination
assessment. The field trapping data had revealed that opossums were easy to trap and had high
recapture rate and thus would be a good target for assessment. However, the serological results
from opossums showed that they are all negative for T. gondii antibodies. It was hard to
comprehend as to the reasons behind the negative results although plausible speculations were
raised. Further study to isolate parasites from opossums could hopefully unravel the mystery.
In conclusion, our current study suggested that future evaluation of T. gondii environmental
contamination should target animals in the higher trophic level instead of focusing on detecting
soil oocyst and rodent infection.
The investigation of eleven fatal toxoplasmosis cases in captive macropods
Fatal toxoplasmosis occurred in 11 captive macropods in a theme park in Tampa, Florida. The 11
macropods successively succumbed to T. gondii infection over four years from 2014 to 2017.
Infection was confirmed via serology, histopathology, parasite isolation as well as PCR-RFLP
genotyping. Genotyping of these parasites either directly from animal tissues or from isolated
parasites revealed three genotypes, #2, #216 and #263. Notably, animals died in the same month
had the identical genotypes, suggesting that these animals were infected during the same
transmission event. The three disdinct genotypes indicate that at least three distinct transmission
events were responsible for these intermittent incidences.
Macropods are among the most susceptible hosts of T. gondii. The infection of macropods
in the wild is unknown as there are no wild macropods in the USA. Of the ten wallabies imported
from New Zealand, nine wallabies succumbed to acute T. gondii infection at a zoological facility
in Virginia, USA (Guthrie et al., 2017). Two genotypes were revealed, namely #4 (n=3) and #263
(n=6). The study presented herein reinforced the high mortality of acute toxoplasmosis in these
susceptible animals and accentuated oocyst-mediated transmission. It was suspected that the
seasonal heavy rainfall in the theme park likely washed oocyst down to the animal exhibit. The
exact source of infection has not been investigated. Further study to isolate oocyst from exhibit
soil for mice bioassay is likely helpful to identify the source of infection. In addition, the isolation
of parasite from feral cats (tissue or feces) roaming on the theme park premises can also aid in the
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identificating of infection source. This study also highlights the urgency of control measures to
reduce T. gondii contamination in zoos and theme parks with the presence of macropods.
The in vitro conversion of T263 from tachyzoite to bradyzoite
In this chapter, we attempted to develop a conversion approach to produce cat vaccine T263 in
vitro in hope to simplify the vaccine preparation and thus reduce its cost. The strategies we tested
included vacuum conditions and low temperature at 31°C. To evaluate the quality of treated
parasites, we used three assays, namely IFA, pepsin digestion, and mice oral infection. We
concluded that vacuum conditions were able to convert TgCkVe6 from tachyzoites to bradyzoites
but was unable to convert T263. Vacuum treated TgCkVe6 expressed BAG1 and CST1; our first
test showed that a small percentage (0.24%) of vacuum treated TgCkVe6 were pepsin resistant,
although the results were not reproductive. Low temperate at 31 °C was able to convert T263 from
tachyzoites to bradyzoites. The expression of BAG1 and CST1 were observed in converted T263.
However, the cyst walls were less intensely stained when compared to those of converted
TgCkVe6. The converted bradyzoites T263 were able to orally infect mice which demonstrate
promise for using this approach to produce T263 vaccine in vitro. Although preserved in liquid
nitrogen for four months, parasites at a dose of 2.5 ×104 cysts were still viable and infectious to
mice. The counterintuitive results were observed in freshly prepared bradyzoites. The explanation
was that the initial infection rate is low, which resulted in an inadequate number of mature
bradyzoites. A short period of CO2 outage likely adversely affected the development of
bradyzoites. Further studies should aim to optimize the protocol to minimize between-batch
inconsistency. A repeat of mice orally infection assay is required to further evaluate in vitro
produced T263 bradyzoites. Finally, a bioassay in cats is necessary to test the efficacy of the in
vitro generated T263 as a vaccine to induce immunity to oocyst shedding.
Future directions
The overarching objective of our current research to break the infection cycle of T. gondii to reduce
infection rates in humans and animals. To accomplish this, much more information of the nature
of T. gondii distribution and transmission is needed. Our contribution to this overarching effort
was to describe the genotypic distribution of T. gondii in host species in North America. Future
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study to estimate a more accurate animal home range is needed for a more precise classification of
animals into the aforementioned three categories. With the understanding of T. gondii transmission
and genetic diversity, we assessed the farm contaminant of T. gondii in attempt to establish the
baseline for contamination. Future study on a pig farm with more concentrated cats is needed to
elucidate the contamination rates in both soil and animals. For that purpose, the home range of
meso-predators need to be determined to ensure their sole association with the study farm. It’s also
imperative to re-assess the soil contamination of T. gondii, especially in areas where the presence
of cats is frequent. In addition, we developed a method to simplify a cat vaccine production. Future
study should focus on increasing the efficiency of tachyzoites to bradyzoites conversion of T263
to increase mice infection rate. Moreover, the oral infectivity of in vitro produced bradyzoites T263
needs to be tested in cats to see whether these parasites can induce immunity to oocyst shedding
in cats.
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Appendix A: IFA–the Staining of BAG1 and CST1

Reagents
1. 4% formaldehyde
2. Permeabilizing buffer: 0.5% triton: 50 µl triton in 9950 µl PBS
1g of BSA powder
3. Blocking buffer: 0.1% triton & 10% BSA in PBS

10 µl triton (× 100)
9990µl PBS

4. BAG1 antibodies (1:100): 50 µl BAG1 in 5ml blocking buffer
5. Alexa Fluor 594 conjugated goat anti-rabbit IgG (1:100): 60 µl Alexa Fluro 5945 in 6 ml
blocking buffer
6. FITC conjugated Dolichos biflorus lectin (DBL) (1:300): 20 µl DBL in 6 ml blocking
buffer
7. Glycerol
Procedure
1. Remove medium and wash cells with ice-cold PBS for three times
2. Add 1ml 4% formaldehyde into each well of a 6-well plate; incubate at RT for 30 min.
3. Wash with ice-cold PBS for three times
4. Permeate cells by adding 1ml of permeabilizing buffer into each well; incubate at RT for
20 min.
5. Wash with ice-cold PBS for three times.
6. Add blocking buffer (1ml for each well); incubate at 37 °C for 1 hour
7. Remove blocking buffer but no need for washing; add BAG1 antibodies (1:100) and
incubate at 4°C overnight.
8. The next day, wash with blocking buffer for three times.
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9. Add secondary antibodies (Alexa Fluor 594 anti-rabbit IgG) at 1:100; incubate at RT for 1
hour.
10. Wash with blocking buffer for three times
11. In each well, add 1ml DBL at 1:300 into each well and incubate for 45 min to 1 hour.
12. wash three times with blocking buffer
13. Take out coverslips, air dry, and mount them onto glass slides using glycerol
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Appendix B: Acid-pepsin Digestion of Treated and Non-treated Parasites

Reagents
1. One T25 flask of HFFs infected with treated parasites; another one with non-treated
parasites
2. 0.17 M NaCl (pH=7)
3. Syringes
4. HFFs confluent in 12-well plates
5. 0.26 mg/ml pepsin in 0.17M NaCl (pH=1.4)
6. 1.2% sodium bicarbonate (pH=8.3)
7. 70% ethanol
8. pH paper
9. 15 ml and 50 ml conical tubes
Procedure
1. Take a T25 flask of HFFs infected with either tachyzoites or in vitro produced bradyzoites;
transfer parasites into one 50-ml tube and spin down at 1500 rpm for 10 min.
2. Remove supernatant and resuspend parasites in 5 ml PBS. Syringe parasites through a 22guage needle for four times to release parasites from PVs or host cells.
3. Enumerate viable parasites by inoculating parasites into confluent HFFs in a 12-well plate.
To do that, make a ten times serial dilution (10-1 to 10-4) of the cell suspension. Inoculate
100 µl of diluted parasites at each concentration into each well of a 12-well plate.
4. Equally split parasites from one T25 into two 15-ml tubes: one will be subjected to pepsin
digestion; one will be negative control.
5. Spin down parasites to remove supernatant. Add 5ml 0.26 mg/ml pepsin in 0.170 M NaCl
(pH=1.4) into one tube and add 5ml PBS into the other tube. Incubate for 30 min at 37°C.
6. Neutralize with 1.2% sodium bicarbonate (pH=8.3). Spin down to remove supernatant.
7. Resuspend in 2 ml PBS; enumerate viable parasites as desecirbed in step 3.
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8. Change media of the 12-well plates the next day and incubate for seven days at 37°C in
5% CO2 incubator.
9. Fix cells with 70% ethanol and allow cells to air dry. Enumerate viable parasites to compare
viability.
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Appendix C: Mouse Bioassay of 31 °C Treated T263

Reagents:
1. HFFs in T25 flasks
2. T263 tachyzoites grown in HFFs
3. 15 outbred female mice (CD1) for three treatments (five per treatment)
4. Feeding tubes, 3cc syringes, marker
5. PBS
Procedure:
1. Infect two sets of three T25 flasks of HFFs with approximately 6-8 × 106 T263 tachyzoites
grown at 37 °C.
2. Place one set of three flasks into 31 °C, 5% CO2 incubator and culture for 7 to 8 days. For
the other set of three flasks of T263, keep at 37°C, 5% CO2 and passage every two days.
3. After 7 to 8 days, in 31°C treated cell culture, cysts (PVs) should be visible under
microscope, take pictures of treated T263.
4. Preserved two T25 flasks into four cryovials in liquid nitrogen (LN): scrape cells off from
each flask and collect cell suspension into a 15 ml tube. Spin down cells at 1800 rpm for
10 mins; remove the supernatant and add 1ml DMEM with 50% FBS to resuspend the
pellet, then add 1ml 20% DMSO in DMEM. Aliquot into two cryovials for each T25 flask
and put in a box with dry ice. The next day, transfer into LN. These are cryopreserved in
vitro produced bradyzoites.
5. For fresh 31°C treated cell culture, 7 to 8 days post infection, scrape cells from three flasks.
Combine, wash, and resuspend in 5 ml PBS. Count cells (a mixed population of HFF cells
with or without PVs enclosed) using hemocytometer. These are fresh in vitro produced
bradyzoites. Prepare 2.5 ×104 cysts/ml in 5ml PBS for a group of 5 mice.
6. The non-treated cell culture is passed every two days at 37 °C; Collect cell suspension and
syringe through a 22-guage needle to completely separate host cells from tachyzoites.
Enumerate tachyzoites using hemocytometer. Prepare 2.5 ×104 tachys/ml in 5 ml PBS for
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a group of 5 mice. It’s reported that at least 106 tachyzoites were required to infect a mouse
(Dubey, 1998).
7. Four vials of LN preserved in vitro produced bradyzoites are thawed at 37 °C in water bath.
Wash and resuspend in 5ml PBS. Enumerate parasites using hemocytometer. Prepare 2.5
×104 cysts/ml in 5ml PBS for a group of 5 mice. Based on published paper, 1000 mature
bradyzoites are required to infect a mouse (Fux et al., 2007).
8. Three groups of five mice are orally infected with three treatments (fresh tachyzoites, LN
preserved in vitro produced bradyzoites, and fresh in vitro produced bradyzoites) (1ml for
each mouse). Be sure to ease the feeding tube (the end tip of the feeding tube facing toward
the experimenter) into mouse digestive tube and deliver all the way down to mouse
stomach. Be careful not to puncture lung as doing so will cause immediate death of the
mouse.
9. Monitor for three weeks. The survivors are euthanized. Blood samples are taken for MAT;
brain, heart, and lung tissues are taken for PCR detection and cyst examination.
10. For cyst examination, FITC-conjugated DBL is used to stain brain homogenate.
Fluorescent microscope is used to examine cyst wall staining with DBL. Refer to DBL
staining for detailed procedure.
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Appendix D: Staining Toxo Cysts in Brain Lysates by FITC-conjugated DBL

Reagents:
1. Fixing and Permeabilizing solution- 6% formaldehyde, 0.2% trition- ×100 in PBS.
H2O

3

10 × PBS

1

10% formaldehyde

6

Triton-x 100

0.02 ml

Total

10 ml

H2O

40

10 × PBS

5

Goat serum

5 ml

2. 10% goat serum in PBS

Total

10 ml

3. FITC-conjugated DBL (Vector) stock solution (1:3 in PBS)
Procedure:
1. Prepare brain suspension in 2ml PBS by syringe pass through gauge 16 and 20 needles.
2. Add 1ml brain lysate to 1ml fixing and permeabilizing solution using a 15 ml polystyrene
centrifuge tube. Incubate for 20 min at 4 °C.
3. Spin for 10min at 1700 rpm in TC centrifuge at 4 °C.
4. Wash once with 4ml PBS/10% goat serum. Spin down tissue cysts and remove supernatant.
5. Add 2 ml 10% goat serum in PBS, 20 µl FITC-conjugated lectin stock solution (final
concentration is 1:300; 1: 1000 is okay too!) for 45 min to 1 hour.
6. Wash twice by centrifugation at 1700 rpm, 15 °C in 4 ml 10% goat serum.
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7. Resuspend cysts in 2ml PBS.
8. Place 10 µl brain suspension onto glass slide and screen under microscope.
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